Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c,Condition 2a,Condition 2b,Condition 2c,Condition 3a,Condition 3b,Condition 4,Condition 5 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0001072,WKY/NCruk,male,196 days,19,,CMO:0000004,systolic blood pressure,,,,121.8,mmHg,2.73,11.9,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11324,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0001039,WKY.SHR-(D1Wox19-D1Mit2)/Njs,male,196 days,20,,CMO:0000004,systolic blood pressure,,,,144,mmHg,1.9007,8.5,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11325,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0001041,WKY.SHR-(D1Rat56-D1M7Mit206)/Njs,male,196 days,15,,CMO:0000004,systolic blood pressure,,,,139.6,mmHg,3.0984,12.0,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11326,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0001040,WKY.SHR-(D1Rat236-D1M7Mit206)/Njs,male,196 days,15,,CMO:0000004,systolic blood pressure,,,,143.4,mmHg,2.1172,8.2,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11327,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0000753,SHR/NCruk,male,196 days,15,,CMO:0000004,systolic blood pressure,,,,205.3,mmHg,3.3049,12.8,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11328,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0000737,SHR.WKY-(D1Wox19-D1Wox34)/Njs,male,196 days,20,,CMO:0000004,systolic blood pressure,,,,187.5,mmHg,2.728,12.2,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11329,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0000740,SHR.WKY-(D1Wox34-D1Rat164)/Njs,male,196 days,18,,CMO:0000004,systolic blood pressure,,,,190.9,mmHg,2.6163,11.1,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11330,control condition,,,,,,,,, 72,"Frantz S, et al., Hypertension 2001 Aug;38(2):216-21",arterial blood pressure trait,,RS:0000741,SHR.WKY-(D1Wox34-Sah)/Njs,male,196 days,20,,CMO:0000004,systolic blood pressure,,,,179.2,mmHg,3.1529,14.1,MMO:0000011,vascular indwelling catheter method,,,beat to beat for 1 hour,,,,control condition,11331,control condition,,,,,,,,, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",arterial blood pressure trait,,RS:0000374,GH/Omr,male,143 days to 127 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,190.9,mmHg,2.1167,9.7,MMO:0000011,vascular indwelling catheter method,left femoral artery and vein,4 hrs/day for 3 days ,microrenathane catheter; recover for 1 week after surgery,,,,control condition,11522,control condition,,,,,,,,, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",arterial blood pressure trait,,RS:0001668,BN.GH-(D2Rat22-D2Mgh11)/Mcwi,male,143 days to 127 days,19,,CMO:0000004,systolic blood pressure,,,serial mean,124.6,mmHg,1.6977,7.4,MMO:0000011,vascular indwelling catheter method,left femoral artery and vein,4 hrs/day for 3 days ,microrenathane catheter; recover for 1 week after surgery,,,,control condition,11529,control condition,,,,,,,,, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",arterial blood pressure trait,,RS:0001667,BN.GH-(D6Mit12-D6Rat15)/Mcwi,male,143 days to 127 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,114.4,mmHg,2.375,9.5,MMO:0000011,vascular indwelling catheter method,left femoral artery and vein,4 hrs/day for 3 days ,microrenathane catheter; recover for 1 week after surgery,,,,control condition,11536,control condition,,,,,,,,, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",arterial blood pressure trait,,RS:0001665,BN.GH-(D18Rat41-D18Mgh4)/Mcwi,male,143 days to 127 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,116.7,mmHg,1.5057,6.9,MMO:0000011,vascular indwelling catheter method,left femoral artery and vein,4 hrs/day for 3 days ,microrenathane catheter; recover for 1 week after surgery,,,,control condition,11543,control condition,,,,,,,,, 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",arterial blood pressure trait,,RS:0000137,BN/Elh,male,143 days to 127 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,116.4,mmHg,1.7021,7.8,MMO:0000011,vascular indwelling catheter method,left femoral artery and vein,4 hrs/day for 3 days ,microrenathane catheter; recover for 1 week after surgery,,,,control condition,11550,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000817,SS/Jr,male,57 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,168,mmHg,5.1,12.4924,MMO:0000031,tail cuff plethysmography,tail,between 7 am and 12 pm,,,,,control condition,11584,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,57 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,148,mmHg,4.7,11.5126,MMO:0000031,tail cuff plethysmography,tail,between 7 am and 12 pm,,,,,control condition,11585,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000817,SS/Jr,male,85 days to 84 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,182,mmHg,4.1,10.0429,MMO:0000031,tail cuff plethysmography,tail,2 days between 7 am and 12 pm,,,,,control condition,11588,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,85 days to 84 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,187,mmHg,5.2,12.7373,MMO:0000031,tail cuff plethysmography,tail,2 days between 7 am and 12 pm,,,,,control condition,11589,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000817,SS/Jr,male,141 days to 140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,193,mmHg,10.5,25.7196,MMO:0000031,tail cuff plethysmography,tail,2 days between 7 am and 12 pm,,,,,control condition,11592,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,141 days to 140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,182,mmHg,6.9,16.9015,MMO:0000031,tail cuff plethysmography,tail,2 days between 7 am and 12 pm,,,,,control condition,11593,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000817,SS/Jr,male,183 days to 182 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,208,mmHg,4.6,11.2677,MMO:0000031,tail cuff plethysmography,tail,2 days between 7 am and 12 pm,,,,,control condition,11596,control condition,,,,,,,,, 104,"Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,183 days to 182 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,193,mmHg,9.5,23.2702,MMO:0000031,tail cuff plethysmography,tail,2 days between 7 am and 12 pm,,,,,control condition,11597,control condition,,,,,,,,, 108,"Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205",arterial blood pressure trait,,RS:0000523,LEW/NIcoCrlf,male,77 days to 70 days,5,,CMO:0000004,systolic blood pressure,,,,161,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0,,,,,physical restraint in tube type rodent restrainer,11616,physical restraint in tube type rodent restrainer,,,,,,,,, 108,"Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205",arterial blood pressure trait,,RS:0000755,SHR/NIcoCrlf,male,77 days to 70 days,12,,CMO:0000004,systolic blood pressure,,,,229,mmHg,2.0,6.9282,MMO:0000031,tail cuff plethysmography,,,,,,,physical restraint in tube type rodent restrainer,11617,physical restraint in tube type rodent restrainer,,,,,,,,, 108,"Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205",arterial blood pressure trait,,RS:0000523,LEW/NIcoCrlf,female,77 days to 70 days,6,,CMO:0000004,systolic blood pressure,,,,157,mmHg,2.0,4.899,MMO:0000031,tail cuff plethysmography,,0,,,,,physical restraint in tube type rodent restrainer,11618,physical restraint in tube type rodent restrainer,,,,,,,,, 108,"Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205",arterial blood pressure trait,,RS:0000755,SHR/NIcoCrlf,female,77 days to 70 days,12,,CMO:0000004,systolic blood pressure,,,,194,mmHg,2.0,6.9282,MMO:0000031,tail cuff plethysmography,,,,,,,physical restraint in tube type rodent restrainer,11619,physical restraint in tube type rodent restrainer,,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,128 days to 124 days,7,,CMO:0000004,systolic blood pressure,,,continuous mean,250.5,mmHg,4.1198,10.9,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,control condition,11620,control condition,,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,128 days to 124 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,197.9,mmHg,4.0417,9.9,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,control condition,11621,control condition,,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,128 days to 124 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,160.3,mmHg,3.9192,9.6,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,control condition,11622,control condition,,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,128 days to 124 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,142.1,mmHg,2.7761,6.8,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,control condition,11623,control condition,,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,140 days to 137 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,214.3,mmHg,5.8788,14.4,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11632,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,140 days to 137 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,168.7,mmHg,2.2454,5.5,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11633,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,140 days to 137 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,147.1,mmHg,3.7559,9.2,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11634,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,,,,, 111,"Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7",arterial blood pressure trait,,RS:0000556,LH/Mav,male,217 days to 203 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,174.1,mmHg,,,MMO:0000011,vascular indwelling catheter method,abdominal aorta,10800,,,,,control condition,11645,control condition,,,,,,,,, 111,"Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7",arterial blood pressure trait,,RS:0000560,LN/Mav,male,217 days to 203 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,136.4,mmHg,,,MMO:0000011,vascular indwelling catheter method,abdominal aorta,10800,,,,,control condition,11646,control condition,,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,112 days,11,,CMO:0000004,systolic blood pressure,,,,124,mmHg,1.3568,4.5,MMO:0000015,radiotelemetry,,,,,,,control condition,11651,control condition,,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001065,WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb,not specified,124 days,9,,CMO:0000004,systolic blood pressure,,,,138.3,mmHg,1.5333,4.6,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),11652,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,112 days,12,,CMO:0000004,systolic blood pressure,,,,130.7,mmHg,0.8949,3.1,MMO:0000015,radiotelemetry,,,,,,,control condition,11653,control condition,,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001066,WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb,not specified,112 days,11,,CMO:0000004,systolic blood pressure,,,,131,mmHg,1.3266,4.4,MMO:0000015,radiotelemetry,,,,,,,control condition,11654,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0002074,N:HS,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,128,mmHg,1.8878,28.0,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11669,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000154,BN/SsN,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,137,mmHg,1.0787,16.0,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11670,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000023,ACI/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,141,mmHg,0.8765,13.0,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11671,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000714,WKY/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,143,mmHg,0.7416,11.0,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11672,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000573,M520/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,121,mmHg,0.0809,1.2,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11673,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000589,MR/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,130,mmHg,0.0607,0.9,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11674,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000166,BUF/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,132,mmHg,0.0742,1.1,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11675,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0001082,WN/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,130,mmHg,0.0337,0.5,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11676,control condition,,,,,,,,, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000313,F344/NRrrc,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,149,mmHg,1.0787,16.0,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,control condition,11677,control condition,,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000004,systolic blood pressure,,,,219.6,mmHg,6.8,15.2053,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11678,control condition,,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000771,WKY/Izm,male,91 days,5,,CMO:0000004,systolic blood pressure,,,,131.8,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11679,control condition,,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,91 days,5,,CMO:0000004,systolic blood pressure,,,,181.8,mmHg,5.1,11.4039,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11680,control condition,,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000004,systolic blood pressure,,,,200.2,mmHg,8.7,19.4538,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11681,control condition,,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,female,91 days,5,,CMO:0000004,systolic blood pressure,,,,157,mmHg,7.6,16.9941,MMO:0000031,tail cuff plethysmography,,,,,0,,control condition,11682,control condition,,,,,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",arterial blood pressure trait,,RS:0000771,WKY/Izm,female,91 days,5,,CMO:0000004,systolic blood pressure,,,,127,mmHg,5.0,11.1803,MMO:0000031,tail cuff plethysmography,,0,,,0,,control condition,11683,control condition,,,,,,,,, 116,"Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,0 days,8,,CMO:0000004,systolic blood pressure,,,,120.1,mmHg,0.9546,2.7,MMO:0000015,radiotelemetry,,,,,,,control condition,11684,control condition,,,,,,,,, 116,"Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82",arterial blood pressure trait,,RS:0001064,WKY.SHRSP-(Asgr1-Vamp2)/Bbb,not specified,0 days,9,,CMO:0000004,systolic blood pressure,,,,124.3,mmHg,1.3,3.9,MMO:0000015,radiotelemetry,,,,,,,control condition,11685,control condition,,,,,,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",arterial blood pressure trait,,RS:0000744,SHR/FubRkb,not specified,173 days,10,,CMO:0000004,systolic blood pressure,,,,175.3,mmHg,2.8,8.8544,MMO:0000053,tail cuff piezoplethysmography,,0.0,12-18 recordings on 3 consecutive days,,,,control condition,11688,control condition,,,,,,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",arterial blood pressure trait,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,173 days,19,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.6,6.9742,MMO:0000053,tail cuff piezoplethysmography,,0.0,12-18 recordings on 3 consecutive days,,,,control condition,11689,control condition,,,,,,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",arterial blood pressure trait,,RS:0000596,MWF/FubRkb,not specified,173 days,18,,CMO:0000004,systolic blood pressure,,,,145.1,mmHg,1.1,4.6669,MMO:0000053,tail cuff piezoplethysmography,,0.0,12-18 recordings on 3 consecutive days,,,,control condition,11690,control condition,,,,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000786,SR/Jr,male,77 days to 70 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,144,mmHg,4.0,10.583,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min nightly for a week,,,,controlled sodium content diet (8 %) (between 48 and 55 days) then controlled exposure to darkness,11695,controlled sodium content diet (8 %) (between 48 and 55 days),,,controlled exposure to darkness,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000786,SR/Jr,male,77 days to 70 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,4.0,10.583,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min daily for a week,,,,controlled sodium content diet (8 %) (between 48 and 55 days) then controlled exposure to ambient light,11696,controlled sodium content diet (8 %) (between 48 and 55 days),,,controlled exposure to ambient light,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000786,SR/Jr,female,63 days to 56 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,2.0,5.6569,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min nightly for a week,,,,controlled sodium content diet (8 %) (between 62 and 69 days) then controlled exposure to darkness,11699,controlled sodium content diet (8 %) (between 62 and 69 days),,,controlled exposure to darkness,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000786,SR/Jr,female,63 days to 56 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,124,mmHg,2.0,5.6569,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min daily for a week,,,,controlled sodium content diet (8 %) (between 62 and 69 days) then controlled exposure to ambient light,11700,controlled sodium content diet (8 %) (between 62 and 69 days),,,controlled exposure to ambient light,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,male,77 days to 70 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,136,mmHg,1.0,2.8284,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min nightly for a week,,,,controlled sodium content diet (8 %) (between 48 and 55 days) then controlled exposure to darkness,11703,controlled sodium content diet (8 %) (between 48 and 55 days),,,controlled exposure to darkness,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,male,77 days to 70 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,1.0,2.8284,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min daily for a week,,,,controlled sodium content diet (8 %) (between 48 and 55 days) then controlled exposure to ambient light,11704,controlled sodium content diet (8 %) (between 48 and 55 days),,,controlled exposure to ambient light,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,female,63 days to 56 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,122,mmHg,2.0,5.6569,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min nightly for a week,,,,controlled sodium content diet (8 %) (between 62 and 69 days) then controlled exposure to darkness,11707,controlled sodium content diet (8 %) (between 62 and 69 days),,,controlled exposure to darkness,,,,,, 119,"St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,female,63 days to 56 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,118,mmHg,2.0,5.6569,MMO:0000070,intra-aortic abdominal radiotelemetry,,604800.0,5 s every 5 min daily for a week,,,,controlled sodium content diet (8 %) (between 62 and 69 days) then controlled exposure to ambient light,11708,controlled sodium content diet (8 %) (between 62 and 69 days),,,controlled exposure to ambient light,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",arterial blood pressure trait,,RS:0000397,HTG,male,181 days to 151 days,10,,CMO:0000004,systolic blood pressure,,,,156.4,mmHg,2.1,6.6408,MMO:0000011,vascular indwelling catheter method,carotid artery and jugular vein,,polyethylene catheter,,,,control condition,11711,control condition,,,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",arterial blood pressure trait,,RS:0000397,HTG,female,181 days to 151 days,10,,CMO:0000004,systolic blood pressure,,,,149.3,mmHg,2.7,8.5381,MMO:0000011,vascular indwelling catheter method,carotid artery and jugular vein,,polyethylene catheter,,,,control condition,11713,control condition,,,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",arterial blood pressure trait,,RS:0000121,LEW,male,181 days to 151 days,9,,CMO:0000004,systolic blood pressure,,,,124.3,mmHg,3.9,11.7,MMO:0000011,vascular indwelling catheter method,carotid artery and jugular vein,,polyethylene catheter,,,,control condition,11715,control condition,,,,,,,,, 120,"Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47.",arterial blood pressure trait,,RS:0000121,LEW,female,181 days to 151 days,12,,CMO:0000004,systolic blood pressure,,,,138.8,mmHg,2.8,9.6995,MMO:0000011,vascular indwelling catheter method,carotid artery and jugular vein,,polyethylene catheter,,,,control condition,11717,control condition,,,,,,,,, 121,"Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6",arterial blood pressure trait,,RS:0000559,LN/MavRrrc,not specified,217 days to 203 days,15,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,1.6783,6.5,MMO:0000011,vascular indwelling catheter method,abdominal aorta,3600,,,,,control condition,11719,control condition,,,,,,,,, 121,"Vincent M, et al., J Clin Invest 1997 Oct 15;100(8):2000-6",arterial blood pressure trait,,RS:0000554,LH/MavRrrc,not specified,217 days to 203 days,17,,CMO:0000004,systolic blood pressure,,,serial mean,173,mmHg,2.1828,9.0,MMO:0000011,vascular indwelling catheter method,abdominal aorta,3600,,,,,control condition,11720,control condition,,,,,,,,, 122,"Zagato et al., 2000, Hypertension, 36(5), 734-9",arterial blood pressure trait,,RS:0000581,MNS/Gib,not specified,112 days,14,,CMO:0000004,systolic blood pressure,,,continuous mean,138.3,mmHg,2.8,10.4766,MMO:0000011,vascular indwelling catheter method,carotid artery,1 min tracing every 3-4 min for 1 h,Gould BS3200 BP recorder,,,,control condition,11723,control condition,,,,,,,,, 122,"Zagato et al., 2000, Hypertension, 36(5), 734-9",arterial blood pressure trait,,RS:0000581,MNS/Gib,not specified,112 days to 84 days,17,,CMO:0000004,systolic blood pressure,,,serial mean,131.2,mmHg,1.1,4.5354,MMO:0000053,tail cuff piezoplethysmography,,4 readingsin 4 sessions,W+W BP recorder,,,,control condition,11725,control condition,,,,,,,,, 122,"Zagato et al., 2000, Hypertension, 36(5), 734-9",arterial blood pressure trait,,RS:0000578,MHS/Gib,not specified,112 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,163.7,mmHg,1.9,8.9118,MMO:0000011,vascular indwelling catheter method,carotid artery,1 min tracing every 3-4 min for 1 h,Gould BS3200 BP recorder,,,,control condition,11726,control condition,,,,,,,,, 122,"Zagato et al., 2000, Hypertension, 36(5), 734-9",arterial blood pressure trait,,RS:0000578,MHS/Gib,not specified,112 days to 84 days,23,,CMO:0000004,systolic blood pressure,,,serial mean,169.4,mmHg,1.0,4.7958,MMO:0000053,tail cuff piezoplethysmography,,4 readingsin 4 sessions,W+W BP recorder,,,,control condition,11728,control condition,,,,,,,,, 145,"Cicila GT, et al., Mamm Genome 1999 Feb;10(2):112-6.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,65 days to 61 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 sessions ,serial mean,202.7,mmHg,3.7,16.5469,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (between 24 and 28 days),11775,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 145,"Cicila GT, et al., Mamm Genome 1999 Feb;10(2):112-6.",arterial blood pressure trait,,RS:0001562,SS.SR-(D3Mco19-D3Mco5)/Jr,male,65 days to 61 days,19,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 sessions ,serial mean,181.3,mmHg,2.2,9.5896,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (between 24 and 28 days),11776,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,100 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,244,mmHg,6.2,28.412,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days),11781,controlled sodium content diet (1 %) (for 30 days),,,controlled sodium content diet (0.2 %) (for 40 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000909,SS.SR-(Cyp11b1)/Jr,male,100 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,200.3,mmHg,6.0,24.0,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days),11782,controlled sodium content diet (1 %) (for 30 days),,,controlled sodium content diet (0.2 %) (for 40 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,61 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,199.3,mmHg,7.5,33.541,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 24 days),11787,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000909,SS.SR-(Cyp11b1)/Jr,male,61 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,4.3,19.2302,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 24 days),11788,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,79 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,231.4,mmHg,7.2,32.1994,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 42 days),11789,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000909,SS.SR-(Cyp11b1)/Jr,male,79 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,198.1,mmHg,5.7,25.4912,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 42 days),11790,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,61 days,22,,CMO:0000004,systolic blood pressure,,,serial mean,264,mmHg,5.5,25.7973,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (4 %) (for 24 days),11791,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000817,SS/Jr,female,61 days,24,,CMO:0000004,systolic blood pressure,,,serial mean,250.1,mmHg,4.9,24.005,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (4 %) (for 24 days),11792,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000909,SS.SR-(Cyp11b1)/Jr,male,61 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,200.9,mmHg,8.2,27.1963,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (4 %) (for 24 days),11793,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 146,"Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902.",arterial blood pressure trait,,RS:0000909,SS.SR-(Cyp11b1)/Jr,female,61 days,12,,CMO:0000004,systolic blood pressure,,,serial mean,215.5,mmHg,8.5,29.4449,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (4 %) (for 24 days),11794,controlled sodium content diet (0.2 %) (for 7 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,224.9,mmHg,4.8,21.4663,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11795,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0002420,SS.SR-(D7Rat16-D7Mgh5)/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,210.5,mmHg,2.8,12.522,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11796,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,243.4,mmHg,4.0,17.8885,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11801,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0002421,SS.SR-(D7Rat16-D7Rat189)/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,219,mmHg,3.4,15.2053,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11802,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,230.6,mmHg,4.7,21.019,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11807,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0002422,SS.SR-(D7Mco7-D7Rat81)/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,228.8,mmHg,2.4,10.7331,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11808,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,235.1,mmHg,4.6,20.5718,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11813,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000912,SS.SR-(D7Uia1-D7Mco7)/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,205,mmHg,1.8,8.0498,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11814,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,232.7,mmHg,3.2,14.3108,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11819,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000911,SS.SR-(D7Mco7-D7Wox19)/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,209,mmHg,2.2,9.8387,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11820,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,19,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,221.8,mmHg,2.9,12.6408,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11825,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 147,"Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60.",arterial blood pressure trait,,RS:0002423,SS.SR-(D7Rat16-D7Rat176)/Jr,male,70 days to 68 days,19,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,223.7,mmHg,4.0,17.4356,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days),11826,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,68 days to 64 days,18,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,217,mmHg,4.0,16.9706,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11831,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000888,SS.MNS-(D10Mco14-D10Mit11)/Jr,not specified,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,175,mmHg,1.7,7.6026,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11832,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000892,SS.MNS-(D10M11Mit119-D10Mit11)/Jr,not specified,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,182,mmHg,2.2,9.8387,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11833,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,205,mmHg,2.9,12.9692,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11837,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000893,SS.MNS-(D10Mco10-Aldoc)/Jr,not specified,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,214,mmHg,3.6,16.0997,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11838,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,68 days to 64 days,41,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,205,mmHg,2.6,16.6481,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11841,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 148,"Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35.",arterial blood pressure trait,,RS:0000895,SS.MNS-(Aldoc-D10Mco1)/Jr,not specified,68 days to 64 days,38,,CMO:0000004,systolic blood pressure,,average of 12 readings from 4 daily sessions ,serial mean,210,mmHg,2.7,16.6439,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (2 %) (between 25 and 28 days),11842,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 150,"Rapp JP, et al., J Clin Invest 1998 Apr 15;101(8):1591-5.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,76 days to 70 days,24,,CMO:0000004,systolic blood pressure,,,serial mean,217,mmHg,3.4,16.6565,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (between 15 and 18 days) then controlled sodium content diet (2 %) (between 25 and 28 days),11845,controlled sodium content diet (0.2 %) (between 15 and 18 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 150,"Rapp JP, et al., J Clin Invest 1998 Apr 15;101(8):1591-5.",arterial blood pressure trait,,RS:0000919,SS.WKY-(D2N35-Mme)/Mco,male,76 days to 70 days,24,,CMO:0000004,systolic blood pressure,,,serial mean,185,mmHg,1.8,8.8182,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (between 15 and 18 days) then controlled sodium content diet (2 %) (between 25 and 28 days),11846,controlled sodium content diet (0.2 %) (between 15 and 18 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 150,"Rapp JP, et al., J Clin Invest 1998 Apr 15;101(8):1591-5.",arterial blood pressure trait,,RS:0000892,SS.MNS-(D10M11Mit119-D10Mit11)/Jr,male,76 days to 70 days,24,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,1.9,9.3081,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (between 15 and 18 days) then controlled sodium content diet (2 %) (between 25 and 28 days),11847,controlled sodium content diet (0.2 %) (between 15 and 18 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 150,"Rapp JP, et al., J Clin Invest 1998 Apr 15;101(8):1591-5.",arterial blood pressure trait,,RS:0000920,"SS.WKY-(D2N35-Mme),MNS-(D10Mit11-D10M11Mit119)/Mco",male,76 days to 70 days,24,,CMO:0000004,systolic blood pressure,,,serial mean,170,mmHg,1.4,6.8586,MMO:0000031,tail cuff plethysmography,,,,,,,controlled sodium content diet (0.2 %) (between 15 and 18 days) then controlled sodium content diet (2 %) (between 25 and 28 days),11848,controlled sodium content diet (0.2 %) (between 15 and 18 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,female,92 days to 89 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,4.0,18.3303,MMO:0000011,vascular indwelling catheter method,left femoral artery,,"3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day",,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),11849,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,female,92 days to 89 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,197,mmHg,7.0,32.078,MMO:0000011,vascular indwelling catheter method,left femoral artery,,"3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day",,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),11850,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 206,"Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46",arterial blood pressure trait,,RS:0000742,WKY,male,175 days,24,,CMO:0000004,systolic blood pressure,,,continuous mean,167.3,mmHg,2.3678,11.6,MMO:0000011,vascular indwelling catheter method,aorta,,,,,,control condition,11901,control condition,,,,,,,,, 206,"Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46",arterial blood pressure trait,,RS:0000015,SHR,male,175 days,28,,CMO:0000004,systolic blood pressure,,,continuous mean,232.2,mmHg,2.2867,12.1,MMO:0000011,vascular indwelling catheter method,aorta,,,,,,control condition,11903,control condition,,,,,,,,, 206,"Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46",arterial blood pressure trait,,RS:0001039,WKY.SHR-(D1Wox19-D1Mit2)/Njs,male,175 days,29,,CMO:0000004,systolic blood pressure,,,continuous mean,178.8,mmHg,2.3212,12.5,MMO:0000011,vascular indwelling catheter method,aorta,,,,,,control condition,11905,control condition,,,,,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,197,mmHg,3.74,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11907,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 206,"Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46",arterial blood pressure trait,,RS:0000737,SHR.WKY-(D1Wox19-D1Wox34)/Njs,male,175 days,31,,CMO:0000004,systolic blood pressure,,,continuous mean,220.9,mmHg,2.5684,14.3,MMO:0000011,vascular indwelling catheter method,aorta,,,,,,control condition,11908,control condition,,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,63 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,1.9,6.0083,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 28 days),11910,controlled sodium content diet (0.2 %) (for 28 days),,,,,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,204,mmHg,3.72,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11911,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,198,mmHg,3.62,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11912,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,221,mmHg,3.95,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11913,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0001520,SS.LEW-(D10Mco113-D10Got93)/Mco,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,199,mmHg,2.04,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11915,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0001526,SS.LEW-(D10Mco84-D10Mco134)/Mco,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,187,mmHg,2.67,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11916,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0001527,SS.LEW-(D10Mco84-D10Mco143)/Mco,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,194,mmHg,4.18,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11917,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0001528,SS.LEW-(D10Mco84-D10Rat58)/Mco,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,236,mmHg,4.7,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11918,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0001525,SS.LEW-(D10Mco84-D10Mco129)/Mco,male,66 days to 64 days,N/A,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,213,mmHg,5.37,,MMO:0000031,tail cuff plethysmography,,,warm up to 28 C,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),11919,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 229,"Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,94 days to 91 days,35,,CMO:0000004,systolic blood pressure,,,continuous mean,206,mmHg,6.0,35.4965,MMO:0000011,vascular indwelling catheter method,femoral artery,259200.0,3 h per day,,,,controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours),11984,controlled sodium content diet (0.1 %) (for 28 days),,,controlled sodium content diet (8 %) (for 31 days),controlled exposure to ambient light (for 12 hours),,,,, 229,"Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,male,94 days to 91 days,42,,CMO:0000004,systolic blood pressure,,,continuous mean,127,mmHg,3.0,19.4422,MMO:0000011,vascular indwelling catheter method,femoral artery,259200.0,3 h per day,,,,controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours),12006,controlled sodium content diet (0.1 %) (for 28 days),,,controlled sodium content diet (8 %) (for 31 days),controlled exposure to ambient light (for 12 hours),,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0000817,SS/Jr,male,84 days to 81 days,9,,CMO:0000004,systolic blood pressure,,recorded every 5 minutes for 4 days,,213,mmHg,7.47,22.41,MMO:0000070,intra-aortic abdominal radiotelemetry,aorta,345600.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 42 days),12072,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 205,"Saad Y, et al., Hypertension. 2007",arterial blood pressure trait,,RS:0001526,SS.LEW-(D10Mco84-D10Mco134)/Mco,male,84 days to 81 days,8,,CMO:0000004,systolic blood pressure,,recorded every 5 minutes for 4 days,,188,mmHg,4.27,12.0774,MMO:0000070,intra-aortic abdominal radiotelemetry,aorta,345600.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 42 days),12075,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 231,"Deng AY, et al., Hypertension 1997 Aug;30(2 Pt 1):199-202",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 65 days,24,,CMO:0000004,systolic blood pressure,,,,205.8,mmHg,3.91,19.155,MMO:0000052,tail cuff photoplethysmography,tail,,"average of 4 days, 3 to 4 consistent readings each day, IITC",,,,controlled sodium content diet (2 %) (between 25 and 28 days),12093,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 231,"Deng AY, et al., Hypertension 1997 Aug;30(2 Pt 1):199-202",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 65 days,21,,CMO:0000004,systolic blood pressure,,,,209.8,mmHg,4.11,18.8344,MMO:0000052,tail cuff photoplethysmography,tail,,"average of 4 days, 3 to 4 consistent readings each day, IITC",,,,controlled sodium content diet (2 %) (between 25 and 28 days),12099,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 231,"Deng AY, et al., Hypertension 1997 Aug;30(2 Pt 1):199-202",arterial blood pressure trait,,RS:0000919,SS.WKY-(D2N35-Mme)/Mco,male,68 days to 65 days,27,,CMO:0000004,systolic blood pressure,,,,161.9,mmHg,2.45,12.7306,MMO:0000052,tail cuff photoplethysmography,tail,,"average of 4 days, 3 to 4 consistent readings each day, IITC",,,,controlled sodium content diet (2 %) (between 25 and 28 days),12105,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 231,"Deng AY, et al., Hypertension 1997 Aug;30(2 Pt 1):199-202",arterial blood pressure trait,,RS:0000886,SS.MNS-(Adh1-D2Mit5)/Mco,male,68 days to 65 days,20,,CMO:0000004,systolic blood pressure,,,,181.1,mmHg,1.9,8.4971,MMO:0000052,tail cuff photoplethysmography,tail,,"average of 4 days, 3 to 4 consistent readings each day, IITC",,,,controlled sodium content diet (2 %) (between 25 and 28 days),12108,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,204,mmHg,2.84,12.7009,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12127,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,209,mmHg,3.51,15.6972,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12128,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,195,mmHg,3.35,14.9817,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12129,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,210,mmHg,4.6,20.5718,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12130,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0000817,SS/Jr,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,198,mmHg,3.96,17.7097,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12131,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001551,SS.MNS-(D10Mco62-D10Mco30)/Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,180,mmHg,2.86,12.7903,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12132,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001550,SS.MNS-(D10Mco62-D10Got99)/Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,197,mmHg,3.04,13.5953,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12134,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001545,SS.MNS-(D10Mco30-D10Got112)/Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,190,mmHg,2.55,11.4039,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12135,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001544,SS.MNS-(D10Mco30-D10Got101)/Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,190,mmHg,2.4,10.7331,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12137,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001546,SS.MNS-(D10Mco30-D10Got91)/1Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,206,mmHg,5.06,22.629,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12138,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001547,SS.MNS-(D10Mco30-D10Got91)/2Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,201,mmHg,2.71,12.1195,MMO:0000031,tail cuff plethysmography,tail,345600,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12139,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 232,"Saad Y, et al., Mamm Genome. 2008 Jan 4",arterial blood pressure trait,,RS:0001548,SS.MNS-(D10Mco30-D10Got91)/3Mco,male,68 days to 64 days,20,,CMO:0000004,systolic blood pressure,,Average of 3-4 consistent measurements taken each day over 4 consecutive days,,193,mmHg,3.5,15.6525,MMO:0000031,tail cuff plethysmography,tail,345600.0,warm up to 28 C,,,,controlled sodium content diet (2 %) (for 24 days),12140,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,91 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,2.2,6.957,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 56 days),12164,controlled sodium content diet (0.2 %) (for 56 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,147 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,3.1,9.8031,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 112 days),12165,controlled sodium content diet (0.2 %) (for 112 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,203 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,3.2,10.1193,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 168 days),12166,controlled sodium content diet (0.2 %) (for 168 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,63 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,150,mmHg,3.5,11.068,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days),12167,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 28 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,91 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,159,mmHg,2.0,6.3246,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 56 days),12168,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 56 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,147 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,150,mmHg,2.3,7.2732,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 112 days),12169,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 112 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000786,SR/Jr,male,203 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,4.0,12.6491,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days),12170,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 168 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,63 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,1.8,5.0912,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 28 days),12171,controlled sodium content diet (0.2 %) (for 28 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,91 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,3.3,9.3338,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 56 days),12172,controlled sodium content diet (0.2 %) (for 56 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,147 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,5.1,14.425,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 112 days),12173,controlled sodium content diet (0.2 %) (for 112 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,203 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,3.3,9.3338,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 168 days),12174,controlled sodium content diet (0.2 %) (for 168 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,63 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,4.4,12.4451,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days),12175,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 28 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,91 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,4.5,12.7279,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 56 days),12176,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 56 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,147 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,2.6,7.3539,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 112 days),12177,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 112 days),,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000520,LEW/NCrl,male,203 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,2.5,7.0711,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days),12178,controlled sodium content diet (0.2 %) (for 5 days),,,controlled sodium content diet (8 %) (for 168 days),,,,,, 235,"McBride MW, et al., Hypertension 2003 Mar;41(3 Pt 2):847-53.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,not specified,112 days to 91 days,9,,CMO:0000004,systolic blood pressure,,,continuous mean,198,mmHg,6.1,18.3,MMO:0000015,radiotelemetry,abdominal aorta,1814400,"implanted at 84 days with 7 day recovery, 21 days of readings, killed after 112 days; Dataquest IV telemetry system (Data Sciences International)",,,,control condition,12227,control condition,,,,,,,,, 235,"McBride MW, et al., Hypertension 2003 Mar;41(3 Pt 2):847-53.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,not specified,112 days to 91 days,8,,CMO:0000004,systolic blood pressure,,,continuous mean,140,mmHg,2.7,7.6368,MMO:0000015,radiotelemetry,abdominal aorta,1814400,"implanted at 84 days with 7 day recovery, 21 days of readings, killed after 112 days; Dataquest IV telemetry system (Data Sciences International)",,,,control condition,12229,control condition,,,,,,,,, 235,"McBride MW, et al., Hypertension 2003 Mar;41(3 Pt 2):847-53.",arterial blood pressure trait,,RS:0000768,SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc,not specified,112 days to 91 days,11,,CMO:0000004,systolic blood pressure,,,continuous mean,172,mmHg,3.8,12.6032,MMO:0000015,radiotelemetry,abdominal aorta,1814400,"implanted at 84 days with 7 day recovery, 21 days of readings, killed after 112 days; Dataquest IV telemetry system (Data Sciences International)",,,,control condition,12231,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12233,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,139,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12234,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,197,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12236,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,194,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12237,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12238,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,125,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12239,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12240,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12241,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002110,SBH.SBN-(D1Mgh2-D1Rat101)/Ygl,male,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,2.0,5.2915,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12242,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002110,SBH.SBN-(D1Mgh2-D1Rat101)/Ygl,female,0 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.3166,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12243,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002110,SBH.SBN-(D1Mgh2-D1Rat101)/Ygl,male,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,181,mmHg,7.0,18.5203,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12244,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002110,SBH.SBN-(D1Mgh2-D1Rat101)/Ygl,female,0 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,4.0,13.2665,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12245,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002114,SBH.SBN-(D1Wox11-D1Rat137)/Ygl,male,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12246,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002114,SBH.SBN-(D1Wox11-D1Rat137)/Ygl,female,0 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,1.0,2.4495,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12247,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002114,SBH.SBN-(D1Wox11-D1Rat137)/Ygl,male,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,172,mmHg,7.0,21.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12248,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002114,SBH.SBN-(D1Wox11-D1Rat137)/Ygl,female,0 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,162,mmHg,6.0,14.6969,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12249,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002113,SBH.SBN-(D1Rat137-D1Rat83)/Ygl,male,0 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,2.0,4.899,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12250,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002113,SBH.SBN-(D1Rat137-D1Rat83)/Ygl,female,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,1.0,2.6458,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12251,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002113,SBH.SBN-(D1Rat137-D1Rat83)/Ygl,male,0 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,167,mmHg,4.0,9.798,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12253,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002113,SBH.SBN-(D1Rat137-D1Rat83)/Ygl,female,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,173,mmHg,3.0,7.9373,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12256,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002112,SBH.SBN-(D1Rat137-D1Rat123)/Ygl,male,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,1.0,3.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12258,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002112,SBH.SBN-(D1Rat137-D1Rat123)/Ygl,female,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,1.0,3.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12263,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002112,SBH.SBN-(D1Rat137-D1Rat123)/Ygl,male,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,169,mmHg,8.0,24.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12264,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002112,SBH.SBN-(D1Rat137-D1Rat123)/Ygl,female,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,162,mmHg,6.0,18.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12265,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002108,SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12266,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002108,SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl,female,0 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,4.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12267,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002108,SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,163,mmHg,5.0,18.0278,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12268,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002108,SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl,female,0 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,3.0,12.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12269,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002111,SBH.SBN-(D1Mgh2-D1Rat74)/Ygl,male,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12270,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002111,SBH.SBN-(D1Mgh2-D1Rat74)/Ygl,female,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12271,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002111,SBH.SBN-(D1Mgh2-D1Rat74)/Ygl,male,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,158,mmHg,4.0,14.9666,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12272,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002111,SBH.SBN-(D1Mgh2-D1Rat74)/Ygl,female,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,154,mmHg,5.0,18.0278,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12273,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002119,SBN.SBH-(D1Rat27-D1Mit7)/Ygl,male,0 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.1623,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12276,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002119,SBN.SBH-(D1Rat27-D1Mit7)/Ygl,female,0 days,5,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.2361,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12278,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002119,SBN.SBH-(D1Rat27-D1Mit7)/Ygl,male,0 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,2.0,6.3246,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12280,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002119,SBN.SBH-(D1Rat27-D1Mit7)/Ygl,female,0 days,5,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,2.2361,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12289,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002117,SBN.SBH-(D1Rat101-D1Rat74)/Ygl,male,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,1.0,2.6458,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12290,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002117,SBN.SBH-(D1Rat101-D1Rat74)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12292,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002117,SBN.SBH-(D1Rat101-D1Rat74)/Ygl,male,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,1.0,2.6458,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12293,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002117,SBN.SBH-(D1Rat101-D1Rat74)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12294,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002116,SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl,male,0 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.3166,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12295,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002116,SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12298,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002116,SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl,male,0 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.3166,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12300,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002116,SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12301,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002118,SBN.SBH-(D1Rat148-D1Rat89)/Ygl,male,0 days,12,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.4641,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12303,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002118,SBN.SBH-(D1Rat148-D1Rat89)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,control condition,12304,control condition,,,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002118,SBN.SBH-(D1Rat148-D1Rat89)/Ygl,male,0 days,12,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.4641,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12306,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002118,SBN.SBH-(D1Rat148-D1Rat89)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12308,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,231,mmHg,3.3,14.758,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12450,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,202,mmHg,1.72,7.6921,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12451,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,209,mmHg,2.97,13.2822,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12452,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,222,mmHg,3.7,16.5469,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12453,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,221,mmHg,3.44,15.3841,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12454,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,218,mmHg,3.83,17.1283,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12455,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,235,mmHg,4.8,21.4663,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12456,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,209,mmHg,3.26,14.5792,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12457,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,191,mmHg,3.48,15.563,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12459,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000863,SS.LEW-(D1Mco2-D1Rat49)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.47,6.574,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12460,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000829,SS.LEW-(D1Mco87-D1Rat71)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,207,mmHg,2.87,12.835,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12461,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000831,SS.LEW-(D1Rat35-D1Rat49)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,195,mmHg,2.87,12.835,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12462,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000830,SS.LEW-(D1Mco36-D1Rat49)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,188,mmHg,3.08,13.7742,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12463,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000827,SS.LEW-(D1Mco38-D1Rat49)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,181,mmHg,3.03,13.5506,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12464,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000828,SS.LEW-(D1Uia2-D1Rat49)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,187,mmHg,2.42,10.8226,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12465,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000825,SS.LEW-(D1Rat196-D1Mgh7)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,212,mmHg,4.63,20.706,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12467,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000824,SS.LEW-(D1Rat196-D1Mco36)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,183,mmHg,2.25,10.0623,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12469,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000871,SS.LEW-(D1Uia8-D1Mco38)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,205,mmHg,1.76,7.871,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12470,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0000865,SS.LEW-(D1Uia8-D1Rat18)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,191,mmHg,2.24,10.0176,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12471,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0002424,SS.LEW-(D1Uia8-D1Rat124)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,195,mmHg,1.7,7.6026,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12473,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 266,"Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14.",arterial blood pressure trait,,RS:0002425,SS.LEW-(D1Uia8-D1Rat213)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,,169,mmHg,2.6,11.6276,MMO:0000031,tail cuff plethysmography,,,average of 3-4 consistent readings,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),12475,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",arterial blood pressure trait,,RS:0000759,SHRSP,male,91 days,4,,CMO:0000004,systolic blood pressure,,average of 3 consistent readings,serial mean,219.5,mmHg,7.65,15.3,MMO:0000052,tail cuff photoplethysmography,,0,UR1000; Ueda,,,,controlled sodium content diet (0.4 %) (for 63 days),12556,controlled sodium content diet (0.4 %) (for 63 days),,,,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",arterial blood pressure trait,,RS:0000759,SHRSP,female,91 days,4,,CMO:0000004,systolic blood pressure,,average of 3 consistent readings,serial mean,200.1,mmHg,9.8,19.6,MMO:0000052,tail cuff photoplethysmography,,0,UR1000; Ueda,,,,controlled sodium content diet (0.4 %) (for 63 days),12560,controlled sodium content diet (0.4 %) (for 63 days),,,,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",arterial blood pressure trait,,RS:0000015,SHR,male,91 days,4,,CMO:0000004,systolic blood pressure,,average of 3 consistent readings,serial mean,181.8,mmHg,1.75,3.5,MMO:0000052,tail cuff photoplethysmography,,0,UR1000; Ueda,,,,controlled sodium content diet (0.4 %) (for 63 days),12582,controlled sodium content diet (0.4 %) (for 63 days),,,,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",arterial blood pressure trait,,RS:0000015,SHR,female,91 days,4,,CMO:0000004,systolic blood pressure,,average of 3 consistent readings,serial mean,152.2,mmHg,6.0,12.0,MMO:0000052,tail cuff photoplethysmography,,0,UR1000; Ueda,,,,controlled sodium content diet (0.4 %) (for 63 days),12583,controlled sodium content diet (0.4 %) (for 63 days),,,,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",arterial blood pressure trait,,RS:0000742,WKY,male,91 days,4,,CMO:0000004,systolic blood pressure,,average of 3 consistent readings,serial mean,131.7,mmHg,2.25,4.5,MMO:0000052,tail cuff photoplethysmography,,0,UR1000; Ueda,,,,controlled sodium content diet (0.4 %) (for 63 days),12584,controlled sodium content diet (0.4 %) (for 63 days),,,,,,,,, 268,"Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81.",arterial blood pressure trait,,RS:0000742,WKY,female,91 days,4,,CMO:0000004,systolic blood pressure,,average of 3 consistent readings,serial mean,127,mmHg,5.75,11.5,MMO:0000052,tail cuff photoplethysmography,,0,UR1000; Ueda,,,,controlled sodium content diet (0.4 %) (for 63 days),12585,controlled sodium content diet (0.4 %) (for 63 days),,,,,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001601,WKY/Bbb,male,124 days to 110 days,20,,CMO:0000004,systolic blood pressure,,,,126.13,mmHg,0.55,2.4597,MMO:0000070,intra-aortic abdominal radiotelemetry,,0,,,,,controlled sodium content drinking water (1 %) (for 12 days),12654,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001046,WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb,male,124 days to 110 days,12,,CMO:0000004,systolic blood pressure,,,,128.65,mmHg,1.22,4.2262,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12657,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001044,WKY.SHRSP-(Shbg-Atp1b2)/Bbb,male,124 days to 110 days,33,,CMO:0000004,systolic blood pressure,,,,129.42,mmHg,0.85,4.8829,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12659,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001045,WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb,male,124 days to 110 days,10,,CMO:0000004,systolic blood pressure,,,,136.96,mmHg,1.91,6.04,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12661,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,60 days to 42 days,15,,CMO:0000004,systolic blood pressure,,,,173.5,mmHg,4.0,15.4919,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 17 and 18 days),12664,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 17 and 18 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,69 days to 42 days,15,,CMO:0000004,systolic blood pressure,,,,181.9,mmHg,4.1,15.8792,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 26 and 27 days),12665,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 26 and 27 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,60 days to 42 days,15,,CMO:0000004,systolic blood pressure,,,,154.7,mmHg,1.7,6.5841,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 17 and 18 days),12666,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 17 and 18 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,69 days to 42 days,15,,CMO:0000004,systolic blood pressure,,,,160.5,mmHg,2.3,8.9079,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 26 and 27 days),12668,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 26 and 27 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,60 days to 42 days,16,,CMO:0000004,systolic blood pressure,,,,152.7,mmHg,2.6,10.4,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 17 and 18 days),12670,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 17 and 18 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,69 days to 42 days,16,,CMO:0000004,systolic blood pressure,,,,157.8,mmHg,3.2,12.8,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 26 and 27 days),12672,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 26 and 27 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002208,SS.SR-(D7Mco19-D7Mco7)/Jr,male,60 days to 42 days,14,,CMO:0000004,systolic blood pressure,,,,160.5,mmHg,3.0,11.225,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 17 and 18 days),12676,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 17 and 18 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002208,SS.SR-(D7Mco19-D7Mco7)/Jr,male,69 days to 42 days,14,,CMO:0000004,systolic blood pressure,,,,170.8,mmHg,3.3,12.3475,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 26 and 27 days),12678,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 26 and 27 days),,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,126 days to 91 days,10,,CMO:0000004,systolic blood pressure,,,,137.4,mmHg,2.17,6.8621,MMO:0000011,vascular indwelling catheter method,abdominal aorta,3024000,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,control condition,12726,control condition,,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,10,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,146.4,mmHg,2.53,8.0006,MMO:0000011,vascular indwelling catheter method,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12727,controlled sodium content drinking water (1 %) (for 21 days),,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,126 days to 91 days,13,,CMO:0000004,systolic blood pressure,,averaged over 35 days,,187.3,mmHg,3.27,11.7902,MMO:0000013,vascular fluid filled catheter,abdominal aorta,3024000,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,control condition,12728,control condition,,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,13,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,225.2,mmHg,5.27,19.0013,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12729,controlled sodium content drinking water (1 %) (for 21 days),,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,126 days to 91 days,8,,CMO:0000004,systolic blood pressure,,averaged over 35 days,,167.6,mmHg,2.84,8.0327,MMO:0000013,vascular fluid filled catheter,abdominal aorta,3024000,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,control condition,12730,control condition,,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,8,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,189.6,mmHg,3.43,9.7015,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12731,controlled sodium content drinking water (1 %) (for 21 days),,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0001653,SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc,male,126 days to 91 days,7,,CMO:0000004,systolic blood pressure,,averaged over 35 days,,175.2,mmHg,2.7,7.1435,MMO:0000013,vascular fluid filled catheter,abdominal aorta,3024000,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,control condition,12732,control condition,,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0001653,SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc,male,147 days to 126 days,7,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,195.9,mmHg,1.53,4.048,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12733,controlled sodium content drinking water (1 %) (for 21 days),,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000768,SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc,male,126 days to 91 days,12,,CMO:0000004,systolic blood pressure,,averaged over 35 days,,173.1,mmHg,4.66,16.1427,MMO:0000013,vascular fluid filled catheter,abdominal aorta,3024000,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,control condition,12734,control condition,,,,,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000768,SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc,male,147 days to 126 days,12,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,218.2,mmHg,7.28,25.2187,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12735,controlled sodium content drinking water (1 %) (for 21 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000015,SHR,male,99 days,24,,CMO:0000004,systolic blood pressure,,,continuous mean,196.6,mmHg,3.2,15.6767,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12749,controlled sodium content drinking water (1 %) (for 15 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,179.3,mmHg,3.5,16.7854,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12750,controlled sodium content drinking water (1 %) (for 15 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,99 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,177.6,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12751,controlled sodium content drinking water (1 %) (for 15 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,188.7,mmHg,2.4,11.51,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12752,controlled sodium content drinking water (1 %) (for 15 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,178.5,mmHg,2.7,12.9487,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12753,controlled sodium content drinking water (1 %) (for 15 days),,,,,,,,, 310,"St Lezin E, et al., Hypertension 1999 Aug;34(2):187-91.",arterial blood pressure trait,,RS:0000402,SHR/Ola,male,119 days to 98 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,177,mmHg,2.9,7.6727,MMO:0000015,radiotelemetry,,,10 sec every 10 min for 1 week,,,,control condition,12771,control condition,,,,,,,,, 310,"St Lezin E, et al., Hypertension 1999 Aug;34(2):187-91.",arterial blood pressure trait,,RS:0000721,SHR.BN-(D1Mit3-Igf2)/Ipcv,male,119 days to 98 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,161,mmHg,2.2,5.8207,MMO:0000015,radiotelemetry,,,10 sec every 10 min for 1 week,,,,control condition,12774,control condition,,,,,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,195,mmHg,3.27,14.6239,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12807,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,194,mmHg,3.38,15.1158,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12808,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,203,mmHg,2.98,13.327,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12809,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,198,mmHg,1.78,9.7495,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12810,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001498,SS.LEW-(D1Mco36-D1Rat131)/1Mco,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,178,mmHg,2.22,9.9281,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12817,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001499,SS.LEW-(D1Mco36-D1Rat131)/2Mco,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,170,mmHg,2.33,10.4201,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12818,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001496,SS.LEW-(D1Mco36-D1Mco77)/Mco,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,184,mmHg,3.07,13.7295,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12819,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001497,SS.LEW-(D1Mco36-D1Rat106)/Mco,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,173,mmHg,1.74,9.5304,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12820,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001534,SS.LEW-(D1Mco36-D1Mco101)/Mco,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,173,mmHg,1.36,7.449,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12821,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001500,SS.LEW-(D1Mco85-D1Rat49)/Mco,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,196,mmHg,1.93,8.6312,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12822,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001501,SS.LEW-(D1Mco99-D1Rat49)/Mco,male,66 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,,197,mmHg,3.99,17.8438,MMO:0000031,tail cuff plethysmography,,4,"semi- automatic equipment from IITC, Woodland Hills, CA",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),12823,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,75 days to 73 days,10,,CMO:0000004,systolic blood pressure,,aveerage of 4-hour interval averages over 4 days,,211,mmHg,2.05,6.4827,MMO:0000015,radiotelemetry,,345600,"C-40 transmitter (Data Sciences International, St. Paul, MN)",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 33 days),12915,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 33 days),,,,,, 313,"Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7.",arterial blood pressure trait,,RS:0001534,SS.LEW-(D1Mco36-D1Mco101)/Mco,male,75 days to 73 days,10,,CMO:0000004,systolic blood pressure,,aveerage of 4-hour interval averages over 4 days,,178,mmHg,1.56,4.9332,MMO:0000015,radiotelemetry,,345600,"C-40 transmitter (Data Sciences International, St. Paul, MN)",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 33 days),12919,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 33 days),,,,,, 323,"Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33.",arterial blood pressure trait,,RS:0000749,SHR/Mol,not specified,98 days to 70 days,24,,CMO:0000004,systolic blood pressure,,,,196,mmHg,2.0412,10.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,control condition,12924,control condition,,,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",arterial blood pressure trait,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,both,98 days to 84 days,46,,CMO:0000004,systolic blood pressure,,,serial mean,120,mmHg,1.4744,10.0,MMO:0000054,tail cuff volume pressure recording,tail,0.0,"average of 3 measurements, on 3 different days",,,,control condition,12992,control condition,,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,207,mmHg,4.1,18.3358,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13000,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0001561,SS.SHR-(D9Wox16-D9Rat64)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,180,mmHg,2.07,9.2573,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13001,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,213,mmHg,4.85,21.6899,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13011,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,213,mmHg,4.63,20.706,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13013,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,16,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,205,mmHg,4.91,19.64,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13015,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,203,mmHg,4.11,18.3805,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13016,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,214,mmHg,5.61,25.0887,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13018,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002205,SS.SHR-(D9Wox16-D9Mco77)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,209,mmHg,3.78,16.9047,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13019,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002204,SS.SHR-(D9Wox16-D9Mco73)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,202,mmHg,4.95,22.1371,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13020,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002207,SS.SHR-(D9Wox16-D9Rat76)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,204,mmHg,3.88,17.3519,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13021,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002206,SS.SHR-(D9Wox16-D9Mco85)/Mco,male,70 days to 64 days,14,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,180,mmHg,3.71,13.8815,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13022,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002202,SS.SHR-(D9Mco74-D9Rat64)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,175,mmHg,3.22,14.4003,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13023,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002201,SS.SHR-(D9Mco72-D9Mco93)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,166,mmHg,2.57,11.4934,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13024,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002203,SS.SHR-(D9Rat7-D9Mco93)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 3 averaged readings per day over 4 days,serial mean,195,mmHg,4.32,19.3196,MMO:0000052,tail cuff photoplethysmography,tail,345600,28 degrees C,,,,controlled sodium content diet (2 %) (between 24 and 28 days),13025,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,79 days to 75 days,5,,CMO:0000004,systolic blood pressure,,average of 12 4-hour averages over 48 hours using 5 or 6 rats,serial mean,185,mmHg,1.97,4.4051,MMO:0000070,intra-aortic abdominal radiotelemetry,lower abdominal aorta,172800,"C-40 transmitter (Data Sciences International, St. Paul, MN)",,,,controlled sodium content diet (2 %) (between 35 and 37 days),13026,controlled sodium content diet (2 %) (between 35 and 37 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0001561,SS.SHR-(D9Wox16-D9Rat64)/Mco,male,79 days to 75 days,5,,CMO:0000004,systolic blood pressure,,average of 12 4-hour averages over 48 hours using 5 or 6 rats,serial mean,147,mmHg,1.56,3.4883,MMO:0000070,intra-aortic abdominal radiotelemetry,lower abdominal aorta,172800,"C-40 transmitter (Data Sciences International, St. Paul, MN)",,,,controlled sodium content diet (2 %) (between 35 and 37 days),13027,controlled sodium content diet (2 %) (between 35 and 37 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002202,SS.SHR-(D9Mco74-D9Rat64)/Mco,male,79 days to 75 days,5,,CMO:0000004,systolic blood pressure,,average of 12 4-hour averages over 48 hours using 5 or 6 rats,serial mean,156,mmHg,1.73,3.8684,MMO:0000070,intra-aortic abdominal radiotelemetry,lower abdominal aorta,172800,"C-40 transmitter (Data Sciences International, St. Paul, MN)",,,,controlled sodium content diet (2 %) (between 35 and 37 days),13028,controlled sodium content diet (2 %) (between 35 and 37 days),,,,,,,,, 305,"Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41.",arterial blood pressure trait,,RS:0002201,SS.SHR-(D9Mco72-D9Mco93)/Mco,male,79 days to 75 days,5,,CMO:0000004,systolic blood pressure,,average of 12 4-hour averages over 48 hours using 5 or 6 rats,serial mean,146,mmHg,1.44,3.2199,MMO:0000070,intra-aortic abdominal radiotelemetry,lower abdominal aorta,172800,"C-40 transmitter (Data Sciences International, St. Paul, MN)",,,,controlled sodium content diet (2 %) (between 35 and 37 days),13030,controlled sodium content diet (2 %) (between 35 and 37 days),,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000729,SHR/N,male,84 days,14,,CMO:0000004,systolic blood pressure,,,,176,mmHg,8.0,29.9333,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,control condition,13043,control condition,,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000729,SHR/N,female,84 days,16,,CMO:0000004,systolic blood pressure,,,,163,mmHg,12.0,48.0,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,control condition,13051,control condition,,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000004,systolic blood pressure,,,,129,mmHg,8.0,30.9839,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,control condition,13059,control condition,,,,,,,,, 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000004,systolic blood pressure,,,,130,mmHg,5.0,23.4521,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,control condition,13067,control condition,,,,,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,242,mmHg,3.7,16.5469,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13082,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,218,mmHg,3.1,13.8636,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13083,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,215,mmHg,3.72,16.6363,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13084,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,191,mmHg,1.58,7.066,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13085,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,44,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,190,mmHg,1.61,10.6795,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days),13116,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,189,mmHg,2.92,13.0586,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13117,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,196,mmHg,2.53,11.3145,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13119,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,206,mmHg,2.23,12.2142,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13125,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0000846,SS.LEW-(D10Arb9-D10Got101)/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,217,mmHg,4.28,19.1407,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13127,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001506,SS.LEW-(D10Arb9-D10Rat57)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,183,mmHg,2.07,9.2573,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13129,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001518,SS.LEW-(D10Rat29-D10Got93)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,184,mmHg,3.05,13.64,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13131,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001504,SS.LEW-(D10Arb9-D10Mco84)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,186,mmHg,3.21,14.3556,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13132,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001505,SS.LEW-(D10Arb9-D10Rat161)/Mco,male,70 days to 64 days,32,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,192,mmHg,2.45,13.8593,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13133,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001529,SS.LEW-(D10Mco89-D10Got101)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,192,mmHg,3.89,17.3966,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13134,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001533,SS.LEW-(D10Rat29-D10Mco88)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,191,mmHg,4.07,18.2016,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13135,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 282,"Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10.",arterial blood pressure trait,,RS:0001519,SS.LEW-(D10Mco84-D10Got93)/Mco,male,70 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 4 daily averages of 3-4 measurements/day,serial mean,189,mmHg,2.28,12.4881,MMO:0000052,tail cuff photoplethysmography,tail,345600,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),13136,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",arterial blood pressure trait,,RS:0000746,SHR/Izm,male,91 days,10,,CMO:0000004,systolic blood pressure,,,,185.9,mmHg,2.0871,6.6,MMO:0000031,tail cuff plethysmography,,,,,,,controlled fat content diet (5 %) (for 63 days) and controlled potassium content diet (0.75 %) ,13276,controlled fat content diet (5 %) (for 63 days),controlled potassium content diet (0.75 %) ,,,,,,,, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",arterial blood pressure trait,,RS:0000771,WKY/Izm,male,91 days,10,,CMO:0000004,systolic blood pressure,,,,132.2,mmHg,2.182,6.9,MMO:0000031,tail cuff plethysmography,,,,,,,controlled fat content diet (5 %) (for 63 days) and controlled potassium content diet (0.75 %) ,13277,controlled fat content diet (5 %) (for 63 days),controlled potassium content diet (0.75 %) ,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,71 days to 64 days,46,,CMO:0000004,systolic blood pressure,,,serial mean,207,mmHg,2.2,14.9211,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64733,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000862,SS.LEW-(D1Mco2-D1Mco35)/Jr,not specified,71 days to 64 days,39,,CMO:0000004,systolic blood pressure,,,serial mean,181,mmHg,1.3,8.1185,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64734,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,71 days to 64 days,40,,CMO:0000004,systolic blood pressure,,,serial mean,216,mmHg,2.4,15.1789,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64736,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000883,SS.LEW-(D5Mit9-D5Mco10)/Jr,not specified,71 days to 64 days,40,,CMO:0000004,systolic blood pressure,,,serial mean,201,mmHg,2.0,12.6491,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64737,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,71 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,219,mmHg,3.4,15.2053,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64738,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000884,SS.LEW-(D10Mit10-D10Mgh1)/Jr,not specified,71 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,177,mmHg,2.1,9.3915,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64740,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,71 days to 64 days,19,,CMO:0000004,systolic blood pressure,,,serial mean,205,mmHg,5.9,25.7175,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64741,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 222,"Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23",arterial blood pressure trait,,RS:0000861,SS.LEW-(D17Mco3-D17Mco10)/Jr,not specified,71 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,210,mmHg,3.7,16.5469,MMO:0000031,tail cuff plethysmography,tail,0,,,,,controlled sodium content diet (2 %) (between 24 and 27 days),64742,controlled sodium content diet (2 %) (between 24 and 27 days),,,,,,,,, 301,"Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6.",arterial blood pressure trait,,RS:0001304,F344/Snk,not specified,105 days,16,,CMO:0000004,systolic blood pressure,,,,136,mmHg,1.25,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,64881,control condition,,,,,,,,, 301,"Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6.",arterial blood pressure trait,,RS:0000757,SHR/Snk,not specified,105 days,15,,CMO:0000004,systolic blood pressure,,,,177,mmHg,1.0328,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,64882,control condition,,,,,,,,, 301,"Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6.",arterial blood pressure trait,,RS:0001419,SHR.F344-(D12Mgh5-D12Mgh6)/Snk,not specified,105 days,10,,CMO:0000004,systolic blood pressure,,,,166,mmHg,2.5298,8.0,MMO:0000031,tail cuff plethysmography,,0,,,,,control condition,64883,control condition,,,,,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,69 days to 67 days,5,,CMO:0000004,systolic blood pressure,,,,181,mmHg,3.6,8.0498,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 27 and 28 days),65041,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 27 and 28 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,69 days to 67 days,5,,CMO:0000004,systolic blood pressure,,,,137.8,mmHg,1.6,3.5777,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 27 and 28 days),65042,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 27 and 28 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,69 days to 67 days,6,,CMO:0000004,systolic blood pressure,,,,143.3,mmHg,1.5,3.6742,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 27 and 28 days),65043,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 27 and 28 days),,,,,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,78 days to 76 days,5,,CMO:0000004,systolic blood pressure,,,,217.9,mmHg,2.1,4.6957,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 9 and 10 days),65044,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 9 and 10 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,78 days to 76 days,6,,CMO:0000004,systolic blood pressure,,,,169.6,mmHg,2.1,5.1439,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 9 and 10 days),65045,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 9 and 10 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,78 days to 76 days,5,,CMO:0000004,systolic blood pressure,,,,157.7,mmHg,2.3,5.143,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 9 and 10 days),65046,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 9 and 10 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,109 days to 107 days,3,,CMO:0000004,systolic blood pressure,,,,228.2,mmHg,2.6,4.5033,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 39 and 40 days),65047,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 39 and 40 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,109 days to 107 days,4,,CMO:0000004,systolic blood pressure,,,,215.6,mmHg,4.1,8.2,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 39 and 40 days),65048,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 39 and 40 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,109 days to 107 days,4,,CMO:0000004,systolic blood pressure,,,,196.6,mmHg,3.6,7.2,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 39 and 40 days),65049,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 39 and 40 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,116 days to 114 days,3,,CMO:0000004,systolic blood pressure,,,,219.3,mmHg,4.2,7.2746,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 47 days),65050,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 47 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,116 days to 114 days,4,,CMO:0000004,systolic blood pressure,,,,223.7,mmHg,4.6,9.2,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 47 days),65051,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 47 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,116 days to 114 days,5,,CMO:0000004,systolic blood pressure,,,,203.8,mmHg,3.7,8.2735,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 47 days),65052,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 46 and 47 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,149 days to 147 days,1,,CMO:0000004,systolic blood pressure,,,,219.7,mmHg,1.7,1.7,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 79 and 80 days),65053,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 79 and 80 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,149 days to 147 days,2,,CMO:0000004,systolic blood pressure,,,,228.2,mmHg,3.0,4.2426,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 79 and 80 days),65054,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 79 and 80 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,149 days to 147 days,2,,CMO:0000004,systolic blood pressure,,,,234.4,mmHg,4.1,5.7983,MMO:0000070,intra-aortic abdominal radiotelemetry,,86400,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 79 and 80 days),65055,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 79 and 80 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,87 days to 85 days,19,,CMO:0000004,systolic blood pressure,,,,257.2,mmHg,5.1,22.2304,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 17 and 18 days),65072,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 17 and 18 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002213,SS.SR-(D3Arb14-D3Mco36)/Mco,male,87 days to 85 days,10,,CMO:0000004,systolic blood pressure,,,,242.6,mmHg,6.2,19.6061,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 17 and 18 days),65073,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 17 and 18 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002214,SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco,male,87 days to 85 days,9,,CMO:0000004,systolic blood pressure,,,,214.9,mmHg,8.9,26.7,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 17 and 18 days),65074,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 17 and 18 days),,, 283,"Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2.",arterial blood pressure trait,,RS:0002208,SS.SR-(D7Mco19-D7Mco7)/Jr,male,87 days to 85 days,10,,CMO:0000004,systolic blood pressure,,,,250.5,mmHg,9.8,30.9903,MMO:0000052,tail cuff photoplethysmography,,172800,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 17 and 18 days),65075,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (for 28 days),,,controlled sodium content diet (4 %) (between 17 and 18 days),,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0000753,SHR/NCruk,male,114 days to 112 days,20,,CMO:0000004,systolic blood pressure,,,,174,mmHg,0.313,1.4,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65250,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0001425,SHR.WKY-(D1Rat420-D1Got161)/Njs,male,114 days to 112 days,18,,CMO:0000004,systolic blood pressure,,,,163.2,mmHg,0.4478,1.9,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65251,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0001424,SHR.WKY-(D1Got158-D1Got161)/Njs,male,114 days to 112 days,17,,CMO:0000004,systolic blood pressure,,,,166.1,mmHg,0.6063,2.5,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65252,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0001426,SHR.WKY-(D1Rat420-D1Rat278)/Njs,male,114 days to 112 days,13,,CMO:0000004,systolic blood pressure,,,,174,mmHg,0.6379,2.3,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65253,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0000753,SHR/NCruk,male,142 days to 140 days,20,,CMO:0000004,systolic blood pressure,,,,189.5,mmHg,0.3801,1.7,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65254,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0001425,SHR.WKY-(D1Rat420-D1Got161)/Njs,male,142 days to 140 days,18,,CMO:0000004,systolic blood pressure,,,,180.3,mmHg,0.3771,1.6,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65255,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0001424,SHR.WKY-(D1Got158-D1Got161)/Njs,male,142 days to 140 days,17,,CMO:0000004,systolic blood pressure,,,,183,mmHg,0.1698,0.7,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65256,control condition,,,,,,,,, 564,"Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1.",arterial blood pressure trait,,RS:0001426,SHR.WKY-(D1Rat420-D1Rat278)/Njs,male,142 days to 140 days,13,,CMO:0000004,systolic blood pressure,,,,191.8,mmHg,0.2774,1.0,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,65257,control condition,,,,,,,,, 565,"Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,207,mmHg,4.7,21.019,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65305,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 565,"Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7.",arterial blood pressure trait,,RS:0002372,SS.LEW-(D1Mco102-D1Got46)/Mco,male,70 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,188,mmHg,3.5,15.6525,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65308,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 565,"Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 66 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,190,mmHg,5.4,24.1495,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 36 and 40 days),65309,controlled sodium content diet (0.4 %) (between 36 and 40 days),,,,,,,,, 565,"Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7.",arterial blood pressure trait,,RS:0002373,SS.LEW-(D1Mco102-D1Mco129)/1Mco,male,70 days to 66 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,172,mmHg,1.9,8.4971,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 36 and 40 days),65310,controlled sodium content diet (0.4 %) (between 36 and 40 days),,,,,,,,, 565,"Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7.",arterial blood pressure trait,,RS:0002374,SS.LEW-(D1Mco102-D1Mco129)/2Mco,male,70 days to 66 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,176,mmHg,2.2,9.8387,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 36 and 40 days),65311,controlled sodium content diet (0.4 %) (between 36 and 40 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000113,BN,male,99 days,64,,CMO:0000004,systolic blood pressure,,,continuous mean,134.4,mmHg,8.7,69.6,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65342,controlled sodium content drinking water (1 %) (for 15 days),,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000015,SHR,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,188,mmHg,2.0,9.5917,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,control condition,65347,control condition,,,,,,,,, 568,"Ueno T, et al., Physiol Res 2003;52(6):689-700.",arterial blood pressure trait,,RS:0000397,HTG,not specified,0 days,10,,CMO:0000004,systolic blood pressure,,,continuous mean,163.4,mmHg,,,MMO:0000011,vascular indwelling catheter method,,,,,,,losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),65381,losartan (10 mg/kg) (for 0.2 hours),,,pentolinium (5 mg/kg) (for 0.1 hours),,,NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),,, 568,"Ueno T, et al., Physiol Res 2003;52(6):689-700.",arterial blood pressure trait,,RS:0000511,LEW/Cub,not specified,0 days,9,,CMO:0000004,systolic blood pressure,,,continuous mean,128.5,mmHg,,,MMO:0000011,vascular indwelling catheter method,,,,,,,losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),65383,losartan (10 mg/kg) (for 0.2 hours),,,pentolinium (5 mg/kg) (for 0.1 hours),,,NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours),,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,99 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,175,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,control condition,65393,control condition,,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,99 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,168,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,control condition,65400,control condition,,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,99 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,173,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,control condition,65406,control condition,,,,,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,99 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,181,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,control condition,65411,control condition,,,,,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,female,94 days to 92 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,110,mmHg,3.0,11.225,MMO:0000011,vascular indwelling catheter method,left femoral artery,0,,,,,controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) ,65462,controlled sodium content diet (0.4 %) (for 16 hours),furosemide (10 mg/kg) ,,,,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,female,94 days to 92 days,12,,CMO:0000004,systolic blood pressure,,,serial mean,160,mmHg,6.0,20.7846,MMO:0000011,vascular indwelling catheter method,left femoral artery,0,,,,,controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) ,65463,controlled sodium content diet (0.4 %) (for 16 hours),furosemide (10 mg/kg) ,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,210,mmHg,3.3,14.758,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65479,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,216,mmHg,5.1,22.8079,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65480,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,191,mmHg,3.5,15.6525,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65481,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,206,mmHg,4.2,18.783,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65482,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,202,mmHg,4.1,18.3358,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65483,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000865,SS.LEW-(D1Uia8-D1Rat18)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,191,mmHg,2.2,9.8387,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65484,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000875,SS.LEW-(D1Uia8-D1Rat211)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,207,mmHg,5.8,25.9384,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65485,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000868,SS.LEW-(D1Mco8-D1Rat213)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,183,mmHg,3.0,13.4164,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65486,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000867,SS.LEW-(D1Mco75-D1Rat18)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,182,mmHg,3.3,14.758,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65487,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000870,SS.LEW-(D1Rat211-D1Rat18)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,180,mmHg,2.8,12.522,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65488,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000866,SS.LEW-(D1Mco4-D1Rat18)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,178,mmHg,2.3,10.2859,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65489,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000870,SS.LEW-(D1Rat211-D1Rat18)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,179,mmHg,2.9,12.9692,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65490,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000867,SS.LEW-(D1Mco75-D1Rat18)/Mco,male,70 days to 63 days,20,,CMO:0000004,systolic blood pressure,,average of 4days,,193,mmHg,4.2,18.783,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (between 24 and 28 days),65492,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,80 days to 73 days,8,,CMO:0000004,systolic blood pressure,,average of 24 hr,,199,mmHg,5.0,14.1421,MMO:0000070,intra-aortic abdominal radiotelemetry,,10,,,,,controlled sodium content diet (2 %) (between 34 and 38 days),65493,controlled sodium content diet (2 %) (between 34 and 38 days),,,,,,,,, 611,"Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84.",arterial blood pressure trait,,RS:0000870,SS.LEW-(D1Rat211-D1Rat18)/Mco,male,80 days to 73 days,8,,CMO:0000004,systolic blood pressure,,average of 24 hr,,171,mmHg,3.4,9.6167,MMO:0000070,intra-aortic abdominal radiotelemetry,,10,,,,,controlled sodium content diet (2 %) (between 34 and 38 days),65498,controlled sodium content diet (2 %) (between 34 and 38 days),,,,,,,,, 615,"Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,77 days to 66 days,15,,CMO:0000004,systolic blood pressure,measurement taken every 4 hours during a 24-hour period,,serial mean,203,mmHg,4.0,15.4919,MMO:0000015,radiotelemetry,,86400.0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days),65536,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 615,"Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8.",arterial blood pressure trait,,RS:0000878,SS.LEW-(D3Rat52-D3Rat17)/Ayd,male,77 days to 66 days,6,,CMO:0000004,systolic blood pressure,measurement taken every 4 hours during a 24-hour period,,serial mean,164,mmHg,4.0,9.798,MMO:0000015,radiotelemetry,,86400.0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days),65545,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 615,"Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8.",arterial blood pressure trait,,RS:0000881,SS.LEW-(D3Rat52-D3Chm63)/Ayd,male,77 days to 66 days,8,,CMO:0000004,systolic blood pressure,measurement taken every 4 hours during a 24-hour period,,serial mean,173,mmHg,8.0,22.6274,MMO:0000015,radiotelemetry,,86400.0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days),65546,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 615,"Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8.",arterial blood pressure trait,,RS:0000882,SS.LEW-(D3Rat52-D3Rat130)/Ayd,male,77 days to 66 days,7,,CMO:0000004,systolic blood pressure,measurement taken every 4 hours during a 24-hour period,,serial mean,167,mmHg,4.0,10.583,MMO:0000015,radiotelemetry,,86400.0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days),65548,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 615,"Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8.",arterial blood pressure trait,,RS:0000879,SS.LEW-(D3Chm64-D3Rat17)/Ayd,male,77 days to 66 days,8,,CMO:0000004,systolic blood pressure,measurement taken every 4 hours during a 24-hour period,,serial mean,228,mmHg,8.0,22.6274,MMO:0000015,radiotelemetry,,86400.0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days),65550,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 615,"Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8.",arterial blood pressure trait,,RS:0000880,SS.LEW-(D3Mco21-D3Rat17)/Ayd,male,77 days to 66 days,6,,CMO:0000004,systolic blood pressure,measurement taken every 4 hours during a 24-hour period,,serial mean,194,mmHg,9.0,22.0454,MMO:0000015,radiotelemetry,,86400.0,,,,,controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days),65552,controlled sodium content diet (0.2 %) (for 14 days),,,controlled sodium content diet (2 %) (for 42 days),,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,178.4,mmHg,2.1,3.6373,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65579,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,161.8,mmHg,3.0,5.1962,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65580,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,185.1,mmHg,1.1,1.9053,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65581,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,166.5,mmHg,3.8,6.5818,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65582,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,126 days to 91 days,4,,CMO:0000004,systolic blood pressure,,,continuous mean,127.8,mmHg,7.9,15.8,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65598,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,126 days to 91 days,4,,CMO:0000004,systolic blood pressure,,,continuous mean,132.1,mmHg,7.9,15.8,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65599,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,123.8,mmHg,3.4,5.889,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65600,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,128,mmHg,3.3,5.7158,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65601,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,164.3,mmHg,1.9,3.2909,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65602,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,144.7,mmHg,2.9,5.0229,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65603,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,166.9,mmHg,1.0,1.7321,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65604,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,146.4,mmHg,3.7,6.4086,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65605,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,178,mmHg,5.0,8.6603,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65614,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,156.3,mmHg,4.9,8.487,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65615,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,182,mmHg,6.9,11.9512,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65616,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,159.4,mmHg,5.0,8.6603,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65617,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,148.9,mmHg,3.5,6.0622,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65626,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,134.4,mmHg,4.4,7.621,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65627,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,151.3,mmHg,3.5,6.0622,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65628,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,138.1,mmHg,4.8,8.3138,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65629,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,137.9,mmHg,2.6,4.5033,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65638,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,116.3,mmHg,6.4,11.0851,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Days (7 AM to 7 PM),,,,control condition,65639,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,141.5,mmHg,2.0,3.4641,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65640,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,126 days to 91 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,120.4,mmHg,8.1,14.0296,MMO:0000070,intra-aortic abdominal radiotelemetry,,3024000,Nights (7 PM to 7 AM),,,,control condition,65641,control condition,,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,207.9,mmHg,5.5,9.5263,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65650,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,229.8,mmHg,7.3,12.644,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65651,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,173.4,mmHg,3.9,6.755,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65652,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,185.5,mmHg,4.5,7.7942,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65653,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000004,systolic blood pressure,,,continuous mean,136.6,mmHg,8.2,16.4,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65662,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000004,systolic blood pressure,,,continuous mean,144.2,mmHg,8.8,17.6,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65663,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,131.7,mmHg,3.2,5.5426,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65664,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,138.9,mmHg,2.6,4.5033,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65665,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,180.7,mmHg,2.5,4.3301,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65674,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,191.2,mmHg,3.4,5.889,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65675,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,154.9,mmHg,3.7,6.4086,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65676,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,161.6,mmHg,5.4,9.3531,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65677,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,202.1,mmHg,12.4,21.4774,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65686,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,221.3,mmHg,15.4,26.6736,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65687,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,167.6,mmHg,5.5,9.5263,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65688,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,176.8,mmHg,6.3,10.9119,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65689,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,155.8,mmHg,3.7,6.4086,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65698,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,163,mmHg,3.8,6.5818,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65699,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,140.7,mmHg,8.0,13.8564,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65700,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,149.3,mmHg,7.0,12.1244,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65701,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,146.1,mmHg,2.2,3.8105,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65710,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,156,mmHg,2.5,4.3301,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65711,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,120.6,mmHg,8.5,14.7224,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65712,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,130.6,mmHg,8.2,14.2028,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65713,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,40,,CMO:0000004,systolic blood pressure,,,serial mean,213,mmHg,2.5,15.8114,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65790,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,40,,CMO:0000004,systolic blood pressure,,,serial mean,218.3,mmHg,2.6,16.4438,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65791,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,210.6,mmHg,3.4,15.2053,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65792,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,206.6,mmHg,2.4,10.7331,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65793,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,203.6,mmHg,4.2,18.783,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65794,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,41,,CMO:0000004,systolic blood pressure,,,serial mean,204.7,mmHg,2.1,13.4466,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65795,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0001566,SS.SR-(D3Mco36-D3Mco46)/Jr,male,72 days to 64 days,40,,CMO:0000004,systolic blood pressure,,,serial mean,201.3,mmHg,2.2,13.914,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65796,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0001565,SS.SR-(D3Mco36-D3Got166)/Jr,male,72 days to 64 days,40,,CMO:0000004,systolic blood pressure,,,serial mean,197.5,mmHg,2.5,15.8114,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65797,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0001564,SS.SR-(D3Mco36-D3Got159)/Jr,male,72 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,178.6,mmHg,4.0,17.8885,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65798,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0001568,SS.SR-(D3Mco78-D3Got130)/Jr,male,72 days to 64 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,209.1,mmHg,4.8,21.4663,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65799,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,19,,CMO:0000004,systolic blood pressure,,,serial mean,190.9,mmHg,3.6,15.692,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65800,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 237,"Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,72 days to 64 days,39,,CMO:0000004,systolic blood pressure,,,serial mean,191.8,mmHg,2.6,16.237,MMO:0000031,tail cuff plethysmography,,345600,Rats warmed to 28 degrees C for measurement.,,,,controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days),65801,controlled sodium content diet (0.4 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,, 633,"Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6",arterial blood pressure trait,,RS:0000817,SS/Jr,male,62 days,20,,CMO:0000004,systolic blood pressure,,only mentioned blood pressure,,195,mmHg,2.7,12.0748,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (for 24 days),65829,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 633,"Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6",arterial blood pressure trait,,RS:0000915,SS.SR-Inha/Jr,male,62 days,20,,CMO:0000004,systolic blood pressure,,only mentioned blood pressure,,176,mmHg,2.6,11.6276,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (2 %) (for 24 days),65830,controlled sodium content diet (2 %) (for 24 days),,,,,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000817,SS/Jr,both,134 days to 131 days,21,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,244,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (1 %) (for 60 days) then controlled sodium content diet (0.2 %) (between 41 and 44 days),65963,controlled sodium content diet (1 %) (for 60 days),,,controlled sodium content diet (0.2 %) (between 41 and 44 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,male,134 days to 131 days,11,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,209,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (1 %) (for 60 days) then controlled sodium content diet (0.2 %) (between 41 and 44 days),65964,controlled sodium content diet (1 %) (for 60 days),,,controlled sodium content diet (0.2 %) (between 41 and 44 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000817,SS/Jr,both,68 days to 65 days,20,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,199,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (2 %) (between 25 and 28 days),65967,controlled sodium content diet (0.2 %) (for 10 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,male,68 days to 65 days,20,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,175,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (2 %) (between 25 and 28 days),65968,controlled sodium content diet (0.2 %) (for 10 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000817,SS/Jr,male,84 days to 81 days,20,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,231,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (2 %) (between 41 and 44 days),65971,controlled sodium content diet (0.2 %) (for 10 days),,,controlled sodium content diet (2 %) (between 41 and 44 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,male,84 days to 81 days,20,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,208,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (2 %) (between 41 and 44 days),65973,controlled sodium content diet (0.2 %) (for 10 days),,,controlled sodium content diet (2 %) (between 41 and 44 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000817,SS/Jr,both,68 days to 65 days,38,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,260,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (4 %) (between 24 and 28 days),65974,controlled sodium content diet (0.2 %) (for 10 days),,,controlled sodium content diet (4 %) (between 24 and 28 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000914,SS.SR-(D13Mit9-D13Mit1)/Jr,both,68 days to 65 days,22,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,238,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (4 %) (between 24 and 28 days),66027,controlled sodium content diet (0.2 %) (for 10 days),,,controlled sodium content diet (4 %) (between 24 and 28 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,68 days to 65 days,27,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,211,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 24 days) then controlled sodium content diet (4 %) (for 24 days),66028,controlled sodium content diet (0.2 %) (for 24 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000910,SS.SR-(D13N1-D13Mit1)/Jr,not specified,68 days to 65 days,26,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,217,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 24 days) then controlled sodium content diet (4 %) (for 24 days),66029,controlled sodium content diet (0.2 %) (for 24 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 650,"Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41",arterial blood pressure trait,,RS:0000913,SS.SR-(Syt2-D13Mit1)/Jr,not specified,68 days to 65 days,25,,CMO:0000004,systolic blood pressure,data obtained at three consistent sessions per day,,serial mean,219,mmHg,,,MMO:0000031,tail cuff plethysmography,,345600,,,,,controlled sodium content diet (0.2 %) (for 24 days) then controlled sodium content diet (4 %) (for 24 days),66030,controlled sodium content diet (0.2 %) (for 24 days),,,controlled sodium content diet (4 %) (for 24 days),,,,,, 651,"Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21.",arterial blood pressure trait,,RS:0000402,SHR/Ola,male,0 days,29,,CMO:0000004,systolic blood pressure,,,,214,mmHg,4.0,21.5407,MMO:0000011,vascular indwelling catheter method,carotid artery segment,,,,,,control condition,66034,control condition,,,,,,,,, 651,"Pravenec M, et al., J Hypertens 1989 Mar;7(3):217-21.",arterial blood pressure trait,,RS:0000116,BN-Lx/Cub,male,0 days,8,,CMO:0000004,systolic blood pressure,,,,132,mmHg,3.0,8.4853,MMO:0000011,vascular indwelling catheter method,carotid artery segment,,,,,,control condition,66035,control condition,,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,53 days,10,,CMO:0000004,systolic blood pressure,,,,151,mmHg,5.1,16.1276,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet,66115,controlled sodium content diet,,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,53 days,10,,CMO:0000004,systolic blood pressure,,,,154,mmHg,3.3,10.4355,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet,66116,controlled sodium content diet,,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,67 days,10,,CMO:0000004,systolic blood pressure,,,,218,mmHg,7.8,24.6658,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (4 %) (for 14 days),66117,controlled sodium content diet (4 %) (for 14 days),,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,67 days,10,,CMO:0000004,systolic blood pressure,,,,179,mmHg,5.0,15.8114,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (4 %) (for 14 days),66118,controlled sodium content diet (4 %) (for 14 days),,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,81 days,10,,CMO:0000004,systolic blood pressure,,,,238,mmHg,7.0,22.1359,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (4 %) (for 28 days),66119,controlled sodium content diet (4 %) (for 28 days),,,,,,,,, 691,"Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8.",arterial blood pressure trait,,RS:0000754,SHR/NHsd,male,81 days,10,,CMO:0000004,systolic blood pressure,,,,204,mmHg,3.9,12.3329,MMO:0000031,tail cuff plethysmography,,0,,,,,controlled sodium content diet (4 %) (for 28 days),66120,controlled sodium content diet (4 %) (for 28 days),,,,,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",arterial blood pressure trait,,RS:0000372,BB.SHR-(D6Rat184-D6Rat3)/K,both,98 days to 84 days,32,,CMO:0000004,systolic blood pressure,,,serial mean,119,mmHg,1.4142,8.0,MMO:0000054,tail cuff volume pressure recording,tail,0.0,"average of 3 measurements, on 3 different days",,,,control condition,66146,control condition,,,,,,,,, 116,"Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,0 days,8,,CMO:0000004,systolic blood pressure,,,,124.8,mmHg,1.096,3.1,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet,67196,controlled sodium content diet,,,,,,,,, 116,"Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82",arterial blood pressure trait,,RS:0001064,WKY.SHRSP-(Asgr1-Vamp2)/Bbb,not specified,0 days,9,,CMO:0000004,systolic blood pressure,,,,131.4,mmHg,1.2667,3.8,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet,67197,controlled sodium content diet,,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,11,,CMO:0000004,systolic blood pressure,,,,129.2,mmHg,1.6583,5.5,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67200,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001065,WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb,not specified,112 days,9,,CMO:0000004,systolic blood pressure,,,,134,mmHg,1.3,3.9,MMO:0000015,radiotelemetry,,0.0,,,,,control condition,67201,control condition,,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,12,,CMO:0000004,systolic blood pressure,,,,134.1,mmHg,0.9815,3.4,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67202,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001066,WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb,not specified,124 days,11,,CMO:0000004,systolic blood pressure,,,,135.2,mmHg,1.4473,4.8,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67203,controlled sodium content drinking water (1 %) (for 12 days),,,,,,,,, 730,"Viel EC, et al., Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44. Epub 2009 Dec 31.",arterial blood pressure trait,,RS:0000922,SS/Hsd,male,84 days,12,,CMO:0000004,systolic blood pressure,,,,175,mmHg,3.0,10.3923,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,67226,control condition,,,,,,,,, 730,"Viel EC, et al., Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44. Epub 2009 Dec 31.",arterial blood pressure trait,,RS:0000134,BN/Crl,male,84 days,12,,CMO:0000004,systolic blood pressure,,,,113,mmHg,5.0,17.3205,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,67227,control condition,,,,,,,,, 730,"Viel EC, et al., Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44. Epub 2009 Dec 31.",arterial blood pressure trait,,RS:0000802,SS-Chr 2BN/Mcwi,male,84 days,12,,CMO:0000004,systolic blood pressure,,,,150,mmHg,3.0,10.3923,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,67228,control condition,,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",arterial blood pressure trait,,RS:0002409,SS/JrSeac,not specified,77 days,5,,CMO:0000004,systolic blood pressure,,,,125,mmHg,9.8387,22.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 35 days),67248,controlled sodium content diet (0.3 %) (for 35 days),,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",arterial blood pressure trait,,RS:0002409,SS/JrSeac,not specified,77 days,5,,CMO:0000004,systolic blood pressure,,,,246,mmHg,10.7331,24.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (8 %) (for 35 days),67249,controlled sodium content diet (8 %) (for 35 days),,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",arterial blood pressure trait,,RS:0002409,SS/JrSeac,not specified,126 days,5,,CMO:0000004,systolic blood pressure,,,,117,mmHg,11.1803,25.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 84 days),67250,controlled sodium content diet (0.3 %) (for 84 days),,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",arterial blood pressure trait,,RS:0002409,SS/JrSeac,not specified,126 days,5,,CMO:0000004,systolic blood pressure,,,,249,mmHg,18.3358,41.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (8 %) (for 84 days),67251,controlled sodium content diet (8 %) (for 84 days),,,,,,,,, 733,"Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1.",arterial blood pressure trait,,RS:0002409,SS/JrSeac,not specified,42 days,20,,CMO:0000004,systolic blood pressure,,,,119,mmHg,3.1305,14.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,67252,control condition,,,,,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,20,,CMO:0000004,systolic blood pressure,,,,222,mmHg,5.01,22.4054,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67311,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003337,SS.SHR-(D9Mco72-D9Mco105)/Mco,not specified,70 days to 65 days,20,,CMO:0000004,systolic blood pressure,,,,183,mmHg,4.15,18.5594,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67508,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,194,mmHg,7.36,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67509,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003332,SS.SHR-(D9Mco72-D9Rat89)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,183,mmHg,7.72,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67510,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,197,mmHg,3.53,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67511,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003333,SS.SHR-(D9Mco72-D9Rat55)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,188,mmHg,3.67,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67512,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,197,mmHg,3.85,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67513,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003334,SS.SHR-(D9Mco72-D9Mco109)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,188,mmHg,3.21,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67514,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,214,mmHg,5.26,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67515,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003335,SS.SHR-(D9Mco72-D9Uia4)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,181,mmHg,3.91,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67516,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,263,mmHg,5.6,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67517,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003337,SS.SHR-(D9Mco72-D9Mco105)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,207,mmHg,3.5,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67518,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003336,SS.SHR-(D9Mco72-D9Mco106)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,176,mmHg,5.24,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67520,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,200,mmHg,4.22,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67521,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003341,SS.SHR-(D9Rat7-D9Rat84)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,185,mmHg,4.84,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67522,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003338,SS.SHR-(D9Rat7-D9Got111)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,183,mmHg,4.14,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67523,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0000817,SS/Jr,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,213,mmHg,5.14,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67524,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003340,SS.SHR-(D9Rat7-D9Mco91)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,208,mmHg,5.78,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67525,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 749,"Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4.",arterial blood pressure trait,,RS:0003339,SS.SHR-(D9Rat7-D9Rat52)/Mco,not specified,70 days to 65 days,N/A,,CMO:0000004,systolic blood pressure,,,,203,mmHg,6.11,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days),67526,controlled sodium content diet (0.3 %) (between 10 and 12 days),,,controlled sodium content diet (2 %) (between 25 and 28 days),,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",arterial blood pressure trait,,RS:0001072,WKY/NCruk,male,42 days,16,,CMO:0000004,systolic blood pressure,,,,93.9,mmHg,0.725,2.9,MMO:0000052,tail cuff photoplethysmography,,0.0,,,,,control condition,67766,control condition,,,,,,,,, 110,"Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7",arterial blood pressure trait,,RS:0001039,WKY.SHR-(D1Wox19-D1Mit2)/Njs,male,42 days,19,,CMO:0000004,systolic blood pressure,,,,94.1,mmHg,0.5277,2.3,MMO:0000052,tail cuff photoplethysmography,,0.0,,,,,control condition,67767,control condition,,,,,,,,, 810,"Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23.",arterial blood pressure trait,,RS:0001481,SS/JrHsd,male,140 days to 139 days,6,,CMO:0000004,systolic blood pressure,,,,220,mmHg,7.1035,17.4,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 55 and 56 days),67851,controlled sodium content diet (8 %) (between 55 and 56 days),,,,,,,,, 810,"Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23.",arterial blood pressure trait,,RS:0001454,SR/JrHsd,male,140 days to 139 days,5,,CMO:0000004,systolic blood pressure,,,,130,mmHg,1.2522,2.8,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 55 and 56 days),67854,controlled sodium content diet (8 %) (between 55 and 56 days),,,,,,,,, 810,"Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23.",arterial blood pressure trait,,RS:0001481,SS/JrHsd,female,168 days to 167 days,8,,CMO:0000004,systolic blood pressure,,,,199.5,mmHg,6.9296,19.6,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 83 and 84 days),67857,controlled sodium content diet (8 %) (between 83 and 84 days),,,,,,,,, 810,"Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23.",arterial blood pressure trait,,RS:0001454,SR/JrHsd,female,168 days to 167 days,5,,CMO:0000004,systolic blood pressure,,,,120.8,mmHg,3.3988,7.6,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 83 and 84 days),67858,controlled sodium content diet (8 %) (between 83 and 84 days),,,,,,,,, 835,"Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64.",arterial blood pressure trait,,RS:0000971,WAG/RijKyo,not specified,180 days,9,,CMO:0000004,systolic blood pressure,,,,135,mmHg,3.4,10.2,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68049,control condition,,,,,,,,, 835,"Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64.",arterial blood pressure trait,,RS:0001334,ISIAH,not specified,180 days,11,,CMO:0000004,systolic blood pressure,,,,175,mmHg,4.8,15.9198,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68063,control condition,,,,,,,,, 835,"Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64.",arterial blood pressure trait,,RS:0000971,WAG/RijKyo,not specified,180 days,9,,CMO:0000004,systolic blood pressure,,,,140,mmHg,5.1,15.3,MMO:0000031,tail cuff plethysmography,,0.0,,,,,physical restraint in mechanical restrainer (for 0.5 hours),68064,physical restraint in mechanical restrainer (for 0.5 hours),,,,,,,,, 835,"Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64.",arterial blood pressure trait,,RS:0001334,ISIAH,not specified,180 days,11,,CMO:0000004,systolic blood pressure,,,,215,mmHg,5.9,19.5681,MMO:0000031,tail cuff plethysmography,,0.0,,,,,physical restraint in mechanical restrainer (for 0.5 hours),68065,physical restraint in mechanical restrainer (for 0.5 hours),,,,,,,,, 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",arterial blood pressure trait,,RS:0000744,SHR/FubRkb,female,168 days,10,,CMO:0000004,systolic blood pressure,,,,157.1,mmHg,2.9,9.1706,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68172,control condition,,,,,,,,, 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",arterial blood pressure trait,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000004,systolic blood pressure,,,,139,mmHg,1.6,7.1554,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68173,control condition,,,,,,,,, 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",arterial blood pressure trait,,RS:0000596,MWF/FubRkb,female,168 days,18,,CMO:0000004,systolic blood pressure,,,,138.5,mmHg,1.2,5.0912,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68174,control condition,,,,,,,,, 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",arterial blood pressure trait,,RS:0001054,WKY.SHRSP-(D1Wox29-D1Arb21)/Izm,not specified,112 days,10,,CMO:0000004,systolic blood pressure,,,,148,mmHg,1.7709,5.6,MMO:0000031,tail cuff plethysmography,,0.0,10 s every 5 min,,,,control condition,68690,control condition,,,,,,,,, 971,"Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9.",arterial blood pressure trait,,RS:0001054,WKY.SHRSP-(D1Wox29-D1Arb21)/Izm,not specified,112 days,10,,CMO:0000004,systolic blood pressure,,,,157,mmHg,1.3914,4.4,MMO:0000031,tail cuff plethysmography,,0.0,10 s every 5 min,,,,cold ambient air exposure (4 degrees C) (for 90 days),68691,cold ambient air exposure (4 degrees C) (for 90 days),,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0001433,SHRSP.WKY-(D1Wox29-D1Arb21)/Izm,male,84 days,14,,CMO:0000004,systolic blood pressure,,avg of 5 measurements,serial mean,194,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68738,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002487,SHRSP.WKY-(D1Smu13-D1Arb21)/Izm,male,84 days,13,,CMO:0000004,systolic blood pressure,,avg of 5 measurements,serial mean,179,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68739,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0001683,SHRSP.WKY-(Apbb1-D1Arb21)/Izm,male,84 days,14,,CMO:0000004,systolic blood pressure,,avg of 5 measurements,serial mean,187,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68740,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0001054,WKY.SHRSP-(D1Wox29-D1Arb21)/Izm,male,84 days,16,,CMO:0000004,systolic blood pressure,,avg of 5 measurements,serial mean,125,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68741,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0001051,WKY.SHRSP-(D1Smu13-D1Smu11)/Izm,male,84 days,16,,CMO:0000004,systolic blood pressure,,avg of 5 measurements,serial mean,119,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68742,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0001063,WKY.SHRSP-(Ntrk3-D1Smu13)/Izm,male,84 days,18,,CMO:0000004,systolic blood pressure,,avg of 5 measurements,serial mean,122,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68743,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002492,SHRSP.WKY-(D1Smu13-D1Wox33)/Izm,male,84 days,10,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for SPwch1.72,serial mean,205,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68744,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002493,WKY.SHRSP-(D1Rat171-D1Wox33)/Izm,male,84 days,10,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,124,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68745,control condition,,,,,,,,, 1037,"Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8.",arterial blood pressure trait,,RS:0000397,HTG,not specified,120 days,10,,CMO:0000004,systolic blood pressure,,,,156.7,mmHg,1.7393,5.5,MMO:0000013,vascular fluid filled catheter,right common carotid artery,0.0,,,,,control condition,68980,control condition,,,,,,,,, 1037,"Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8.",arterial blood pressure trait,,RS:0000148,BN/OrlIcoCrlf,not specified,120 days,10,,CMO:0000004,systolic blood pressure,,,,114.9,mmHg,1.0752,3.4,MMO:0000013,vascular fluid filled catheter,right common carotid artery,0.0,,,,,control condition,68981,control condition,,,,,,,,, 1039,"Pravenec M, et al., Hypertension. 2008 Jan;51(1):148-53. Epub 2007 Dec 10.",arterial blood pressure trait,,RS:0001638,SHR.BN-(D10Mgh3-D10Rat85)/Ipcv,male,77 days to 70 days,8,,CMO:0000004,systolic blood pressure,,5 s every 5 min for a week,serial mean,150,mmHg,1.3,3.677,MMO:0000015,radiotelemetry,,0.0,,,,,controlled cholesterol content diet (2 %) (for 28 days),68993,controlled cholesterol content diet (2 %) (for 28 days),,,,,,,,, 1039,"Pravenec M, et al., Hypertension. 2008 Jan;51(1):148-53. Epub 2007 Dec 10.",arterial blood pressure trait,,RS:0001637,SHR.BN-(D10Mgh3-Srebf1)/Ipcv,male,77 days to 70 days,8,,CMO:0000004,systolic blood pressure,,5 s every 5 min for a week,serial mean,150,mmHg,2.2,6.2225,MMO:0000015,radiotelemetry,,0.0,,,,,controlled cholesterol content diet (2 %) (for 28 days),68994,controlled cholesterol content diet (2 %) (for 28 days),,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,42 days,18,,CMO:0000004,systolic blood pressure,,,,111,mmHg,0.9428,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69125,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,56 days,18,,CMO:0000004,systolic blood pressure,,,,139,mmHg,1.6499,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69126,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,70 days,18,,CMO:0000004,systolic blood pressure,,,,185,mmHg,1.7206,7.3,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69127,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,84 days,18,,CMO:0000004,systolic blood pressure,,,,191,mmHg,3.017,12.8,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69128,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,98 days,18,,CMO:0000004,systolic blood pressure,,,,191,mmHg,1.6499,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69129,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,112 days,18,,CMO:0000004,systolic blood pressure,,,,199,mmHg,0.2357,1.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69130,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,126 days,18,,CMO:0000004,systolic blood pressure,,,,188,mmHg,2.8284,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69131,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,,,,, 1128,"Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78.",arterial blood pressure trait,,RS:0000021,ACI/Eur,male,98 days to 91 days,21,,CMO:0000004,systolic blood pressure,,,,113,mmHg,1.964,9.0,MMO:0000031,tail cuff plethysmography,,0.0,performed at 5 to 6 weeks of age,unilateral nephrectomy,39,days,unilateral nephrectomy,69141,unilateral nephrectomy,,,,,,,,, 1128,"Shiozawa M, et al., J Am Soc Nephrol 2000 Nov;11(11):2068-78.",arterial blood pressure trait,,RS:0000018,FHH/Eur,male,98 days to 91 days,26,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.9612,10.0,MMO:0000031,tail cuff plethysmography,,0.0,performed at 5 to 6 weeks of age,unilateral nephrectomy,39,days,unilateral nephrectomy,69142,unilateral nephrectomy,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,42 days,31,,CMO:0000004,systolic blood pressure,,,,107,mmHg,1.2572,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69161,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.4368,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69162,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,70 days,26,,CMO:0000004,systolic blood pressure,,,,187,mmHg,2.5495,13.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69163,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,84 days,5,,CMO:0000004,systolic blood pressure,,,,201,mmHg,8.7207,19.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69164,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,42 days,33,,CMO:0000004,systolic blood pressure,,,,110,mmHg,0.6093,3.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69165,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,56 days,33,,CMO:0000004,systolic blood pressure,,,,148,mmHg,3.1334,18.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69166,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,70 days,33,,CMO:0000004,systolic blood pressure,,,,174,mmHg,3.3075,19.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69167,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,84 days,33,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.2185,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69168,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,98 days,32,,CMO:0000004,systolic blood pressure,,,,199,mmHg,1.7678,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69169,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,112 days,29,,CMO:0000004,systolic blood pressure,,,,202,mmHg,1.6713,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69170,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,126 days,26,,CMO:0000004,systolic blood pressure,,,,197,mmHg,4.1184,21.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69171,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,42 days,31,,CMO:0000004,systolic blood pressure,,,,108,mmHg,0.898,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69172,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,146,mmHg,1.2572,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69173,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,70 days,31,,CMO:0000004,systolic blood pressure,,,,176,mmHg,1.8859,10.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69174,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,84 days,31,,CMO:0000004,systolic blood pressure,,,,181,mmHg,1.6524,9.2,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69175,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,98 days,31,,CMO:0000004,systolic blood pressure,,,,197,mmHg,1.7961,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69176,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,112 days,31,,CMO:0000004,systolic blood pressure,,,,206,mmHg,1.4368,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69177,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,126 days,31,,CMO:0000004,systolic blood pressure,,,,208,mmHg,1.4368,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69178,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,42 days,31,,CMO:0000004,systolic blood pressure,,,,112,mmHg,0.3592,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69179,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,144,mmHg,1.9757,11.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69180,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,70 days,31,,CMO:0000004,systolic blood pressure,,,,166,mmHg,1.9577,10.9,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69181,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,84 days,31,,CMO:0000004,systolic blood pressure,,,,191,mmHg,0.7184,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69182,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,98 days,30,,CMO:0000004,systolic blood pressure,,,,195,mmHg,1.4606,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69183,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,112 days,28,,CMO:0000004,systolic blood pressure,,,,199,mmHg,1.8898,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69184,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,126 days,25,,CMO:0000004,systolic blood pressure,,,,201,mmHg,1.4,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69185,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,42 days,33,,CMO:0000004,systolic blood pressure,,,,114,mmHg,0.1741,1.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69186,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,56 days,33,,CMO:0000004,systolic blood pressure,,,,164,mmHg,2.6112,15.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69187,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,70 days,33,,CMO:0000004,systolic blood pressure,,,,186,mmHg,1.2011,6.9,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69188,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,84 days,20,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.5652,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69189,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,98 days,3,,CMO:0000004,systolic blood pressure,,,,195,mmHg,2.8868,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69190,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,42 days,31,,CMO:0000004,systolic blood pressure,,,,106,mmHg,0.1796,1.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69191,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,153,mmHg,2.1553,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69192,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,70 days,31,,CMO:0000004,systolic blood pressure,,,,190,mmHg,0.898,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69193,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,84 days,22,,CMO:0000004,systolic blood pressure,,,,200,mmHg,0.8528,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69194,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,42 days,35,,CMO:0000004,systolic blood pressure,,,,112,mmHg,0.6761,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,69195,control condition,,,,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,56 days,35,,CMO:0000004,systolic blood pressure,,,,153,mmHg,2.0284,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69196,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,70 days,35,,CMO:0000004,systolic blood pressure,,,,188,mmHg,2.1129,12.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69197,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,84 days,34,,CMO:0000004,systolic blood pressure,,,,192,mmHg,0.7889,4.6,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69198,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,98 days,14,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.6036,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69199,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,112 days,5,,CMO:0000004,systolic blood pressure,,,,198,mmHg,1.3416,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69200,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,,,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,126 days,1,,CMO:0000004,systolic blood pressure,,,,193,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69201,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,,,,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,female,91 days to 89 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,3.5,15.6525,MMO:0000011,vascular indwelling catheter method,left femoral artery,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours),69443,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,controlled exposure to darkness (for 12 hours), 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,female,91 days to 89 days,15,,CMO:0000004,systolic blood pressure,,,serial mean,184,mmHg,7.7,29.822,MMO:0000011,vascular indwelling catheter method,left femoral artery,0.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours),69444,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,controlled exposure to darkness (for 12 hours), 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,female,92 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,140.6,mmHg,4.4,19.6774,MMO:0000011,vascular indwelling catheter method,left femoral artery,10800.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69509,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,female,92 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,208,mmHg,7.6,30.4,MMO:0000011,vascular indwelling catheter method,left femoral artery,10800.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69510,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,female,93 days,21,,CMO:0000004,systolic blood pressure,,,serial mean,127.2,mmHg,4.1,18.7886,MMO:0000011,vascular indwelling catheter method,left femoral artery,10800.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69515,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,female,93 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,183,mmHg,10.0,33.1662,MMO:0000011,vascular indwelling catheter method,left femoral artery,10800.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69516,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000145,BN/NHsdMcwi,female,94 days,17,,CMO:0000004,systolic blood pressure,,,serial mean,134.6,mmHg,4.1,16.9047,MMO:0000011,vascular indwelling catheter method,left femoral artery,10800.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69521,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 151,"Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,female,94 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,182.9,mmHg,4.1,13.5982,MMO:0000011,vascular indwelling catheter method,left femoral artery,10800.0,,,,,controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days),69522,controlled sodium content diet (0.4 %) (for 35 days),,,controlled sodium content diet (0.1 %) (for 35 days),,,controlled sodium content diet (8 %) (between 22 and 24 days),,, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,98 days,10,,CMO:0000004,systolic blood pressure,,,,144,mmHg,4.0,12.6491,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) then controlled sodium content diet (0.3 %) (for 28 days),69687,controlled sodium content diet (8 %) (for 28 days),,,controlled sodium content diet (0.3 %) (for 28 days),,,,,, 736,"Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,98 days,4,,CMO:0000004,systolic blood pressure,,,,141,mmHg,8.0,16.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days) then adrenalectomy then controlled sodium content diet (0.3 %) (for 28 days) and dexamethasone (20 ug/d) ,69688,controlled sodium content diet (8 %) (for 28 days),,,adrenalectomy,,,controlled sodium content diet (0.3 %) (for 28 days),dexamethasone (20 ug/d) ,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,112 days,7,,CMO:0000004,systolic blood pressure,,daytime (7 AM - 7 PM),,125.9,mmHg,0.4914,1.3,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled exposure to ambient light (for 12 hours),70081,controlled exposure to ambient light (for 12 hours),,,,,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,112 days,7,,CMO:0000004,systolic blood pressure,,nighttime (7 PM - 7 AM),,130,mmHg,0.5669,1.5,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled exposure to darkness (for 12 hours),70082,controlled exposure to darkness (for 12 hours),,,,,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,126 days,7,,CMO:0000004,systolic blood pressure,,daytime (7 AM - 7 PM),,126.4,mmHg,1.0583,2.8,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 14 days),70085,controlled sodium content diet (8 %) (for 14 days),,,controlled exposure to ambient light (for 14 days),,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,126 days,7,,CMO:0000004,systolic blood pressure,,nighttime (7 PM - 7 AM),,131.7,mmHg,0.8315,2.2,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours),70086,controlled sodium content diet (8 %) (for 14 days),,,controlled exposure to darkness (for 12 hours),,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0003522,WKY.SHR-(D1Mgh14-D1Rat77)/Iwai,male,112 days,8,,CMO:0000004,systolic blood pressure,,daytime (7 AM - 7 PM),,125.5,mmHg,0.5657,1.6,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled exposure to ambient light (for 12 hours),70089,controlled exposure to ambient light (for 12 hours),,,,,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0003522,WKY.SHR-(D1Mgh14-D1Rat77)/Iwai,male,112 days,8,,CMO:0000004,systolic blood pressure,,nighttime (7 PM - 7 AM),,132.8,mmHg,0.4596,1.3,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled exposure to darkness (for 12 hours),70090,controlled exposure to darkness (for 12 hours),,,,,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0003522,WKY.SHR-(D1Mgh14-D1Rat77)/Iwai,male,126 days,8,,CMO:0000004,systolic blood pressure,,daytime (7 AM - 7 PM),,128.6,mmHg,0.8132,2.3,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 12 hours),70093,controlled sodium content diet (8 %) (for 14 days),,,controlled exposure to ambient light (for 12 hours),,,,,, 1281,"Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9.",arterial blood pressure trait,,RS:0003522,WKY.SHR-(D1Mgh14-D1Rat77)/Iwai,male,126 days,8,,CMO:0000004,systolic blood pressure,,nighttime (7 PM - 7 AM),,136.2,mmHg,1.0253,2.9,MMO:0000011,vascular indwelling catheter method,left common carotid artery,0.0,,,,,controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours),70094,controlled sodium content diet (8 %) (for 14 days),,,controlled exposure to darkness (for 12 hours),,,,,, 324,"Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405.",arterial blood pressure trait,,RS:0000069,BB.SHR-(Gnal-D18Mit9)/K,both,98 days to 84 days,25,,CMO:0000004,systolic blood pressure,,,serial mean,122,mmHg,2.8,14.0,MMO:0000054,tail cuff volume pressure recording,tail,0.0,"average of 3 measurements, on 3 different days",,,,control condition,70109,control condition,,,,,,,,, 1358,"Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30.",arterial blood pressure trait,,RS:0001481,SS/JrHsd,female,112 days to 108 days,9,,CMO:0000004,systolic blood pressure,,,,194.4,mmHg,6.2,18.6,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70351,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1358,"Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30.",arterial blood pressure trait,,RS:0003552,SS.SR-(rs65785750-rs13452155)/Opaz,female,112 days to 108 days,10,,CMO:0000004,systolic blood pressure,,,,185.9,mmHg,3.8,12.0167,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70352,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1358,"Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30.",arterial blood pressure trait,,RS:0003553,SS.SR-(rs65785750-rs106808193)/Opaz,female,112 days to 108 days,8,,CMO:0000004,systolic blood pressure,,,,167.9,mmHg,3.2,9.051,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70353,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1418,"Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,0 days,13,,CMO:0000004,systolic blood pressure,,,,132,mmHg,4.0,14.4222,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,control condition,70415,control condition,,,,,,,,, 1418,"Blanc J, et al., J Hypertens. 1999 Nov;17(11):1527-34.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,0 days,15,,CMO:0000004,systolic blood pressure,,,,185,mmHg,5.0,19.3649,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,controlled NG-nitroarginine methyl ester content drinking water (20 mg/kg/d) (between 0 and 672 hours),70417,controlled NG-nitroarginine methyl ester content drinking water (20 mg/kg/d) (between 0 and 672 hours),,,,,,,,, 1458,"Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013.",arterial blood pressure trait,,RS:0001481,SS/JrHsd,male,112 days to 108 days,8,,CMO:0000004,systolic blood pressure,,,,211.7,mmHg,2.4,6.7882,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70501,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1458,"Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013.",arterial blood pressure trait,,RS:0003598,SS.SR-(D2Rat352-rs63922710)/Opaz,female,112 days to 108 days,6,,CMO:0000004,systolic blood pressure,,,,168.4,mmHg,2.0,4.899,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70558,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1458,"Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013.",arterial blood pressure trait,,RS:0003598,SS.SR-(D2Rat352-rs63922710)/Opaz,male,112 days to 108 days,6,,CMO:0000004,systolic blood pressure,,,,180.8,mmHg,3.7,9.0631,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70562,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1458,"Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013.",arterial blood pressure trait,,RS:0003599,SS.SR-(rs106870553-rs63922710)/Opaz,female,112 days to 108 days,10,,CMO:0000004,systolic blood pressure,,,,187,mmHg,3.0,9.4868,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (between 24 and 28 days),70566,controlled sodium content diet (8 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,205,mmHg,3.4,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70580,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,220,mmHg,5.6,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70581,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,191,mmHg,2.1,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70582,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,196,mmHg,6.8,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70583,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003611,SS.LEW-(D5Mco39-D5Mco41)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,190,mmHg,5.6,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70584,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003604,SS.LEW-(D5Mco39-D5Mco57)(D5Mco41-D5Mco47)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,205,mmHg,5.1,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70585,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003607,SS.LEW-(D5Mco39-D5Mco57)(D5Mco42-D5Mco47)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,226,mmHg,5.5,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70586,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003610,SS.LEW-(D5Mco39-D5Mco57)(D5Mco43-D5Mco47)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,181,mmHg,2.5,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70587,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003602,SS.LEW-(D5Mco39-D5Mco57)/1Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,199,mmHg,4.2,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70588,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003605,SS.LEW-(D5Mco39-D5Mco57)/2Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,221,mmHg,6.3,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70589,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003608,SS.LEW-(D5Mco39-D5Mco57)/3Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,184,mmHg,4.3,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70590,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003603,SS.LEW-(D5Mco41-D5Mco47)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,204,mmHg,5.4,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70591,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003606,SS.LEW-(D5Mco42-D5Mco47)/1Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,231,mmHg,4.3,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70592,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003612,SS.LEW-(D5Mco42-D5Mco47)/2Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,187,mmHg,5.2,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70593,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003609,SS.LEW-(D5Mco43-D5Mco47)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,179,mmHg,3.2,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70594,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 1482,"Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11.",arterial blood pressure trait,,RS:0003613,SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco,male,66 days to 62 days,N/A,,CMO:0000004,systolic blood pressure,,,,157,mmHg,4.3,,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (2 %) (between 24 and 28 days),70595,controlled sodium content diet (2 %) (between 24 and 28 days),,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000026,ACI/NHok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,137,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74889,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000028,ACI/NKyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,144,mmHg,6.532,16.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74892,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000028,ACI/NKyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,123,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74895,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000029,ACI-Lystbg-Kyo/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74898,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000030,ACI/NMna,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74901,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000031,ACI/NSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74904,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000040,ALB/Hok,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74907,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000155,BN/SsNHsd,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74910,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000156,BN/SsNSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,137,mmHg,6.532,16.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74913,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000157,BN/fMaiHok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74916,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000165,BUF/Mna,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,110,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74919,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000247,DA/Slc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,145,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74922,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000249,DRH/Seac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,137,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74925,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000249,DRH/Seac,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,160,mmHg,7.7567,19.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74928,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000252,DMY/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74931,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000269,ExHC/Seac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,146,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74934,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000305,F344/DuCrlCrlj,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74937,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000312,F344/Jcl,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,136,mmHg,8.9815,22.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74940,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000317,FH/HamSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74943,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000349,FXLE12/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,160,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74946,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000350,FXLE13/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,153,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74949,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000351,FXLE14/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,8.165,20.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74952,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000352,FXLE15/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,8.165,20.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74955,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000353,FXLE16/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,155,mmHg,11.431,28.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74958,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000354,FXLE17/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74961,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000355,FXLE18/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,120,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74964,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000356,FXLE19/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74967,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000357,FXLE20/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,6.532,16.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74970,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000358,FXLE21/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74973,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000359,FXLE22/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,160,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74976,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000360,FXLE23/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74979,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000361,FXLE24/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74982,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000364,F344/NSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,149,mmHg,6.532,16.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74985,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000366,ACI/NJcl,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,157,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74988,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000378,DON/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,112,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74991,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000378,DON/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,8.165,20.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74994,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000388,HAA/FDSC,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74997,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000388,HAA/FDSC,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,8.165,20.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75000,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000395,HOB/Snk,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75003,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000399,HTX/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,144,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75006,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000400,HWY/Slc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75009,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000410,IS/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,95,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75012,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000410,IS/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,116,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75015,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000415,KHR/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,7.7567,19.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75018,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000424,LAA/FDSC,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,116,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75021,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000424,LAA/FDSC,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75024,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000428,F344/Stm,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75027,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000428,F344/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,137,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75030,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000430,BN/Seac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,117,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75033,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000431,LE/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75036,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000434,KYN/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,119,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75039,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000441,LEA/Hkm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,120,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75042,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000442,LEA/Hok,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,133,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75045,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000442,LEA/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75048,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000446,LEC/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,117,mmHg,13.0639,32.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75051,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000446,LEC/Hok,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,7.7567,19.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75054,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000481,GAERS/Mave,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75057,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000481,GAERS/Mave,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,154,mmHg,7.7567,19.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75060,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000482,GK/Slc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75063,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000486,HOB-Unc5chob/Snk,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75066,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000486,HOB-Unc5chob/Snk,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,10.2062,25.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75069,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000532,LEW/SsNSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,153,mmHg,11.431,28.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75072,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000535,LEXF10A/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75075,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000536,LEXF10B/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75078,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000537,LEXF10C/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75081,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000538,LEXF11/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,153,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75084,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000539,LEXF1A/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75087,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000540,LEXF1C/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75090,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000541,LEXF2A/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,122,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75093,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000542,LEXF2B/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,137,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75096,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000543,LEXF2C/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75099,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000544,LEXF3/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,145,mmHg,11.431,28.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75102,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000545,LEXF4/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75105,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000546,LEXF5/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75108,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000547,LEXF6B/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,124,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75111,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000548,LEXF7A/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,149,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75114,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000549,LEXF7B/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,151,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75117,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000550,LEXF7C/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,151,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75120,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000551,LEXF8A/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,8.165,20.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75123,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000552,LEXF8D/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75126,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000553,LEXF9/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,169,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75129,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000575,MES/Slc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,124,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75132,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000600,NAR/Slc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,157,mmHg,11.0227,27.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75135,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000606,NER/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,122,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75138,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000606,NER/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,120,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75141,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000632,OM/NSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75144,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000647,PVG/Seac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,149,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75147,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000647,PVG/Seac,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75150,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000659,RCS/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75153,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000667,RICO/Ngs,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,123,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75156,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000704,SDJ/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75159,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000711,SER/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,151,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75162,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000745,SHR/Hcm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,198,mmHg,6.532,16.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75165,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000746,SHR/Izm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,182,mmHg,7.7567,19.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75168,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000747,SHR/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,154,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75171,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000747,SHR/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,146,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75174,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000752,SHR/NCrlCrlj,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,169,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75177,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000758,SHR/Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,167,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75180,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,190,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75183,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000771,WKY/Izm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,113,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75186,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000778,SHRSP/Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75189,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000778,SHRSP/Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,225,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75192,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000779,SHRSP/2Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,160,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75195,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000780,SHRSR/Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,148,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75198,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000931,THE/Utp,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75201,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000931,THE/Utp,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75204,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000932,TLE/Utp,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,139,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75207,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000934,TM/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75210,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000934,TM/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75213,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000937,TO/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75216,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000938,TO/Hkm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,155,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75219,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000940,TRM/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75222,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000941,TRMR/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,118,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75225,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000953,VF/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,154,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75228,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000963,W/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75231,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000963,W/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75234,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000971,WAG/RijKyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,117,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75237,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000971,WAG/RijKyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,120,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75240,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000976,WBN/KobSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,150,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75243,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001005,WF/Kop,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,144,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75246,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001018,WKA/Seac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,161,mmHg,10.2062,25.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75249,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001019,WKAH/HkmSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75252,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001036,WKY/NCrlCrlj,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75255,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001071,WKY/Hcm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,162,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75258,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001071,WKY/Hcm,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,139,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75261,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001073,WKY/NMna,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,9.3897,23.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75264,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001073,WKY/NMna,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75267,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001076,WKY/Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75270,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001078,WKYO/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,125,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75273,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001078,WKYO/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75276,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001083,WNA/Nshm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,146,mmHg,9.798,24.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75279,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001090,WTC/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,133,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75282,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001090,WTC/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75285,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001103,ZI/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,167,mmHg,9.3897,23.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75288,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001103,ZI/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,174,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75291,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001206,BN/1Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,137,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75294,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001208,BN/KunKtsSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75297,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001209,BN/KtsSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75300,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001313,FXLE25/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,7.7567,19.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75303,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001314,FXLE26/Stm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,162,mmHg,8.5732,21.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75306,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001318,GRY/Idr,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75309,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001318,GRY/Idr,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,116,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75312,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001320,Gunn-Ugt1a1jSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,147,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75315,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001336,KZ-LeprfaTky,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,115,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75318,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001372,MV/Opu,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,139,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75321,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001372,MV/Opu,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75324,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001374,NE/Mave,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,159,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75327,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001374,NE/Mave,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,157,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75330,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002446,ODS-Gulood/od/ShiJcl,male,70 days to 56 days,6,"Strain RS ID changed from RS:0001378 (ODS/Jcl, RGD:1559039) to RS:0002446 (ODS/ShiJcl, RGD:4140404).",CMO:0000004,systolic blood pressure,,,serial mean,124,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75333,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001420,SHR.ODS-Gulood/Shi,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,185,mmHg,8.165,20.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75336,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001428,SHR/Nig,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,167,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75339,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001428,SHR/Nig,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,169,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75342,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001445,SHRSP/Ezo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75345,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001445,SHRSP/Ezo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,222,mmHg,8.9815,22.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75348,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001446,SHRSP/Ngsk,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,183,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75351,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001594,WKAH/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,120,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75354,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001859,DDI/Ddia,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,147,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75357,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001860,DMYC/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75360,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001861,DOB/Oda,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75363,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001861,DOB/Oda,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75366,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75369,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001862,DRH.F344-(D1Mgh8-D1Mgh12)/Shigm,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,150,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75372,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001867,ExHC/Ta,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75375,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001868,F344-Apcm1Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75378,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001870,F344-Egrm1Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75381,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001873,F344-Kmch/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75384,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001875,F344-Kuru2/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,1.2247,3.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75387,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001875,F344-Kuru2/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.2247,3.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75390,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001877,F344-Scn1am1Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,122,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75395,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001878,F344-Scn1am2Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,1.2247,3.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75398,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001879,F344-Tbr1/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75401,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001881,F344-Trdk/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,159,mmHg,6.9402,17.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75404,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001881,F344-Trdk/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75407,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001882,F344-HrKrh/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,134,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75410,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001926,F344.CVD-Unc5ccvd/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75413,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001927,F344.Cg-Foxn1rnu/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,143,mmHg,8.5732,21.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75416,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001930,F344.LEC-xhs1/1Nrs,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,118,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75419,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001931,F344.LEC-xhs1/2Nrs,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75422,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001934,F344.NER-(D1Mgh6-D1Rat73)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,160,mmHg,9.798,24.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75425,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001934,F344.NER-(D1Mgh6-D1Rat73)/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75428,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001935,F344.NER-(D5Mgh4-D5Rat36)/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,150,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75431,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001935,F344.NER-(D5Mgh4-D5Rat36)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,138,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75434,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001936,F344.NER-(D1Mgh6-D1Rat73)(D5Mgh4-D5Rat36)/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,135,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75437,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001936,F344.NER-(D1Mgh6-D1Rat73)(D5Mgh4-D5Rat36)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75440,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001989,OP/Jtt,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,111,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75443,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001994,FOK/Ncu,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75446,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0001994,FOK/Ncu,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,139,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75449,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002024,KB/Oda,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,154,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75452,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002025,KCI/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75455,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002025,KCI/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,123,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75458,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002031,KFRS2/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,113,mmHg,4.0825,10.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75461,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002032,KFRS3A/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,109,mmHg,5.7155,14.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75464,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002033,KFRS3B/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75467,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002034,KFRS4/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,103,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75470,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002039,KFRS6/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75473,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002065,LEW/JmsNgs,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,184,mmHg,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75476,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002077,NER.F344-(D1Mgh6-D1Rat132)(D5Rat100-D5Rat234)/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,117,mmHg,1.633,4.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75479,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002077,NER.F344-(D1Mgh6-D1Rat132)(D5Rat100-D5Rat234)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,119,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75482,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002078,NER.F344-(D1Mgh6-D1Rat132)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75485,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002079,NER.F344-(D5Rat100-D5Rat234)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75488,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002080,NIG-III/Hok,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,8.5732,21.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75491,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002122,SD-Tg(CAG-Rgn)Slc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,129,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75494,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002254,WIST/Iar,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,114,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75497,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002272,WKY/Ezo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,100,mmHg,8.5732,21.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75500,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002272,WKY/Ezo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,118,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75503,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002275,WST.F344-Kmch/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75506,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002277,WTC-swh/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,140,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75509,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002277,WTC-swh/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,153,mmHg,9.3897,23.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75512,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002277,WTC-swh/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142,mmHg,4.899,12.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75515,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002278,WTC-Kcnq1dfkKyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,175,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75518,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002282,WTC.ZI-Atrnzi/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,151,mmHg,10.6145,26.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75521,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002367,LEW/Seac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,133,mmHg,4.4907,11.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75524,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002368,SHRSP/Hos,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,169,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75527,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0002409,SS/JrSeac,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75530,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003614,"F344.Cg-Du, TyrC/Kyo",male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,150,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75533,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003617,"F344.Cg-Du, TyrCKyo+/+",male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75536,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003620,F344.Cg-Foxn1rnuKyo-/+,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,148,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75539,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003622,F344-Sv2am1Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,133,mmHg,3.266,8.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75542,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003622,F344-Sv2am1Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,127,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75545,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003623,KFRS2/Kyo-/+,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,112,mmHg,2.4495,6.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75548,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003626,KFRS3A/Kyo+/+,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,105,mmHg,5.3072,13.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75551,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003627,MKO/Tami,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,133,mmHg,6.1237,15.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75554,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003627,MKO/Tami,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,11.0227,27.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75557,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003628,NER.F344-(D1Rat132)(D5Rat100)/Kyo,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,123,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75560,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003628,NER.F344-(D1Rat132)(D5Rat100)/Kyo,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,116,mmHg,2.0412,5.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75563,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003629,KHR/Kyo-/+,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,111,mmHg,2.8577,7.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75566,specific pathogen-free condition,,,,,,,,, 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0003634,KHR/Kyo-/-,female,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,112,mmHg,3.6742,9.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,75569,specific pathogen-free condition,,,,,,,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,77 days to 63 days,9,,CMO:0000004,systolic blood pressure,,F,,159,mmHg,2.0,6.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled fructose content diet (66 %) (between 14 and 28 days),75851,controlled fructose content diet (66 %) (between 14 and 28 days),,,,,,,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,77 days to 63 days,8,,CMO:0000004,systolic blood pressure,,C,,141,mmHg,2.0,5.6569,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,control condition,75852,control condition,,,,,,,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,77 days to 63 days,10,,CMO:0000004,systolic blood pressure,,FT,,143,mmHg,2.0,6.3246,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days),75853,controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days),,,controlled fructose content diet (66 %) (between 14 and 28 days),,,,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,77 days to 63 days,8,,CMO:0000004,systolic blood pressure,,CT,,142,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days),75854,controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days),,,,,,,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,0 days,N/A,,CMO:0000004,systolic blood pressure,,F,,160,mmHg,3.0,,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled fructose content diet (66 %) (between 14 and 28 days),75925,controlled fructose content diet (66 %) (between 14 and 28 days),,,,,,,,, 1540,"Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,0 days,8,,CMO:0000004,systolic blood pressure,,FT,,158,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days),75926,controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days),,,controlled fructose content diet (66 %) (between 14 and 28 days),,,insulin (2 U/kg/d) (for 14 days),,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,84 days,18,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,213,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,84602,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000771,WKY/Izm,male,84 days,16,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,118,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,84607,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000771,WKY/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,112,mmHg,,10.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled visible light exposure,84612,controlled visible light exposure,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002493,WKY.SHRSP-(D1Rat171-D1Wox33)/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,115,mmHg,,5.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled visible light exposure,84613,controlled visible light exposure,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000771,WKY/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,120,mmHg,,17.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled exposure to darkness,84614,controlled exposure to darkness,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002493,WKY.SHRSP-(D1Rat171-D1Wox33)/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,121,mmHg,,5.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled exposure to darkness,84615,controlled exposure to darkness,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,213,mmHg,,31.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled visible light exposure,84616,controlled visible light exposure,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002492,SHRSP.WKY-(D1Smu13-D1Wox33)/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,212,mmHg,,24.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled visible light exposure,84617,controlled visible light exposure,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,226,mmHg,,30.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled exposure to darkness,84618,controlled exposure to darkness,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002492,SHRSP.WKY-(D1Smu13-D1Wox33)/Izm,male,94 days,N/A,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,219,mmHg,,22.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled exposure to darkness,84619,controlled exposure to darkness,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0000770,SHRSP/Izm,male,84 days,18,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,213,mmHg,3.7712,16.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,84620,control condition,,,,,,,,, 990,"Xiao B, et al., J Hypertens. 2010 Nov 8.",arterial blood pressure trait,,RS:0002492,SHRSP.WKY-(D1Smu13-D1Wox33)/Izm,male,84 days,10,,CMO:0000004,systolic blood pressure,,avg of 5 measurements for,serial mean,205,mmHg,3.7947,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,84621,control condition,,,,,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,198,mmHg,8.0,43.8178,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96920,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0003859,SS.LEW-(D1Mco36-D1Mco54)/Bj,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,226,mmHg,5.0,27.3861,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96940,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0003860,SS.LEW-(D1Mco36-D1Rat200)/Bj,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,226,mmHg,4.0,21.9089,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96941,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0003861,SS.LEW-(D1Mco36-D1Mco61)/Bj,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,227,mmHg,7.0,38.3406,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96942,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0003862,SS.LEW-(D1Rat200-D1Mco136)/Bj,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,212,mmHg,5.0,27.3861,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96943,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0003863,SS.LEW-(D1Mco55-D1Wox6)/Bj,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,157,mmHg,6.0,32.8634,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96944,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0003864,SS.LEW-(D1Mco134-D1Wox6)/Bj,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,155,mmHg,16.0,87.6356,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96945,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,198,mmHg,8.0,43.8178,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96980,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,194,mmHg,5.0,27.3861,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96981,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,208,mmHg,6.0,32.8634,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96982,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,217,mmHg,5.0,27.3861,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96983,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,226,mmHg,4.0,21.9089,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96984,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0001534,SS.LEW-(D1Mco36-D1Mco101)/Mco,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,173,mmHg,1.0,5.4772,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96985,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 28 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1778,"Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18.",arterial blood pressure trait,,RS:0000924,SS/JrTol,male,66 days to 64 days,30,,CMO:0000004,systolic blood pressure,,average of 2-3 readings/day over 4 days,continuous mean,198,mmHg,2.0,10.9545,MMO:0000031,tail cuff plethysmography,,0.0,"restrained, 28 degrees C",,,,controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days),96986,controlled sodium content diet (0.3 %) (between 10 and 12 days),housing in pairs (between 26 and 66 days),,controlled sodium content diet (2 %) (for 24 days),,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0003421,SHR/Bbb,not specified,70 days,18,,CMO:0000004,systolic blood pressure,undefined,,,180,mmHg,0.9428,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97911,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0003421,SHR/Bbb,not specified,98 days,18,,CMO:0000004,systolic blood pressure,undefined,,,189,mmHg,1.4142,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97912,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0003421,SHR/Bbb,not specified,126 days,18,,CMO:0000004,systolic blood pressure,undefined,,,188,mmHg,0.9428,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97913,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,70 days,18,,CMO:0000004,systolic blood pressure,undefined,,,181,mmHg,3.2998,14.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97914,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,91 days,5,,CMO:0000004,systolic blood pressure,undefined,,,193,mmHg,6.261,14.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 49 days) and controlled potassium content diet (6.3 mg/g) (for 49 days) and controlled sodium content diet (3.7 mg/g) (for 49 days),97915,controlled protein content diet (19.7 %) (for 49 days),controlled potassium content diet (6.3 mg/g) (for 49 days),controlled sodium content diet (3.7 mg/g) (for 49 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004100,SHR-Ndufc2em1Mcwi+/+,not specified,70 days,10,,CMO:0000004,systolic blood pressure,undefined,,,177,mmHg,2.2136,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97916,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004100,SHR-Ndufc2em1Mcwi+/+,not specified,98 days,10,,CMO:0000004,systolic blood pressure,undefined,,,183,mmHg,0.6325,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97917,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004100,SHR-Ndufc2em1Mcwi+/+,not specified,126 days,10,,CMO:0000004,systolic blood pressure,undefined,,,188,mmHg,0.6325,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97918,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004098,SHR-Ndufc2em1Mcwi-/+,not specified,70 days,17,,CMO:0000004,systolic blood pressure,undefined,,,174,mmHg,1.4552,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97919,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004098,SHR-Ndufc2em1Mcwi-/+,not specified,98 days,17,,CMO:0000004,systolic blood pressure,undefined,,,178,mmHg,1.4552,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97920,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004098,SHR-Ndufc2em1Mcwi-/+,not specified,126 days,17,,CMO:0000004,systolic blood pressure,undefined,,,182,mmHg,1.6977,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97921,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004101,SHR-Ndufc2em2Mcwi+/+,not specified,70 days,12,,CMO:0000004,systolic blood pressure,undefined,,,181,mmHg,0.866,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97922,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004101,SHR-Ndufc2em2Mcwi+/+,not specified,98 days,12,,CMO:0000004,systolic blood pressure,undefined,,,181,mmHg,2.5981,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97923,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004101,SHR-Ndufc2em2Mcwi+/+,not specified,126 days,12,,CMO:0000004,systolic blood pressure,undefined,,,190,mmHg,0.866,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97924,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004099,SHR-Ndufc2em2Mcwi-/+,not specified,70 days,26,,CMO:0000004,systolic blood pressure,undefined,,,177,mmHg,1.3728,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days),97925,controlled protein content diet (19.7 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),controlled sodium content diet (3.7 mg/g) (for 28 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004099,SHR-Ndufc2em2Mcwi-/+,not specified,98 days,24,,CMO:0000004,systolic blood pressure,undefined,,,189,mmHg,0.4082,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days),97926,controlled protein content diet (19.7 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),controlled sodium content diet (3.7 mg/g) (for 56 days),,,,,,, 1938,"Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.",arterial blood pressure trait,,RS:0004099,SHR-Ndufc2em2Mcwi-/+,not specified,126 days,16,,CMO:0000004,systolic blood pressure,undefined,,,186,mmHg,1.5,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days),97927,controlled protein content diet (19.7 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),controlled sodium content diet (3.7 mg/g) (for 84 days),,,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0004200,SS.SHR-(D9Mco110-D9Mco124)/Bj,male,70 days to 68 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,157,mmHg,0.82,2.1695,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97951,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0004201,SS.SHR-(D9Mco110-D9Mco121)/Bj,male,70 days to 68 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,171,mmHg,7.24,20.4778,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97952,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0004202,SS.SHR-(D9Mco113-D9Mco124)/Bj,male,70 days to 68 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,164,mmHg,5.22,12.7863,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97953,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0004203,SS.SHR-(D9Mco110-D9Got111)/Bj,male,70 days to 68 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,4.17,10.2144,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97954,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0004204,SS.SHR-(D9Mco110-D9Mco114)/Bj,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,201,mmHg,2.65,11.8512,MMO:0000054,tail cuff volume pressure recording,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97955,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0004205,SS.SHR-(D9Mco115-D9Mco124)/Bj,male,70 days to 68 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,193,mmHg,11.25,27.5568,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97956,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,213,mmHg,2.05,5.4238,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97982,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,201,mmHg,7.4,20.9304,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97983,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,203,mmHg,4.17,10.2144,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97984,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 1958,"Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,70 days to 68 days,20,,CMO:0000004,systolic blood pressure,,,serial mean,195,mmHg,4.72,21.1085,MMO:0000054,tail cuff volume pressure recording,,0.0,,,,,controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days),97985,controlled sodium content diet (0.3 %) (for 12 days),,,controlled sodium content diet (2 %) (for 24 days),,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",arterial blood pressure trait,,RS:0003184,SS-Renem1Mcwi+/+,male,69 days to 66 days,5,,CMO:0000004,systolic blood pressure,,,serial mean,153.22,mmHg,1.42,3.1752,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 66 and 69 days),98373,controlled sodium content diet (0.4 %) (between 66 and 69 days),,,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",arterial blood pressure trait,,RS:0004313,SS-Renem1Mcwi+/-,male,69 days to 66 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,144.19,mmHg,2.22,6.66,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium chloride content diet (0.4 %) (between 66 and 69 days),98376,controlled sodium chloride content diet (0.4 %) (between 66 and 69 days),,,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",arterial blood pressure trait,,RS:0003155,SS-Renem1Mcwi-/-,male,69 days to 66 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,72.07,mmHg,2.42,6.8448,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 66 and 69 days),98379,controlled sodium content diet (0.4 %) (between 66 and 69 days),,,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",arterial blood pressure trait,,RS:0003184,SS-Renem1Mcwi+/+,female,69 days to 66 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,138.76,mmHg,4.52,11.9588,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 66 and 69 days),98382,controlled sodium content diet (0.4 %) (between 66 and 69 days),,,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",arterial blood pressure trait,,RS:0004313,SS-Renem1Mcwi+/-,female,69 days to 66 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,139.28,mmHg,2.25,6.364,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 66 and 69 days),98385,controlled sodium content diet (0.4 %) (between 66 and 69 days),,,,,,,,, 2038,"Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17.",arterial blood pressure trait,,RS:0003155,SS-Renem1Mcwi-/-,male,69 days to 66 days,4,,CMO:0000004,systolic blood pressure,,,serial mean,76.38,mmHg,2.94,5.88,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 66 and 69 days),98388,controlled sodium content diet (0.4 %) (between 66 and 69 days),,,,,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0003090,SS-Plod1em1Mcwi-/-,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,165,mmHg,4.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium chloride content diet (0.4 %) (between 56 and 63 days) then controlled sodium chloride content diet (4 %) (for 10 days),98411,controlled sodium chloride content diet (0.4 %) (between 56 and 63 days),,,controlled sodium chloride content diet (4 %) (for 10 days),,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,155,mmHg,2.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days),98412,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 10 days),,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0003073,SS-Nppaem4Mcwi-/-,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,195,mmHg,5.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days),98413,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 10 days),,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0003267,SS-Clcn6em2Mcwi,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,149,mmHg,2.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days),98414,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 10 days),,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0003127,SS-Mthfrem1Mcwi-/+,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,152,mmHg,6.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days),98415,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 10 days),,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0003018,SS-Agtrapem4Mcwi-/-,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,139,mmHg,2.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days),98416,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 10 days),,,,,, 2059,"Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.",arterial blood pressure trait,,RS:0000922,SS/Hsd,male,67 days to 58 days,N/A,,CMO:0000004,systolic blood pressure,,,serial mean,149,mmHg,2.0,,MMO:0000070,intra-aortic abdominal radiotelemetry,,32400.0,,,,,controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days),98417,controlled sodium content diet (0.4 %) (between 56 and 63 days),,,controlled sodium content diet (4 %) (for 10 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,53 days to 44 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,122,mmHg,1.0,3.7417,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,control condition (0.4 %) (between 23 and 32 days),98479,control condition (0.4 %) (between 23 and 32 days),,,,,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004369,SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi,male,53 days to 44 days,15,,CMO:0000004,systolic blood pressure,,strain 26-N,serial mean,117,mmHg,2.0,7.746,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium chloride content diet (0.4 %) (between 23 and 32 days),98480,controlled sodium chloride content diet (0.4 %) (between 23 and 32 days),,,,,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004370,SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi,male,53 days to 44 days,11,,CMO:0000004,systolic blood pressure,,strain 26-O,serial mean,117,mmHg,2.0,6.6332,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days),98481,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,,,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004371,SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi,male,53 days to 44 days,11,,CMO:0000004,systolic blood pressure,,strain 26-P,serial mean,122,mmHg,2.0,6.6332,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days),98482,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,,,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004372,SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi,male,53 days to 44 days,13,,CMO:0000004,systolic blood pressure,,strain 26-Q,serial mean,121,mmHg,1.0,3.6056,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days),98483,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,,,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,67 days to 58 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,185,mmHg,5.0,18.7083,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days),98500,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,controlled sodium content diet (8 %) (for 14 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004369,SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi,male,67 days to 58 days,15,,CMO:0000004,systolic blood pressure,,strain 26-N,serial mean,153,mmHg,4.0,15.4919,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days),98501,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,controlled sodium content diet (8 %) (for 14 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004370,SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi,male,67 days to 58 days,11,,CMO:0000004,systolic blood pressure,,strain 26-O,serial mean,152,mmHg,4.0,13.2665,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days),98502,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,controlled sodium content diet (8 %) (for 14 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004371,SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi,male,67 days to 58 days,11,,CMO:0000004,systolic blood pressure,,strain 26-P,serial mean,152,mmHg,4.0,13.2665,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days),98503,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,controlled sodium content diet (8 %) (for 14 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004372,SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi,male,67 days to 58 days,13,,CMO:0000004,systolic blood pressure,,strain 26-Q,serial mean,185,mmHg,4.0,14.4222,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days),98504,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,controlled sodium content diet (8 %) (for 14 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004373,SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi,male,67 days to 58 days,10,,CMO:0000004,systolic blood pressure,,strain 26-R,serial mean,168,mmHg,5.0,15.8114,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium chloride content diet (0.4 %) (between 23 and 32 days) then controlled sodium chloride content diet (8 %) (for 14 days),98505,controlled sodium chloride content diet (0.4 %) (between 23 and 32 days),,,controlled sodium chloride content diet (8 %) (for 14 days),,,,,, 2079,"Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3.",arterial blood pressure trait,,RS:0004374,SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi,male,67 days to 58 days,15,,CMO:0000004,systolic blood pressure,,strain 26-S,serial mean,181,mmHg,5.0,19.3649,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,carotid a. to thoracic aorta implant,,,,controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days),98506,controlled sodium content diet (0.4 %) (between 23 and 32 days),,,controlled sodium content diet (8 %) (for 14 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,67 days to 60 days,12,,CMO:0000004,systolic blood pressure,,,serial mean,204,mmHg,4.0,13.8564,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98566,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0001711,SS.BN-(D13Rat151-D13Rat197)/Mcwi,male,67 days to 60 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,5.0,18.7083,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98567,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004375,SS.BN-(D13Got42-D13Rat61)/Mcwi,male,67 days to 60 days,13,,CMO:0000004,systolic blood pressure,,strain 26-A,serial mean,191,mmHg,6.0,21.6333,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98568,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004376,SS.BN-(D13Got42-D13Got45)/Mcwi,male,67 days to 60 days,13,,CMO:0000004,systolic blood pressure,,strain 26-B,serial mean,194,mmHg,7.0,25.2389,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98569,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004377,SS.BN-(D13Got42-D13Rat130)/Mcwi,male,67 days to 60 days,14,,CMO:0000004,systolic blood pressure,,strain 26-C,serial mean,182,mmHg,4.0,14.9666,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98570,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004378,SS.BN-(D13Got42-D13Hmgc354)/Mcwi,male,67 days to 60 days,16,,CMO:0000004,systolic blood pressure,,strain 26-D,serial mean,183,mmHg,6.0,24.0,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98571,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004379,SS.BN-(D13Got42-D13Hmgc497)/Mcwi,male,67 days to 60 days,7,,CMO:0000004,systolic blood pressure,,strain 26-E,serial mean,150,mmHg,6.0,15.8745,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98572,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004380,SS.BN-(D13Got42-D13Hmgc885)/Mcwi,male,67 days to 60 days,15,,CMO:0000004,systolic blood pressure,,strain 26-F,serial mean,171,mmHg,5.0,19.3649,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98573,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004381,SS.BN-(D13Got42-D13Hmgc664)/Mcwi,male,67 days to 60 days,5,,CMO:0000004,systolic blood pressure,,strain 26-G,serial mean,170,mmHg,6.0,13.4164,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98574,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004382,SS.BN-(D13Mit5-D13Rat32)/Mcwi,male,67 days to 60 days,14,,CMO:0000004,systolic blood pressure,,strain 26-H,serial mean,210,mmHg,11.0,41.1582,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98575,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004383,SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi,male,67 days to 60 days,14,,CMO:0000004,systolic blood pressure,,strain 26-I,serial mean,196,mmHg,6.0,22.4499,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98576,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004384,SS.BN-(D13Hmgc354-D13Rat32)/Mcwi,male,67 days to 60 days,15,,CMO:0000004,systolic blood pressure,,strain 26-J,serial mean,151,mmHg,5.0,19.3649,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98577,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004385,SS.BN-(D13Rat130-D13Rat32)/Mcwi,male,67 days to 60 days,12,,CMO:0000004,systolic blood pressure,,strain 26-K,serial mean,159,mmHg,4.0,13.8564,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98578,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004368,SS.BN-(D13Got45-D13Hmgc664)/Mcwi,male,67 days to 60 days,14,,CMO:0000004,systolic blood pressure,,strain 26-M,serial mean,156,mmHg,3.0,11.225,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98579,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2098,"Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8.",arterial blood pressure trait,,RS:0004386,SS.BN-(D13Got45-D13Rat32)/Mcwi,male,67 days to 60 days,12,,CMO:0000004,systolic blood pressure,,strain 26-L,serial mean,165,mmHg,5.0,17.3205,MMO:0000579,intra-aortic thoracic radiotelemetry via carotid cannulation,,10800.0,intra-carotid radiotelemetry,,,,controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days),98651,controlled sodium content diet (0.4 %) (between 46 and 50.8 days),,,controlled sodium content diet (8 %) (for 13.4 days),,,,,, 2159,"Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28.",arterial blood pressure trait,,RS:0001013,WI,female,0 days,16,,CMO:0000004,systolic blood pressure,30 min mean,,continuous mean,123.1,mmHg,1.7,6.8,MMO:0000031,tail cuff plethysmography,,1800.0,following 8 wk protocol,swim,1,days,swimming with water weights (for 1 hours),98739,swimming with water weights (for 1 hours),,,,,,,,, 2159,"Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28.",arterial blood pressure trait,,RS:0001013,WI,female,0 days,16,,CMO:0000004,systolic blood pressure,30 min mean,,continuous mean,125.2,mmHg,0.9,3.6,MMO:0000031,tail cuff plethysmography,,1800.0,following 8 wk protocol,,,,swimming (for 0.2 hours),98740,swimming (for 0.2 hours),,,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",arterial blood pressure trait,,RS:0000284,OLETF,male,364 days,12,,CMO:0000004,systolic blood pressure,undefined,,,153.4,mmHg,4.3,14.8956,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 84 days),99421,control condition (for 84 days),,,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",arterial blood pressure trait,,RS:0000284,OLETF,male,364 days,11,,CMO:0000004,systolic blood pressure,undefined,,,138.9,mmHg,5.0,16.5831,MMO:0000031,tail cuff plethysmography,,0.0,,,,,olmesartan medoxomil (0.35 mg/kg/d) (for 84 days),99422,olmesartan medoxomil (0.35 mg/kg/d) (for 84 days),,,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",arterial blood pressure trait,,RS:0000284,OLETF,male,364 days,12,,CMO:0000004,systolic blood pressure,undefined,,,132.1,mmHg,3.3,11.4315,MMO:0000031,tail cuff plethysmography,,0.0,,,,,olmesartan medoxomil (3.8 mg/kg/d) (for 84 days),99423,olmesartan medoxomil (3.8 mg/kg/d) (for 84 days),,,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",arterial blood pressure trait,,RS:0000284,OLETF,male,364 days,11,,CMO:0000004,systolic blood pressure,undefined,,,124,mmHg,3.2,10.6132,MMO:0000031,tail cuff plethysmography,,0.0,,,,,temocapril (3.9 mg/kg/d) (for 84 days),99424,temocapril (3.9 mg/kg/d) (for 84 days),,,,,,,,, 2298,"Koga K, et al., Mol Med. 2002 Oct;8(10):591-9.",arterial blood pressure trait,,RS:0001349,LETO,male,364 days,11,,CMO:0000004,systolic blood pressure,undefined,,,128.5,mmHg,4.7,15.5881,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 84 days),99425,control condition (for 84 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003076,SS-Nppbem2Mcwi+/+,male,84 days,2,,CMO:0000004,systolic blood pressure,,,,126,mmHg,5.0,7.0711,MMO:0000581,intra-aortic abdominal radiotelemetry via abdominal aorta cannulation,,0.0,,,,,control condition (for 84 days),99519,control condition (for 84 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,84 days,2,,CMO:0000004,systolic blood pressure,,,,127,mmHg,5.0,7.0711,MMO:0000581,intra-aortic abdominal radiotelemetry via abdominal aorta cannulation,,0.0,,,,,control condition (for 84 days),99520,control condition (for 84 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003076,SS-Nppbem2Mcwi+/+,male,168 days,5,,CMO:0000004,systolic blood pressure,,,,114,mmHg,11.0,24.5967,MMO:0000581,intra-aortic abdominal radiotelemetry via abdominal aorta cannulation,,0.0,,,,,control condition (for 168 days),99521,control condition (for 168 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,168 days,3,,CMO:0000004,systolic blood pressure,,,,115,mmHg,6.0,10.3923,MMO:0000581,intra-aortic abdominal radiotelemetry via abdominal aorta cannulation,,0.0,,,,,control condition (for 168 days),99522,control condition (for 168 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003076,SS-Nppbem2Mcwi+/+,male,222 days,3,,CMO:0000004,systolic blood pressure,,,,123,mmHg,3.0,5.1962,MMO:0000581,intra-aortic abdominal radiotelemetry via abdominal aorta cannulation,,0.0,,,,,control condition (for 222 days),99523,control condition (for 222 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,222 days,3,,CMO:0000004,systolic blood pressure,,,,210,mmHg,15.0,25.9808,MMO:0000581,intra-aortic abdominal radiotelemetry via abdominal aorta cannulation,,0.0,,,,,control condition (for 222 days),99524,control condition (for 222 days),,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,84 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,172,mmHg,13.0,34.3948,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,99828,vehicle control condition,,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,84 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,141,mmHg,12.0,29.3939,MMO:0000031,tail cuff plethysmography,,0.0,,,,,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,99829,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,168 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,195,mmHg,30.0,79.3725,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,99830,vehicle control condition,,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,168 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,175,mmHg,8.0,19.5959,MMO:0000031,tail cuff plethysmography,,0.0,,,,,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,99831,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,252 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,197,mmHg,26.0,68.7895,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,99832,vehicle control condition,,,,,,,,, 2319,"Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11.",arterial blood pressure trait,,RS:0003075,SS-Nppbem2Mcwi-/-,male,252 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,201,mmHg,17.0,41.6413,MMO:0000031,tail cuff plethysmography,,0.0,,,,,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,99833,gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) ,,,,,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,152,mmHg,1.0607,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,stz,154,days,streptozotocin (60 mg/kg) then insulin,99899,streptozotocin (60 mg/kg) ,,,insulin,,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,128,mmHg,1.0607,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,stz,154,days,streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days),99900,streptozotocin (60 mg/kg) ,,,insulin,,,Moexipril (30-35 mg/kg/d) (for 112 days),,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,127,mmHg,1.0607,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,days,control condition,99901,control condition,,,,,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,150,mmHg,1.4142,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,stz,224,days,streptozotocin (60 mg/kg) then insulin,99923,streptozotocin (60 mg/kg) ,,,insulin,,,,,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,128,mmHg,1.0607,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,stz,224,days,streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days),99924,streptozotocin (60 mg/kg) ,,,insulin,,,Moexipril (30-35 mg/kg/d) (for 112 days),,, 2358,"Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,126,mmHg,1.0607,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,days,control condition,99925,control condition,,,,,,,,, 2418,"McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,126 days,16,,CMO:0000004,systolic blood pressure,,,,155,mmHg,3.0,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,physical restraint (20-30 min/d) (for 4 days),100079,physical restraint (20-30 min/d) (for 4 days),,,,,,,,, 2418,"McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27.",arterial blood pressure trait,,RS:0003288,SS-Leprem2Mcwi,male,126 days,13,,CMO:0000004,systolic blood pressure,,,,201,mmHg,10.0,36.0555,MMO:0000031,tail cuff plethysmography,,0.0,,,,,physical restraint (20-30 min/d) (for 4 days),100080,physical restraint (20-30 min/d) (for 4 days),,,,,,,,, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000709,SDT/Jcl,male,140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,114.9,mmHg,3.1,7.5934,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days),100111,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),,,,,, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000681,SD,male,140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,113.6,mmHg,4.1,10.0429,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days),100112,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),,,,,, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000709,SDT/Jcl,male,140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,131.8,mmHg,5.8,14.207,MMO:0000031,tail cuff plethysmography,,0.0,,unx,84,days,nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days),100113,nephrectomy,,,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),,, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000681,SD,male,140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142.8,mmHg,6.4,15.6767,MMO:0000031,tail cuff plethysmography,,0.0,,unx,84,days,nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days),100114,nephrectomy,,,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),,, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000709,SDT/Jcl,male,140 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,128.6,mmHg,3.7,9.7893,MMO:0000031,tail cuff plethysmography,,0.0,,unx,84,days,nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days),100115,nephrectomy,,,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),paricalcitol (0.1 ug/kg) (for 70 days),, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000681,SD,male,140 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,134.3,mmHg,13.2,37.3352,MMO:0000031,tail cuff plethysmography,,0.0,,unx,84,days,nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) and paricalcitol (0.1 ug/kg) (for 70 days),100116,nephrectomy,,,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),paricalcitol (0.1 ug/kg) (for 70 days),, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000709,SDT/Jcl,male,140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,131.1,mmHg,5.9,14.452,MMO:0000031,tail cuff plethysmography,,0.0,,unx,84,days,nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days),100117,nephrectomy,,,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),paricalcitol (0.3 ug/kg) (for 70 days),, 2419,"Watanabe K, et al., J Atheroscler Thromb. 2017 Jul 1. doi: 10.5551/jat.40170.",arterial blood pressure trait,,RS:0000681,SD,male,140 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,142.6,mmHg,7.1,17.3914,MMO:0000031,tail cuff plethysmography,,0.0,,unx,84,days,nephrectomy then controlled content diet (1.2 %) (for 70 days) then controlled calcium content diet (1 %) (for 70 days) and paricalcitol (0.3 ug/kg) (for 70 days),100118,nephrectomy,,,controlled content diet (1.2 %) (for 70 days),,,controlled calcium content diet (1 %) (for 70 days),paricalcitol (0.3 ug/kg) (for 70 days),, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,60 days,15,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,126,mmHg,1.291,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100167,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,60 days,5,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,123,mmHg,2.6833,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100168,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,90 days,8,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,140,mmHg,2.8284,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100169,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,90 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,133,mmHg,3.0,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100170,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,120 days,15,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,147,mmHg,1.291,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100171,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,120 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,133,mmHg,1.8091,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100172,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,180 days,3,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,157,mmHg,1.7321,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100173,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,180 days,3,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,134,mmHg,2.3094,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100174,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,210 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,161,mmHg,3.0,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100175,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,210 days,5,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,136,mmHg,1.7889,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100176,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,120 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,146,mmHg,2.0412,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100177,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,130 days,1,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,117,mmHg,4.0,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),100178,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,130 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,148,mmHg,1.633,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100179,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,120 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,146,mmHg,1.0,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100180,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,130 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,129,mmHg,2.5,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),100181,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,120 days,5,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,145,mmHg,2.2361,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100182,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,130 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,125,mmHg,1.5,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled losartan content drinking water (5 mg/kg/d) (for 10 days),100183,controlled losartan content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,60 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,124,mmHg,1.0,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100184,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,70 days,4,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,121,mmHg,1.5,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),100185,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,60 days,3,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,126,mmHg,0.5774,1.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100186,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0001381,PCK-Pkhd1pck/CrljCrl,male,70 days,3,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,123,mmHg,0.5774,1.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled losartan content drinking water (5 mg/kg/d) (for 10 days),100187,controlled losartan content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,120 days,1,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,121,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100188,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,120 days,1,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,119,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,100189,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,130 days,1,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,116,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled losartan content drinking water (5 mg/kg/d) (for 10 days),100190,controlled losartan content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000594,MWF,male,280 days,10,,CMO:0000004,systolic blood pressure,undefined,,,171,mmHg,1.2649,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 280 days),100230,control condition (for 280 days),,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000594,MWF,male,280 days,10,,CMO:0000004,systolic blood pressure,undefined,,,170,mmHg,2.5298,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,lisinopril (80-100 mg/l) ,100231,lisinopril (80-100 mg/l) ,,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000742,WKY,male,280 days,9,,CMO:0000004,systolic blood pressure,undefined,,,130,mmHg,2.3333,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 280 days),100232,control condition (for 280 days),,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000594,MWF,male,350 days,10,,CMO:0000004,systolic blood pressure,undefined,,,173,mmHg,1.5811,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 350 days),100233,control condition (for 350 days),,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000594,MWF,male,350 days,10,,CMO:0000004,systolic blood pressure,undefined,,,138,mmHg,1.5811,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,lisinopril (80-100 mg/l) (for 70 days),100234,lisinopril (80-100 mg/l) (for 70 days),,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000594,MWF,male,420 days to 402 days,10,Ages originally entered as low bound 420 days and high bound 402 days.,CMO:0000004,systolic blood pressure,undefined,,,181,mmHg,2.2136,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 420 days),100235,control condition (for 420 days),,,,,,,,, 2459,"Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.",arterial blood pressure trait,,RS:0000594,MWF,male,420 days,10,,CMO:0000004,systolic blood pressure,undefined,,,130,mmHg,8.2219,26.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,lisinopril (80-100 mg/l) (for 140 days),100236,lisinopril (80-100 mg/l) (for 140 days),,,,,,,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",arterial blood pressure trait,,RS:0000742,WKY,male,280 days to 266 days,5,,CMO:0000004,systolic blood pressure,10 min mean,,continuous mean,97.8,mmHg,6.3,14.0872,MMO:0000014,vascular transducer tipped catheter,,0.0,,lad occlusion sham,210,days,sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) ,100315,sham surgical control condition (for 224 days),,,ketamine (80 mg/kg) ,,,xylazine (10 mg/kg) ,,, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",arterial blood pressure trait,,RS:0000742,WKY,male,280 days to 266 days,16,,CMO:0000004,systolic blood pressure,10 min mean,,continuous mean,79.5,mmHg,5.1,20.4,MMO:0000014,vascular transducer tipped catheter,,0.0,,lad occlusion,210,days,left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) ,100316,left anterior descending coronary artery occlusion (for 224 days),,,furosemide (10 mg/kg/d) (for 161 days),,,ketamine (80 mg/kg) ,,xylazine (10 mg/kg) , 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",arterial blood pressure trait,,RS:0000742,WKY,male,280 days to 266 days,32,,CMO:0000004,systolic blood pressure,10 min mean,,continuous mean,75.1,mmHg,2.4,13.5765,MMO:0000014,vascular transducer tipped catheter,,0.0,,lad occlusion,210,days,left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) ,100317,left anterior descending coronary artery occlusion (for 224 days),,,furosemide (10 mg/kg/d) (for 161 days),,,ramipril (1 mg/kg/d) (for 182 days),,ketamine (80 mg/kg) ,xylazine (10 mg/kg) 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,9,,CMO:0000004,systolic blood pressure,,,,106,mmHg,3.0,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100445,0.9% sodium chloride solution (3 ml) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,7,,CMO:0000004,systolic blood pressure,,,,112,mmHg,5.0,13.2288,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,15,days,puromycin aminonucleoside (50 mg/kg) ,100446,puromycin aminonucleoside (50 mg/kg) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,5,,CMO:0000004,systolic blood pressure,,,,95,mmHg,9.0,20.1246,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,15,days,controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) ,100447,controlled enalapril content drinking water (50 mg/l) (for 22 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,8,,CMO:0000004,systolic blood pressure,,,,117,mmHg,2.0,5.6569,MMO:0000031,tail cuff plethysmography,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100448,0.9% sodium chloride solution (3 ml) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,9,,CMO:0000004,systolic blood pressure,,,,121,mmHg,2.0,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100449,puromycin aminonucleoside (50 mg/kg) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,8,,CMO:0000004,systolic blood pressure,,,,100,mmHg,1.0,2.8284,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,,,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) ,100450,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,9,,CMO:0000004,systolic blood pressure,,,,108,mmHg,3.0,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100451,0.9% sodium chloride solution (3 ml) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,8,,CMO:0000004,systolic blood pressure,,,,113,mmHg,4.0,11.3137,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,490,days,puromycin aminonucleoside (50 mg/kg) ,100452,puromycin aminonucleoside (50 mg/kg) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,9,,CMO:0000004,systolic blood pressure,,,,96,mmHg,2.0,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,490,days,controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) ,100453,controlled enalapril content drinking water (50 mg/l) (for 497 days),,,puromycin aminonucleoside (50 mg/kg) ,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,5,,CMO:0000004,systolic blood pressure,,,,119,mmHg,3.0,6.7082,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100592,puromycin aminonucleoside (50 mg/kg) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,5,,CMO:0000004,systolic blood pressure,,,,118,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,70,days,puromycin aminonucleoside (50 mg/kg) (for 70 days) then saralasin (0.3 mg/kg/hr) (for 0.5 hours),100593,puromycin aminonucleoside (50 mg/kg) (for 70 days),,,saralasin (0.3 mg/kg/hr) (for 0.5 hours),,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,5,,CMO:0000004,systolic blood pressure,,,,127,mmHg,5.0,11.1803,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100594,puromycin aminonucleoside (50 mg/kg) ,,,,,,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",arterial blood pressure trait,,RS:0000742,WKY,male,0 days,5,,CMO:0000004,systolic blood pressure,,,,131,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,PA IV 50mg/kg,,,0.9% sodium chloride solution (50 mg/kg) (for 0.5 hours) then 0.9% sodium chloride solution,100595,,,,0.9% sodium chloride solution (50 mg/kg) (for 0.5 hours),,,0.9% sodium chloride solution,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,182.5,mmHg,6.6,16.1666,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days),100862,right nephrectomy (for 56 days),,,,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,180.6,mmHg,7.7,24.3495,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) ,100863,right nephrectomy (for 56 days),,,reserpine (5 mg/l) ,hydralazine (80 mg/l) ,controlled hydralazine content drinking water (25 mg/l) ,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,177,mmHg,5.0,15.8114,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then captopril (30 mg/kg/d) ,100864,right nephrectomy (for 56 days),,,captopril (30 mg/kg/d) ,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,9,,CMO:0000004,systolic blood pressure,undefined,,,183.8,mmHg,5.1,15.3,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) ,100865,right nephrectomy (for 56 days),,,enalapril (20 mg/kg/d) ,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,189.5,mmHg,7.0,22.1359,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then lisinopril (10 mg/kg/d) ,100866,right nephrectomy (for 56 days),,,lisinopril (10 mg/kg/d) ,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,204.3,mmHg,9.7,25.6638,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then angiotensin II receptor antagonist (20 mg/l) ,100867,right nephrectomy (for 56 days),,,angiotensin II receptor antagonist (20 mg/l) ,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,207,mmHg,17.7,39.5784,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then angiotensin II receptor antagonist (80 mg/l) ,100868,right nephrectomy (for 56 days),,,angiotensin II receptor antagonist (80 mg/l) ,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,190,mmHg,10.0,24.4949,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days),100869,right nephrectomy (for 84 days),,,,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,131.1,mmHg,4.0,12.6491,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days),100870,right nephrectomy (for 84 days),,,reserpine (5 mg/l) (for 28 days),hydralazine (80 mg/l) (for 28 days),controlled hydralazine content drinking water (25 mg/l) (for 28 days),,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,131,mmHg,3.9,12.3329,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then captopril (30 mg/kg/d) (for 28 days),100871,right nephrectomy (for 84 days),,,captopril (30 mg/kg/d) (for 28 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,9,,CMO:0000004,systolic blood pressure,undefined,,,141.3,mmHg,6.4,19.2,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then enalapril (20 mg/kg/d) (for 28 days),100872,right nephrectomy (for 84 days),,,enalapril (20 mg/kg/d) (for 28 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,129.4,mmHg,7.9,24.982,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then lisinopril (10 mg/kg/d) (for 28 days),100873,right nephrectomy (for 84 days),,,lisinopril (10 mg/kg/d) (for 28 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,157.1,mmHg,15.3,40.48,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then angiotensin II receptor antagonist (20 mg/l) (for 28 days),100874,right nephrectomy (for 84 days),,,angiotensin II receptor antagonist (20 mg/l) (for 28 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,150,mmHg,9.4,21.019,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,84,days,right nephrectomy (for 84 days) then angiotensin II receptor antagonist (80 mg/l) (for 28 days),100875,right nephrectomy (for 84 days),,,angiotensin II receptor antagonist (80 mg/l) (for 28 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,180.8,mmHg,8.5,20.8207,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days),100876,right nephrectomy (for 112 days),,,,,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,135,mmHg,6.4,20.2386,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days),100877,right nephrectomy (for 112 days),,,captopril (30 mg/kg/d) (for 56 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,9,,CMO:0000004,systolic blood pressure,undefined,,,140.6,mmHg,5.3,15.9,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days),100878,right nephrectomy (for 112 days),,,enalapril (20 mg/kg/d) (for 56 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,135,mmHg,4.5,14.2302,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days),100879,right nephrectomy (for 112 days),,,lisinopril (10 mg/kg/d) (for 56 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,10,,CMO:0000004,systolic blood pressure,undefined,,,149.4,mmHg,8.3,26.2469,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days),100880,right nephrectomy (for 112 days),,,reserpine (5 mg/l) (for 56 days),hydralazine (80 mg/l) (for 56 days),controlled hydralazine content drinking water (25 mg/l) (for 56 days),,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,144,mmHg,9.1,20.3482,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days),100881,right nephrectomy (for 112 days),,,angiotensin II receptor antagonist (80 mg/l) (for 56 days),,,,,, 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,148.6,mmHg,13.5,35.7176,MMO:0000031,tail cuff plethysmography,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days),100882,right nephrectomy (for 112 days),,,angiotensin II receptor antagonist (20 mg/l) (for 56 days),,,,,, 2563,"Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10.",arterial blood pressure trait,,RS:0001013,WI,male,102 days,21,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,119,mmHg,0.75,3.4369,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days),101055,controlled in utero environment (for 21 days),standard diet (100 % of calories) (for 21 days),,,,,,,, 2563,"Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10.",arterial blood pressure trait,,RS:0001013,WI,male,102 days,35,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,135.7,mmHg,0.35,2.0706,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days),101056,controlled in utero environment (for 21 days),standard diet (50 % of calories) (for 21 days),,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",arterial blood pressure trait,,RS:0000681,SD,male,77 days,6,,CMO:0000004,systolic blood pressure,undefined,,,125,mmHg,3.0,7.3485,MMO:0000031,tail cuff plethysmography,,0.0,,lad occlusion,28,days,left anterior descending coronary artery occlusion (for 28 days),101087,left anterior descending coronary artery occlusion (for 28 days),,,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",arterial blood pressure trait,,RS:0000681,SD,male,77 days,6,,CMO:0000004,systolic blood pressure,undefined,,,134,mmHg,2.0,4.899,MMO:0000031,tail cuff plethysmography,,0.0,,sham lad occlusion,28,days,sham surgical control condition (for 28 days),101088,sham surgical control condition (for 28 days),,,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",arterial blood pressure trait,,RS:0000681,SD,male,189 days,10,,CMO:0000004,systolic blood pressure,undefined,,,143,mmHg,3.0,9.4868,MMO:0000031,tail cuff plethysmography,,0.0,,lad occlusion,140,days,left anterior descending coronary artery occlusion (for 140 days),101089,left anterior descending coronary artery occlusion (for 140 days),,,,,,,,, 2564,"Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7.",arterial blood pressure trait,,RS:0000681,SD,male,189 days,6,,CMO:0000004,systolic blood pressure,undefined,,,144,mmHg,2.0,4.899,MMO:0000031,tail cuff plethysmography,,0.0,,sham lad occlusion,140,days,sham surgical control condition (for 140 days),101090,sham surgical control condition (for 140 days),,,,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,122,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,unx,14,days,unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) ,101158,unilateral nephrectomy (for 14 days),,,puromycin aminonucleoside (100 mg/kg) ,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,118,mmHg,2.0,5.2915,MMO:0000031,tail cuff plethysmography,,0.0,,unx,14,days,unilateral nephrectomy (for 14 days) then vehicle control condition,101159,unilateral nephrectomy (for 14 days),,,vehicle control condition,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,94,mmHg,3.0,6.7082,MMO:0000031,tail cuff plethysmography,,0.0,,unx,14,days,unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) ,101160,unilateral nephrectomy (for 14 days),captopril (500 mg/l) (for 14 days),,puromycin aminonucleoside (100 mg/kg) ,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,118,mmHg,3.0,7.9373,MMO:0000031,tail cuff plethysmography,,0.0,,doxorubicin,0,days,doxorubicin (2 mg/kg) ,101161,doxorubicin (2 mg/kg) ,,,,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,125,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,unx,42,days,unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) ,101162,unilateral nephrectomy (for 42 days),,,puromycin aminonucleoside (100 mg/kg) ,,,puromycin aminonucleoside (40 mg/kg) ,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,118,mmHg,2.0,5.2915,MMO:0000031,tail cuff plethysmography,,0.0,,unx,42,days,unilateral nephrectomy (for 14 days) then vehicle control condition,101163,unilateral nephrectomy (for 14 days),,,vehicle control condition,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,95,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,unx,42,days,unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) ,101164,unilateral nephrectomy (for 14 days),captopril (500 mg/l) (for 42 days),,puromycin aminonucleoside (100 mg/kg) ,,,puromycin aminonucleoside (40 mg/kg) ,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,127,mmHg,7.0,18.5203,MMO:0000031,tail cuff plethysmography,,0.0,,doxorubicin,17,days,doxorubicin (2 mg/kg) ,101165,doxorubicin (2 mg/kg) ,,,,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,18,,CMO:0000004,systolic blood pressure,undefined,,,120,mmHg,4.0,16.9706,MMO:0000031,tail cuff plethysmography,,0.0,,control,17,days,control condition,101166,control condition,,,,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,122,mmHg,3.0,7.3485,MMO:0000031,tail cuff plethysmography,,0.0,,unx,70,days,unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) ,101167,unilateral nephrectomy (for 70 days),,,puromycin aminonucleoside (100 mg/kg) ,,,puromycin aminonucleoside (40 mg/kg) ,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,122,mmHg,2.0,5.2915,MMO:0000031,tail cuff plethysmography,,0.0,,unx,70,days,unilateral nephrectomy (for 70 days) then vehicle control condition,101168,unilateral nephrectomy (for 70 days),,,vehicle control condition,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,100,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,unx,70,days,unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) ,101169,unilateral nephrectomy (for 70 days),captopril (500 mg/l) (for 70 days),,puromycin aminonucleoside (100 mg/kg) ,,,puromycin aminonucleoside (40 mg/kg) ,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,137,mmHg,4.0,10.583,MMO:0000031,tail cuff plethysmography,,0.0,,doxorubicin,29,days,doxorubicin (2 mg/kg) ,101170,doxorubicin (2 mg/kg) ,,,,,,,,, 2581,"Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30.",arterial blood pressure trait,,RS:0000592,MW,male,0 days,18,,CMO:0000004,systolic blood pressure,undefined,,,119,mmHg,5.0,21.2132,MMO:0000031,tail cuff plethysmography,,0.0,,control,29,days,control condition,101171,control condition,,,,,,,,, 2584,"Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,144,mmHg,5.0,15.8114,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 84 days),101282,control condition (for 84 days),,,,,,,,, 2584,"Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,547 days,10,,CMO:0000004,systolic blood pressure,,,,146,mmHg,7.0,22.1359,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 547 days),101283,control condition (for 547 days),,,,,,,,, 2584,"Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,730 days,10,,CMO:0000004,systolic blood pressure,,,,143,mmHg,9.0,28.4605,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 730 days),101284,control condition (for 730 days),,,,,,,,, 2584,"Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,912 days,10,,CMO:0000004,systolic blood pressure,,,,151,mmHg,9.0,28.4605,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 912 days),101285,control condition (for 912 days),,,,,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,90,mmHg,6.0,14.6969,MMO:0000031,tail cuff plethysmography,,0.0,,acf,4,days,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days),101344,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days),,,artificial aortocaval fistula (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,106,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,4,days,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days),101345,controlled ramipril content drinking water (3 mg/kg/d) (for 5 days),,,sham surgical control condition (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,103,mmHg,6.0,14.6969,MMO:0000031,tail cuff plethysmography,,0.0,,acf,4,days,vehicle control condition then artificial aortocaval fistula (for 4 days),101346,vehicle control condition,,,artificial aortocaval fistula (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,123,mmHg,5.0,11.1803,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,4,days,vehicle control condition then sham surgical control condition (for 4 days),101347,vehicle control condition,,,sham surgical control condition (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,101,mmHg,5.0,13.2288,MMO:0000031,tail cuff plethysmography,,0.0,,acf,7,days,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days),101348,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days),,,artificial aortocaval fistula (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,129,mmHg,6.0,13.4164,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,7,days,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days),101349,controlled ramipril content drinking water (3 mg/kg/d) (for 8 days),,,sham surgical control condition (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,116,mmHg,4.0,10.583,MMO:0000031,tail cuff plethysmography,,0.0,,acf,7,days,vehicle control condition then artificial aortocaval fistula (for 7 days),101350,vehicle control condition,,,artificial aortocaval fistula (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,130,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,7,days,vehicle control condition then sham surgical control condition (for 7 days),101351,vehicle control condition,,,sham surgical control condition (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,110,mmHg,6.0,15.8745,MMO:0000031,tail cuff plethysmography,,0.0,,acf,9,days,controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days),101352,controlled ramipril content drinking water (3 mg/kg/d) (for 10 days),,,artificial aortocaval fistula (for 9 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,130,mmHg,10.0,26.4575,MMO:0000031,tail cuff plethysmography,,0.0,,acf,9,days,vehicle control condition then artificial aortocaval fistula (for 9 days),101353,vehicle control condition,,,artificial aortocaval fistula (for 9 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,98,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,acf,2,days,controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days),101354,controlled losartan content drinking water (10 mg/kg/d) (for 3 days),,,artificial aortocaval fistula (for 2 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,151,mmHg,5.0,11.1803,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,2,days,controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days),101355,controlled losartan content drinking water (10 mg/kg/d) (for 3 days),,,sham surgical control condition (for 2 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,125,mmHg,10.0,22.3607,MMO:0000031,tail cuff plethysmography,,0.0,,acf,2,days,vehicle control condition then artificial aortocaval fistula (for 2 days),101356,vehicle control condition,,,artificial aortocaval fistula (for 2 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,150,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,2,days,vehicle control condition then sham surgical control condition (for 2 days),101357,vehicle control condition,,,sham surgical control condition (for 2 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,104,mmHg,7.0,19.799,MMO:0000031,tail cuff plethysmography,,0.0,,acf,4,days,controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days),101358,controlled losartan content drinking water (10 mg/kg/d) (for 5 days),,,artificial aortocaval fistula (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,143,mmHg,5.0,12.2474,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,4,days,controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days),101359,controlled losartan content drinking water (10 mg/kg/d) (for 5 days),,,sham surgical control condition (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,122,mmHg,3.0,7.3485,MMO:0000031,tail cuff plethysmography,,0.0,,acf,4,days,vehicle control condition then artificial aortocaval fistula (for 4 days),101360,vehicle control condition,,,artificial aortocaval fistula (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,160,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,4,days,vehicle control condition then sham surgical control condition (for 4 days),101361,vehicle control condition,,,sham surgical control condition (for 4 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,121,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,acf,7,days,controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days),101362,controlled losartan content drinking water (10 mg/kg/d) (for 8 days),,,artificial aortocaval fistula (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,130,mmHg,3.0,7.3485,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,7,days,controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days),101363,controlled losartan content drinking water (10 mg/kg/d) (for 8 days),,,sham surgical control condition (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,123,mmHg,3.0,7.3485,MMO:0000031,tail cuff plethysmography,,0.0,,acf,7,days,vehicle control condition then artificial aortocaval fistula (for 7 days),101364,vehicle control condition,,,artificial aortocaval fistula (for 7 days),,,,,, 2585,"Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54.",arterial blood pressure trait,,RS:0001006,WF/Mol,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,165,mmHg,7.0,15.6525,MMO:0000031,tail cuff plethysmography,,0.0,,sham acf,7,days,vehicle control condition then sham surgical control condition (for 7 days),101365,vehicle control condition,,,sham surgical control condition (for 7 days),,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,118,mmHg,3.6742,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,sham unx,13,days,sham surgical control condition (between 12 and 14 days),101547,sham surgical control condition (between 12 and 14 days),,,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,11,,CMO:0000004,systolic blood pressure,undefined,-,,185,mmHg,7.8393,26.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days),101548,unilateral nephrectomy (between 12 and 14 days),,,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,125,mmHg,6.261,14.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days),101549,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,5,,CMO:0000004,systolic blood pressure,undefined,,,149,mmHg,9.3915,21.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,13,days,unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days),101550,unilateral nephrectomy (between 12 and 14 days),,,enalapril (50 mg/l) (between 12 and 14 days),losartan (180 mg/l) (between 12 and 14 days),aldosterone (30-40 mg/kg/d) (between 12 and 14 days),,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,118,mmHg,4.0825,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,sham unx,28,days,sham surgical control condition (for 28 days),101583,sham surgical control condition (for 28 days),,,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,212,mmHg,7.5593,20.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days),101584,unilateral nephrectomy (for 28 days),,,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,7,,CMO:0000004,systolic blood pressure,undefined,,,109,mmHg,4.1576,11.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days),101585,unilateral nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 28 days),losartan (180 mg/l) (for 28 days),,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,6,,CMO:0000004,systolic blood pressure,undefined,,,186,mmHg,10.6145,26.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days),101586,unilateral nephrectomy (for 28 days),,,enalapril (50 mg/l) (for 28 days),losartan (180 mg/l) (for 28 days),aldosterone (35 mg/kg/d) (for 28 days),,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,201,mmHg,6.7175,19.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,14,days,unilateral nephrectomy (for 14 days),101615,unilateral nephrectomy (for 14 days),,,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,192,mmHg,7.0711,20.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,14,days,unilateral nephrectomy (for 14 days) then spironolactone (5.56 mg/kg/d) (for 14 days),101616,unilateral nephrectomy (for 14 days),,,spironolactone (5.56 mg/kg/d) (for 14 days),,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,208,mmHg,6.0104,17.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days),101617,unilateral nephrectomy (for 28 days),,,,,,,,, 2602,"Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8.",arterial blood pressure trait,,RS:0000681,SD,male,0 days,8,,CMO:0000004,systolic blood pressure,undefined,,,190,mmHg,9.8995,28.0,MMO:0000031,tail cuff plethysmography,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days),101618,unilateral nephrectomy (for 28 days),,,spironolactone (5.56 mg/kg/d) (for 28 days),,,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",arterial blood pressure trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,female,91 days,9,,CMO:0000004,systolic blood pressure,undefined,,,138,mmHg,1.0,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days),101669,bilateral ovariectomy (for 42 days),,,vehicle control condition (for 35 days),,,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",arterial blood pressure trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,female,91 days,12,,CMO:0000004,systolic blood pressure,undefined,,,141,mmHg,4.0,13.8564,MMO:0000031,tail cuff plethysmography,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days),101670,bilateral ovariectomy (for 42 days),,,17 beta-estradiol (0.5 mg) (for 35 days),,,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",arterial blood pressure trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,female,91 days,8,,CMO:0000004,systolic blood pressure,undefined,,,221,mmHg,5.0,14.1421,MMO:0000031,tail cuff plethysmography,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days),101671,bilateral ovariectomy (for 42 days),,,vehicle control condition (for 35 days),,,,,, 2622,"Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23.",arterial blood pressure trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,female,91 days,7,,CMO:0000004,systolic blood pressure,undefined,,,202,mmHg,6.0,15.8745,MMO:0000031,tail cuff plethysmography,,0.0,,ovariectomy,42,days,bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days),101672,bilateral ovariectomy (for 42 days),,,17 beta-estradiol (0.5 mg) (for 35 days),,,,,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",arterial blood pressure trait,,RS:0000742,WKY,male,112 days,5,,CMO:0000004,systolic blood pressure,undefined,,,104,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled in utero environment (100 % of calories) (for 22 days),101683,controlled in utero environment (100 % of calories) (for 22 days),,,,,,,,, 2218,"Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.",arterial blood pressure trait,,RS:0000742,WKY,male,112 days,6,,CMO:0000004,systolic blood pressure,undefined,,,125,mmHg,2.0,4.899,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled in utero environment (30 % of calories) (for 22 days),101684,controlled in utero environment (30 % of calories) (for 22 days),,,,,,,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",arterial blood pressure trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000004,systolic blood pressure,,,,137.7,mmHg,3.04,7.4464,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,101889,control condition,,,,,,,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",arterial blood pressure trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000004,systolic blood pressure,,,,210.62,mmHg,2.54,6.7202,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,101890,control condition,,,,,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,10,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,139,mmHg,2.7,8.5381,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours),102290,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 0 hours),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,139,mmHg,1.4,4.6433,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours),102291,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 0 hours),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,120,mmHg,2.0,4.899,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours),102292,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 0 hours),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,124,mmHg,4.4,10.7778,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 0 hours),102293,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 0 hours),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,10,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,140,mmHg,2.7,8.5381,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days),102294,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 3 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,146,mmHg,2.1,6.9649,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days),102295,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 3 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,129,mmHg,2.9,7.1035,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days),102296,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 3 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,131,mmHg,4.5,11.0227,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 3 days),102297,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 3 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,10,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,152,mmHg,4.4,13.914,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days),102298,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 10 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,160,mmHg,2.7,8.9549,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days),102299,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 10 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,124,mmHg,3.2,7.8384,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days),102300,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 10 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,122,mmHg,1.3,3.1843,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 10 days),102301,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 10 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,10,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,164,mmHg,4.9,15.4952,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days),102302,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 17 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,179,mmHg,5.5,18.2414,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days),102303,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 17 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,120,mmHg,2.2,5.3889,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days),102304,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 17 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,121,mmHg,2.1,5.1439,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 17 days),102305,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 17 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,10,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,168,mmHg,5.3,16.7601,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days),102306,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 20 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,0 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,180,mmHg,5.7,18.9048,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days),102307,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 20 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,125,mmHg,2.0,4.899,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days),102308,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 20 days),,,,,, 2661,"Mell B, et al., Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,0 days,6,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration between 7am and 12pm,,serial mean,126,mmHg,1.5,3.6742,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days) and controlled meropenem content drinking water (50 mg/kg/d) (for 3 days) and controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days) then controlled cecal material content oral gavage (2 ml) (for 20 days),102309,controlled vancomycin content drinking water (50 mg/kg/d) (for 3 days),controlled meropenem content drinking water (50 mg/kg/d) (for 3 days),controlled omeprazole content oral gavage (50 ml/kg/d) (for 3 days),controlled cecal material content oral gavage (2 ml) (for 20 days),,,,,, 2684,"Ishikawa M, et al., Int Heart J. 2013;54(2):98-106.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,126 days,8,,CMO:0000004,systolic blood pressure,undefined,,,138,mmHg,5.0,14.1421,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days),102313,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 77 days),,,,,, 2684,"Ishikawa M, et al., Int Heart J. 2013;54(2):98-106.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,126 days,8,,CMO:0000004,systolic blood pressure,undefined,,,226,mmHg,11.0,31.1127,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days),102314,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 77 days),,,vehicle control condition (for 49 days),,, 2684,"Ishikawa M, et al., Int Heart J. 2013;54(2):98-106.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,126 days,8,,CMO:0000004,systolic blood pressure,undefined,,,235,mmHg,13.0,36.7696,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days),102315,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 77 days),,,tolvaptan (0.05 %) (for 49 days),,, 2688,"Hojnż S, et al., Physiol Res. 2005;54(2):201-6.",arterial blood pressure trait,,RS:0000787,SR/JrIpcv,male,0 days,N/A,,CMO:0000004,systolic blood pressure,undefined,,,137,mmHg,3.0,,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,controlled sodium content diet (0.3 %) ,102395,controlled sodium content diet (0.3 %) ,,,,,,,,, 2688,"Hojnż S, et al., Physiol Res. 2005;54(2):201-6.",arterial blood pressure trait,,RS:0000923,SS/JrIpcv,male,0 days,N/A,,CMO:0000004,systolic blood pressure,undefined,,,159,mmHg,3.0,,MMO:0000011,vascular indwelling catheter method,,0.0,,,,,controlled sodium content diet (0.3 %) ,102396,controlled sodium content diet (0.3 %) ,,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,63 days,7,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,119,mmHg,3.0237,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 7 days),102429,controlled sodium chloride content diet (8 %) (for 7 days),,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,63 days,8,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,126,mmHg,2.1213,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 7 days),102430,controlled sodium chloride content diet (8 %) (for 7 days),,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,70 days,8,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,124,mmHg,3.182,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 14 days),102431,controlled sodium chloride content diet (8 %) (for 14 days),,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,70 days,7,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,166,mmHg,1.8898,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 14 days),102432,controlled sodium chloride content diet (8 %) (for 14 days),,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,77 days,7,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,125,mmHg,3.0237,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days),102433,controlled sodium chloride content diet (8 %) (for 21 days),,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,77 days,8,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,169,mmHg,2.4749,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days),102434,controlled sodium chloride content diet (8 %) (for 21 days),,,,,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,77 days,19,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,128,mmHg,1.3765,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days) then 0.9% sodium chloride solution (for 21 days),102465,controlled sodium chloride content diet (8 %) (for 21 days),,,0.9% sodium chloride solution (for 21 days),,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,77 days,14,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,173,mmHg,2.6726,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days) then 0.9% sodium chloride solution (for 21 days),102466,controlled sodium chloride content diet (8 %) (for 21 days),,,0.9% sodium chloride solution (for 21 days),,,,,, 2689,"Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,77 days,14,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,150,mmHg,2.6726,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 21 days) then adrenomedulin (9.6 ug/d) (for 21 days),102467,controlled sodium chloride content diet (8 %) (for 21 days),,,adrenomedulin (9.6 ug/d) (for 21 days),,,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,77 days,10,,CMO:0000004,systolic blood pressure,undefined,,,140,mmHg,2.2136,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days),102492,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 35 days),,,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",arterial blood pressure trait,,RS:0003329,SR/NEisSlc,male,126 days,10,,CMO:0000004,systolic blood pressure,undefined,,,135,mmHg,2.2136,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days),102493,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 84 days),,,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,77 days,10,,CMO:0000004,systolic blood pressure,undefined,,,233,mmHg,0.6325,2.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days),102494,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 35 days),,,,,, 2690,"Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,male,126 days,10,,CMO:0000004,systolic blood pressure,undefined,,,249,mmHg,5.0596,16.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days),102495,controlled sodium chloride content diet (0.3 %) (for 42 days),,,controlled sodium chloride content diet (8 %) (for 84 days),,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",arterial blood pressure trait,,RS:0004090,LH/MavRrrcAek,male,98 days,9,,CMO:0000004,systolic blood pressure,mean of 15 sec every 5 min for 72 hours,,serial mean,147.5,mmHg,1.4,4.2,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,standard rat chow (for 98 days),102603,standard rat chow (for 98 days),,,,,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",arterial blood pressure trait,,RS:0004091,LN/MavRrrcAek,male,98 days,14,,CMO:0000004,systolic blood pressure,mean of 15 sec every 5 min for 72 hours,,serial mean,114.5,mmHg,1.4,5.2383,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,standard rat chow (for 98 days),102604,standard rat chow (for 98 days),,,,,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",arterial blood pressure trait,,RS:0004090,LH/MavRrrcAek,male,119 days,9,,CMO:0000004,systolic blood pressure,mean of 15 sec every 5 min for 72 hours,,serial mean,161.2,mmHg,2.1,6.3,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 21 days),102609,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 21 days),,,,,, 3014,"Wang J, et al., Circ Cardiovasc Genet. 2015 Apr;8(2):316-26. doi: 10.1161/CIRCGENETICS.114.000520. Epub 2015 Jan 8.",arterial blood pressure trait,,RS:0004091,LN/MavRrrcAek,male,119 days,14,,CMO:0000004,systolic blood pressure,mean of 15 sec every 5 min for 72 hours,,serial mean,116,mmHg,1.4,5.2383,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,standard rat chow (for 98 days) then controlled sodium chloride content diet (4 %) (for 21 days),102610,standard rat chow (for 98 days),,,controlled sodium chloride content diet (4 %) (for 21 days),,,,,, 2703,"Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3.",arterial blood pressure trait,,RS:0001366,LL/Mav,male,56 days to 49 days,13,,CMO:0000004,systolic blood pressure,undefined,,,115,mmHg,3.0,10.8167,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102644,vehicle control condition,,,,,,,,, 2703,"Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,56 days to 49 days,8,,CMO:0000004,systolic blood pressure,undefined,,,136,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102645,vehicle control condition,,,,,,,,, 2703,"Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,56 days to 49 days,37,,CMO:0000004,systolic blood pressure,undefined,,,145,mmHg,2.0,12.1655,MMO:0000031,tail cuff plethysmography,,0.0,,,,,streptozotocin (75 mg/kg) ,102646,streptozotocin (75 mg/kg) ,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0001366,LL/Mav,male,56 days,9,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,115,mmHg,5.0,15.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102702,vehicle control condition,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0001366,LL/Mav,male,56 days,18,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,124,mmHg,3.0,12.7279,MMO:0000031,tail cuff plethysmography,,0.0,,,,,streptozotocin (100 mg/kg) ,102703,streptozotocin (100 mg/kg) ,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,56 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,134,mmHg,4.0,13.2665,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102704,vehicle control condition,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,56 days,14,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,148,mmHg,4.0,14.9666,MMO:0000031,tail cuff plethysmography,,0.0,,,,,streptozotocin (75 mg/kg) ,102705,streptozotocin (75 mg/kg) ,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0001366,LL/Mav,male,112 days,9,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,119,mmHg,4.0,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102726,vehicle control condition,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0001366,LL/Mav,male,112 days,18,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,123,mmHg,2.0,8.4853,MMO:0000031,tail cuff plethysmography,,0.0,,,,,streptozotocin (100 mg/kg) ,102727,streptozotocin (100 mg/kg) ,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,112 days,11,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,160,mmHg,4.0,13.2665,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102728,vehicle control condition,,,,,,,,, 2721,"Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,112 days,14,,CMO:0000004,systolic blood pressure,mean of 3 samples of undefined duration,,serial mean,179,mmHg,4.0,14.9666,MMO:0000031,tail cuff plethysmography,,0.0,,,,,streptozotocin (75 mg/kg) ,102729,streptozotocin (75 mg/kg) ,,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,112 days,8,,CMO:0000004,systolic blood pressure,undefined,,,169,mmHg,5.0,14.1421,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,102808,control condition,,,,,,,,, 2723,"Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,112 days,4,,CMO:0000004,systolic blood pressure,undefined,,,157,mmHg,7.0,14.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,102809,control condition,,,,,,,,, 2439,"Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.",arterial blood pressure trait,,RS:0000681,SD,male,130 days,1,,CMO:0000004,systolic blood pressure,mean of 3 samples - 1 per minute,,serial mean,117,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),102814,controlled enalapril content drinking water (5 mg/kg/d) (for 10 days),,,,,,,,, 2761,"Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,63 days,8,,CMO:0000004,systolic blood pressure,undefined,,,160,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102848,vehicle control condition,,,,,,,,, 2761,"Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,84 days,8,,CMO:0000004,systolic blood pressure,undefined,,,160,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition,102849,vehicle control condition,,,,,,,,, 2761,"Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,63 days,7,,CMO:0000004,systolic blood pressure,undefined,,,113,mmHg,3.0,7.9373,MMO:0000031,tail cuff plethysmography,,0.0,,,,,perindopril (1.5 mg/kg/d) (for 42 days),102850,perindopril (1.5 mg/kg/d) (for 42 days),,,,,,,,, 2761,"Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,63 days,7,,CMO:0000004,systolic blood pressure,undefined,,,144,mmHg,4.0,10.583,MMO:0000031,tail cuff plethysmography,,0.0,,,,,nifedipine (50 mg/kg/d) (for 42 days),102851,nifedipine (50 mg/kg/d) (for 42 days),,,,,,,,, 2761,"Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,63 days,10,,CMO:0000004,systolic blood pressure,undefined,,,133,mmHg,2.0,6.3246,MMO:0000031,tail cuff plethysmography,,0.0,,,,,hydralazine (75 mg/kg/d) (for 42 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 42 days) and reserpine (0.75 mg/kg/d) (for 42 days),102852,hydralazine (75 mg/kg/d) (for 42 days),controlled hydralazine content drinking water (15 mg/kg/d) (for 42 days),reserpine (0.75 mg/kg/d) (for 42 days),,,,,,, 2783,"Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,112 days,10,,CMO:0000004,systolic blood pressure,,,,150,mmHg,5.0,15.8114,MMO:0000014,vascular transducer tipped catheter,,0.0,,,,,control condition,102956,control condition,,,,,,,,, 2783,"Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12.",arterial blood pressure trait,,RS:0001317,GK/MolTac,male,112 days,8,,CMO:0000004,systolic blood pressure,,,,127,mmHg,5.0,14.1421,MMO:0000014,vascular transducer tipped catheter,,0.0,,,,,control condition,102957,control condition,,,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,63 days,16,,CMO:0000004,systolic blood pressure,,,,137,mmHg,3.0,12.0,MMO:0000014,vascular transducer tipped catheter,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 35 days),103246,controlled sodium chloride content diet (0.3 %) (for 35 days),,,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",arterial blood pressure trait,,RS:0000786,SR/Jr,male,63 days,13,,CMO:0000004,systolic blood pressure,,,,138,mmHg,3.0,10.8167,MMO:0000014,vascular transducer tipped catheter,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 35 days),103247,controlled sodium chloride content diet (8 %) (for 35 days),,,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,63 days,15,,CMO:0000004,systolic blood pressure,,,,159,mmHg,3.0,11.619,MMO:0000014,vascular transducer tipped catheter,,0.0,,,,,controlled sodium chloride content diet (0.3 %) (for 35 days),103248,controlled sodium chloride content diet (0.3 %) (for 35 days),,,,,,,,, 2802,"Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404.",arterial blood pressure trait,,RS:0000817,SS/Jr,male,63 days,10,,CMO:0000004,systolic blood pressure,,,,189,mmHg,6.0,23.2379,MMO:0000014,vascular transducer tipped catheter,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 35 days),103249,controlled sodium chloride content diet (8 %) (for 35 days),,,,,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",arterial blood pressure trait,,RS:0000789,SS,male,42 days,5,,CMO:0000004,systolic blood pressure,,,,113,mmHg,2.2361,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days),103284,controlled sodium content diet (0.3 %) (for 42 days),,,,,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",arterial blood pressure trait,,RS:0000784,SR,male,42 days,5,,CMO:0000004,systolic blood pressure,,,,104,mmHg,2.6833,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days),103285,controlled sodium content diet (0.3 %) (for 42 days),,,,,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",arterial blood pressure trait,,RS:0000789,SS,male,84 days,7,,CMO:0000004,systolic blood pressure,,,,206,mmHg,2.2678,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days),103286,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 42 days),,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",arterial blood pressure trait,,RS:0000784,SR,male,84 days,6,,CMO:0000004,systolic blood pressure,,,,115,mmHg,4.899,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days),103287,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 42 days),,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",arterial blood pressure trait,,RS:0000789,SS,male,126 days,6,,CMO:0000004,systolic blood pressure,,,,197,mmHg,6.9402,17.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days),103288,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 84 days),,,,,, 2803,"Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.",arterial blood pressure trait,,RS:0000784,SR,male,126 days,6,,CMO:0000004,systolic blood pressure,,,,122,mmHg,5.3072,13.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days),103289,controlled sodium content diet (0.3 %) (for 42 days),,,controlled sodium content diet (8 %) (for 84 days),,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",arterial blood pressure trait,,RS:0000784,SR,male,70 days to 63 days,7,,CMO:0000004,systolic blood pressure,,,,135,mmHg,4.9135,13.0,MMO:0000043,oscillometric sphygmomanometer,,0.0,,,,,controlled sodium content diet (6 %) (between 21 and 28 days),103350,controlled sodium content diet (6 %) (between 21 and 28 days),,,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",arterial blood pressure trait,,RS:0000784,SR,male,91 days to 77 days,7,,CMO:0000004,systolic blood pressure,,,,139,mmHg,7.5593,20.0,MMO:0000043,oscillometric sphygmomanometer,,0.0,,,,,controlled sodium content diet (6 %) (between 35 and 49 days),103351,controlled sodium content diet (6 %) (between 35 and 49 days),,,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",arterial blood pressure trait,,RS:0000784,SR,male,132 days to 98 days,7,,CMO:0000004,systolic blood pressure,,,,146,mmHg,6.0474,16.0,MMO:0000043,oscillometric sphygmomanometer,,0.0,,,,,controlled sodium content diet (6 %) (between 56 and 70 days),103352,controlled sodium content diet (6 %) (between 56 and 70 days),,,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",arterial blood pressure trait,,RS:0000789,SS,male,70 days to 63 days,7,,CMO:0000004,systolic blood pressure,,,,208,mmHg,15.4965,41.0,MMO:0000043,oscillometric sphygmomanometer,,0.0,,,,,controlled sodium content diet (6 %) (between 21 and 28 days),103353,controlled sodium content diet (6 %) (between 21 and 28 days),,,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",arterial blood pressure trait,,RS:0000789,SS,male,91 days to 77 days,7,,CMO:0000004,systolic blood pressure,,,,226,mmHg,10.205,27.0,MMO:0000043,oscillometric sphygmomanometer,,0.0,,,,,controlled sodium content diet (6 %) (between 35 and 49 days),103354,controlled sodium content diet (6 %) (between 35 and 49 days),,,,,,,,, 2804,"Kamei K, et al., Circ J. 2007 Mar;71(3):390-6.",arterial blood pressure trait,,RS:0000789,SS,male,132 days to 98 days,7,,CMO:0000004,systolic blood pressure,,,,234,mmHg,15.8745,42.0,MMO:0000043,oscillometric sphygmomanometer,,0.0,,,,,controlled sodium content diet (6 %) (between 56 and 70 days),103355,controlled sodium content diet (6 %) (between 56 and 70 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,84 days,12,,CMO:0000004,systolic blood pressure,between 9a-1p,,,152,mmHg,3.0,10.3923,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (between 147 and 154 days),103432,control condition (between 147 and 154 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,84 days,13,,CMO:0000004,systolic blood pressure,between 9a-1p,,,129,mmHg,2.0,7.2111,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),103433,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,84 days,13,,CMO:0000004,systolic blood pressure,between 9a-1p,,,122,mmHg,2.0,7.2111,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),103434,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,84 days,12,,CMO:0000004,systolic blood pressure,between 9a-1p,,,97,mmHg,3.0,10.3923,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),103435,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,154 days to 147 days,6,,CMO:0000004,systolic blood pressure,2hr mean (10a-12p),,continuous mean,175,mmHg,1.0,2.4495,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,control condition (between 147 and 154 days),103436,control condition (between 147 and 154 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,154 days to 147 days,5,,CMO:0000004,systolic blood pressure,2hr mean (10a-12p),,continuous mean,166,mmHg,3.0,6.7082,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),103437,controlled losartan content drinking water (10 mg/kg/d) (for 63 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,154 days to 147 days,6,,CMO:0000004,systolic blood pressure,2hr mean (10a-12p),,continuous mean,167,mmHg,2.0,4.899,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),103438,controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days),,,,,,,,, 2825,"Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,154 days to 147 days,6,,CMO:0000004,systolic blood pressure,2hr mean (10a-12p),,continuous mean,186,mmHg,8.0,19.5959,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),103439,controlled perindopril content drinking water (3 mg/kg/d) (for 63 days),,,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",arterial blood pressure trait,,RS:0004585,SD-Tg(Ren2)27-/-,male,84 days,6,,CMO:0000004,systolic blood pressure,,,,129,mmHg,3.0,7.3485,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),103468,control condition (for 0 hours),,,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",arterial blood pressure trait,,RS:0000687,SD-Tg(Ren2)27,male,84 days,6,,CMO:0000004,systolic blood pressure,,,,203,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),103469,control condition (for 0 hours),,,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",arterial blood pressure trait,,RS:0000742,WKY,male,84 days,5,,CMO:0000004,systolic blood pressure,,,,125,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),103470,control condition (for 0 hours),,,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",arterial blood pressure trait,,RS:0000015,SHR,male,84 days,5,,CMO:0000004,systolic blood pressure,,,,207,mmHg,8.0,17.8885,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),103471,control condition (for 0 hours),,,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",arterial blood pressure trait,,RS:0001366,LL/Mav,male,84 days,5,,CMO:0000004,systolic blood pressure,,,,108,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),103472,control condition (for 0 hours),,,,,,,,, 2826,"Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1.",arterial blood pressure trait,,RS:0000556,LH/Mav,male,84 days,5,,CMO:0000004,systolic blood pressure,,,,161,mmHg,6.0,13.4164,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),103473,control condition (for 0 hours),,,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,121,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 1 week,,,,control condition and light phase of controlled light/dark cycle (for 12 hours),103522,control condition,light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,115,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 1 week,,,,control condition and light phase of controlled light/dark cycle (for 12 hours),103523,control condition,light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,135,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 1 week,,,,control condition and light phase of controlled light/dark cycle (for 12 hours),103524,control condition,light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,5,,CMO:0000004,systolic blood pressure,,daytime measurement,,134,mmHg,4.0,8.9443,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 1 week,,,,control condition and light phase of controlled light/dark cycle (for 12 hours),103525,control condition,light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,121,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 4 weeks,,,,vehicle control condition (for 28 days) and light phase of controlled light/dark cycle (for 12 hours),103526,vehicle control condition (for 28 days),light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,117,mmHg,2.0,4.899,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 4 weeks,,,,salidroside (40 mg/kg) (for 28 days) and light phase of controlled light/dark cycle (for 12 hours),103527,salidroside (40 mg/kg) (for 28 days),light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,145,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 4 weeks,,,,vehicle control condition (for 28 days) and light phase of controlled light/dark cycle (for 12 hours),103528,vehicle control condition (for 28 days),light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,5,,CMO:0000004,systolic blood pressure,,daytime measurement,,139,mmHg,3.0,6.7082,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 4 weeks,,,,salidroside (40 mg/kg) (for 28 days) and light phase of controlled light/dark cycle (for 12 hours),103529,salidroside (40 mg/kg) (for 28 days),light phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,126,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,measured 12 hr/night for 1 week,,,,control condition and dark phase of controlled light/dark cycle (for 12 hours),103530,control condition,dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,122,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,measured 12 hr/night for 1 week,,,,control condition and dark phase of controlled light/dark cycle (for 12 hours),103531,control condition,dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,143,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,measured 12 hr/night for 1 week,,,,control condition and dark phase of controlled light/dark cycle (for 12 hours),103532,control condition,dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,5,,CMO:0000004,systolic blood pressure,,nighttime measurement,,143,mmHg,4.0,8.9443,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,measured 12 hr/night for 1 week,,,,control condition and dark phase of controlled light/dark cycle (for 12 hours),103533,control condition,dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,126,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/night for 4 weeks,,,,vehicle control condition (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours),103534,vehicle control condition (for 28 days),dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,168 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,123,mmHg,2.0,4.899,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/night for 4 weeks,,,,salidroside (40 mg/kg) (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours),103535,salidroside (40 mg/kg) (for 28 days),dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,145,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/night for 4 weeks,,,,vehicle control condition (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours),103536,vehicle control condition (for 28 days),dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,5,,CMO:0000004,systolic blood pressure,,nighttime measurement,,146,mmHg,3.0,6.7082,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/night for 4 weeks,,,,salidroside (40 mg/kg) (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours),103537,salidroside (40 mg/kg) (for 28 days),dark phase of controlled light/dark cycle (for 12 hours),,,,,,,, 3017,"Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,126 days to 70 days,8,,CMO:0000004,systolic blood pressure,every 10 min for 24hr,,,129,mmHg,1.0,2.8284,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,control condition,105540,control condition,,,,,,,,, 3017,"Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13.",arterial blood pressure trait,,RS:0004673,WI-Mc4rm1Hubr,male,126 days to 70 days,8,,CMO:0000004,systolic blood pressure,every 10 min for 24hr,,,130,mmHg,1.0,2.8284,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,,,,,control condition,105541,control condition,,,,,,,,, 3022,"Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.",arterial blood pressure trait,,RS:0003089,SS-Plekha7em4Mcwi+/+,male,91 days,10,,CMO:0000004,systolic blood pressure,,,,213,mmHg,8.0,25.2982,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days),105762,controlled sodium content diet (8 %) (for 28 days),,,,,,,,, 3022,"Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.",arterial blood pressure trait,,RS:0003088,SS-Plekha7em4Mcwi-/-,male,91 days,10,,CMO:0000004,systolic blood pressure,,,,180,mmHg,7.0,22.1359,MMO:0000580,intra-aortic abdominal radiotelemetry via femoral cannulation,,0.0,,,,,controlled sodium content diet (8 %) (for 28 days),105763,controlled sodium content diet (8 %) (for 28 days),,,,,,,,, 3023,"Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18.",arterial blood pressure trait,,RS:0003284,SS-Adora2bem2Mcwi,male,147 days,8,,CMO:0000004,systolic blood pressure,,,,207,mmHg,7.0,19.799,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 147 days),105860,control condition (for 147 days),,,,,,,,, 3023,"Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,147 days,8,,CMO:0000004,systolic blood pressure,,,,191,mmHg,5.0,14.1421,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 147 days),105861,control condition (for 147 days),,,,,,,,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000004,systolic blood pressure,,,,139,mmHg,1.0,2.6458,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (0.65 %) (for 98 days),106696,controlled sodium chloride content diet (0.65 %) (for 98 days),,,,,,,,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000004,systolic blood pressure,,,,181,mmHg,2.0,5.2915,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 42 days),106697,controlled sodium chloride content diet (8 %) (for 42 days),,,,,,,,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000004,systolic blood pressure,,,,128,mmHg,2.0,5.2915,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days),106698,controlled sodium chloride content diet (0.65 %) (for 98 days),,,streptozotocin (60 mg/kg) ,,,insulin (10 ul) (for 42 days),,, 3038,"Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,98 days,7,,CMO:0000004,systolic blood pressure,,,,181,mmHg,2.0,5.2915,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days),106699,controlled sodium chloride content diet (8 %) (for 42 days),,,streptozotocin (60 mg/kg) ,,,insulin (10 ul) (for 42 days),,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,28 days,5,,CMO:0000004,systolic blood pressure,,,,128,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,106724,control condition,,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,28 days,5,,CMO:0000004,systolic blood pressure,,,,126,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,106725,control condition,,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,28 days,5,,CMO:0000004,systolic blood pressure,,,,140,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,106726,control condition,,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,28 days,5,,CMO:0000004,systolic blood pressure,,,,139,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,106727,control condition,,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,42 days,12,,CMO:0000004,systolic blood pressure,,,,125,mmHg,2.0,6.9282,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),106748,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,70 days,12,,CMO:0000004,systolic blood pressure,,,,128,mmHg,1.0,3.4641,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106749,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,42 days,16,,CMO:0000004,systolic blood pressure,,,,121,mmHg,2.0,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),106750,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,70 days,16,,CMO:0000004,systolic blood pressure,,,,126,mmHg,1.0,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106751,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,42 days,5,,CMO:0000004,systolic blood pressure,,,,137,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),106752,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,70 days,5,,CMO:0000004,systolic blood pressure,,,,195,mmHg,3.0,6.7082,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106753,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,42 days,9,,CMO:0000004,systolic blood pressure,,,,138,mmHg,1.0,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),106754,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,,,,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,70 days,9,,CMO:0000004,systolic blood pressure,,,,196,mmHg,2.0,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106755,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 2339,"Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,not specified,547 days,10,,CMO:0000004,systolic blood pressure,,,,136,mmHg,3.0,9.4868,MMO:0000011,vascular indwelling catheter method,femoral artery,0.0,,,,,controlled cilazapril content drinking water (2.5 ug/ml) (for 547.5 days),106788,controlled cilazapril content drinking water (2.5 ug/ml) (for 547.5 days),,,,,,,,, 2339,"Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,not specified,547 days,10,,CMO:0000004,systolic blood pressure,,,,122,mmHg,4.0,12.6491,MMO:0000011,vascular indwelling catheter method,femoral artery,0.0,,,,,controlled cilazapril content drinking water (12.5 ug/ml) (for 547.5 days),106789,controlled cilazapril content drinking water (12.5 ug/ml) (for 547.5 days),,,,,,,,, 2339,"Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,not specified,547 days,10,,CMO:0000004,systolic blood pressure,,,,132,mmHg,3.0,9.4868,MMO:0000011,vascular indwelling catheter method,femoral artery,0.0,,,,,controlled E4177 content drinking water (25 ug/ml) (for 547.5 days),106790,controlled E4177 content drinking water (25 ug/ml) (for 547.5 days),,,,,,,,, 2339,"Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502.",arterial blood pressure trait,,RS:0003328,SS/NEisSlc,not specified,547 days,10,,CMO:0000004,systolic blood pressure,,,,137,mmHg,3.0,9.4868,MMO:0000011,vascular indwelling catheter method,femoral artery,0.0,,,,,vehicle control condition (for 547.5 days),106791,vehicle control condition (for 547.5 days),,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,56 days,6,,CMO:0000004,systolic blood pressure,,,,115,mmHg,4.76,11.6596,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,vehicle control condition,106802,vehicle control condition,,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",arterial blood pressure trait,,RS:0001480,SS-Sod3m1Mcwi,male,56 days,8,,CMO:0000004,systolic blood pressure,,,,115,mmHg,5.22,14.7644,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,vehicle control condition,106803,vehicle control condition,,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",arterial blood pressure trait,,RS:0000811,SS/JrHsdMcwi,male,56 days,8,,CMO:0000004,systolic blood pressure,,,,108,mmHg,2.62,7.4105,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,monocrotaline (40 mg/kg) ,106804,monocrotaline (40 mg/kg) ,,,,,,,,, 3032,"Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5.",arterial blood pressure trait,,RS:0001480,SS-Sod3m1Mcwi,male,56 days,9,,CMO:0000004,systolic blood pressure,,,,109,mmHg,3.82,11.46,MMO:0000013,vascular fluid filled catheter,,0.0,,,,,monocrotaline (40 mg/kg) ,106805,monocrotaline (40 mg/kg) ,,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",arterial blood pressure trait,,RS:0001317,GK/MolTac,female,60 days,6,,CMO:0000004,systolic blood pressure,,,,114,mmHg,0.09,0.2205,MMO:0000031,tail cuff plethysmography,,0.0,10 consecutive measurements,,,,control condition,106929,control condition,,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",arterial blood pressure trait,,RS:0001317,GK/MolTac,female,240 days,11,,CMO:0000004,systolic blood pressure,,,,124,mmHg,3.0,9.9499,MMO:0000031,tail cuff plethysmography,,0.0,10 consecutive measurements,,,,control condition,106930,control condition,,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",arterial blood pressure trait,,RS:0001317,GK/MolTac,female,420 days,11,,CMO:0000004,systolic blood pressure,,,,116,mmHg,1.7,5.6383,MMO:0000031,tail cuff plethysmography,,0.0,10 consecutive measurements,,,,control condition,106931,control condition,,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",arterial blood pressure trait,,RS:0001602,WKY/NMolTac,female,60 days,6,,CMO:0000004,systolic blood pressure,,,,114,mmHg,0.7,1.7146,MMO:0000031,tail cuff plethysmography,,0.0,10 consecutive measurements,,,,control condition,106932,control condition,,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",arterial blood pressure trait,,RS:0001602,WKY/NMolTac,female,240 days,9,,CMO:0000004,systolic blood pressure,,,,118,mmHg,4.9,14.7,MMO:0000031,tail cuff plethysmography,,0.0,10 consecutive measurements,,,,control condition,106933,control condition,,,,,,,,, 3071,"Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.",arterial blood pressure trait,,RS:0001602,WKY/NMolTac,female,420 days,11,,CMO:0000004,systolic blood pressure,,,,104,mmHg,1.8,5.9699,MMO:0000031,tail cuff plethysmography,,0.0,10 consecutive measurements,,,,control condition,106934,control condition,,,,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000004,systolic blood pressure,,,,260,mmHg,6.0,18.9737,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107095,controlled sodium chloride content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000004,systolic blood pressure,,high salt high fat diet,,267,mmHg,7.0,22.1359,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107096,controlled sodium chloride content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000004,systolic blood pressure,,standard rat chow,,253,mmHg,9.0,28.4605,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,standard condition (for 126 days),107097,standard condition (for 126 days),,,,,,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,224 days to 203 days,10,,CMO:0000004,systolic blood pressure,,standard rat chow,,179,mmHg,3.0,9.4868,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,standard condition (for 126 days),107098,standard condition (for 126 days),,,,,,,,, 3083,"Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15.",arterial blood pressure trait,,RS:0002538,SHRSP/A3NCrl,male,175 days to 161 days,8,,CMO:0000004,systolic blood pressure,,,,143,mmHg,6.0,16.9706,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 91 days) and controlled fat content diet (24.5 %) (for 91 days) then controlled SB-239063 content diet (1200 ppm) (for 35 days),107384,controlled sodium chloride content drinking water (1 %) (for 91 days),controlled fat content diet (24.5 %) (for 91 days),,controlled SB-239063 content diet (1200 ppm) (for 35 days),,,,,, 3083,"Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15.",arterial blood pressure trait,,RS:0002538,SHRSP/A3NCrl,male,175 days to 161 days,6,,CMO:0000004,systolic blood pressure,,,,162,mmHg,4.0,9.798,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 91 days) and controlled fat content diet (24.5 %) (for 91 days) then vehicle control condition (for 35 days),107385,controlled sodium chloride content drinking water (1 %) (for 91 days),controlled fat content diet (24.5 %) (for 91 days),,vehicle control condition (for 35 days),,,,,, 3083,"Lenhard SC, etal., J Pharmacol Exp Ther. 2003 Dec;307(3):939-46. doi: 10.1124/jpet.103.057398. Epub 2003 Oct 15.",arterial blood pressure trait,,RS:0002538,SHRSP/A3NCrl,male,175 days to 161 days,7,,CMO:0000004,systolic blood pressure,,,,160,mmHg,5.0,13.2288,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 91 days),107386,control condition (for 91 days),,,,,,,,, 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,189 days to 168 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,284,mmHg,8.0,19.5959,MMO:0000031,tail cuff plethysmography,tail,0.0,average 3 week intervals for 12 weeks,,,,controlled sodium chloride content drinking water (1 %) (for 84 days) and controlled fat content diet (24.5 %) (for 84 days) and vehicle control condition (for 84 days),107499,controlled sodium chloride content drinking water (1 %) (for 84 days),controlled fat content diet (24.5 %) (for 84 days),vehicle control condition (for 84 days),,,,,,, 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,189 days to 168 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,250,mmHg,9.0,22.0454,MMO:0000031,tail cuff plethysmography,tail,0.0,average 3 week intervals for 12 weeks,,,,controlled sodium chloride content drinking water (1 %) (for 84 days) and controlled fat content diet (24.5 %) (for 84 days) and eprosartan (60 mg/kg/d) (for 84 days),107500,controlled sodium chloride content drinking water (1 %) (for 84 days),controlled fat content diet (24.5 %) (for 84 days),eprosartan (60 mg/kg/d) (for 84 days),,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,140 days to 120 days,24,,CMO:0000004,systolic blood pressure,,,,244,mmHg,4.0,19.5959,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,107568,control condition,,,,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,male,140 days to 120 days,10,,CMO:0000004,systolic blood pressure,,,,147,mmHg,10.0,31.6228,MMO:0000031,tail cuff plethysmography,,0.0,,,,,reproduction condition,107569,reproduction condition,,,,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,female,140 days to 120 days,24,,CMO:0000004,systolic blood pressure,,,,230,mmHg,6.0,29.3939,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,107570,control condition,,,,,,,,, 3093,"Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,female,140 days to 120 days,15,,CMO:0000004,systolic blood pressure,,,,94,mmHg,10.0,38.7298,MMO:0000031,tail cuff plethysmography,,0.0,,,,,reproduction condition,107571,reproduction condition,,,,,,,,, 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",arterial blood pressure trait,,RS:0000714,WKY/N,both,270 days to 180 days,9,,CMO:0000004,systolic blood pressure,,,,109,mmHg,7.0,21.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,107636,control condition,,,,,,,,, 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,both,270 days to 180 days,13,,CMO:0000004,systolic blood pressure,,,,207,mmHg,25.2,90.8599,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,107637,control condition,,,,,,,,, 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,both,141 days,7,,CMO:0000004,systolic blood pressure,,,,194,mmHg,16.7,44.184,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,107638,control condition,,,,,,,,, 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",arterial blood pressure trait,,RS:0000775,SHRSP/A3N,both,141 days,6,,CMO:0000004,systolic blood pressure,,,,131,mmHg,5.6,13.7171,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled hydralazine content drinking water (100 mg/l) (for 60 days) and controlled hydrochlorothiazide content drinking water (100 mg/l) (for 60 days) then controlled hydralazine content drinking water (200 mg/l) (for 60 days) and controlled hydrochlorothiazide content drinking water (200 mg/l) (for 60 days),107639,controlled hydralazine content drinking water (100 mg/l) (for 60 days),controlled hydrochlorothiazide content drinking water (100 mg/l) (for 60 days),,controlled hydralazine content drinking water (200 mg/l) (for 60 days),controlled hydrochlorothiazide content drinking water (200 mg/l) (for 60 days),,,,, 3096,"Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4.",arterial blood pressure trait,,RS:0003766,WAG/Nov,male,180 days to 150 days,10,,CMO:0000004,systolic blood pressure,,,,125,mmHg,10.2,32.2552,MMO:0000160,unspecified method,,0.0,,,,,control condition,107670,control condition,,,,,,,,, 3096,"Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4.",arterial blood pressure trait,,RS:0001334,ISIAH,male,180 days to 150 days,10,,CMO:0000004,systolic blood pressure,,,,179,mmHg,12.7,40.1609,MMO:0000160,unspecified method,,0.0,,,,,control condition,107671,control condition,,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",arterial blood pressure trait,,RS:0001014,Hsd:WI,male,100 days,16,,CMO:0000004,systolic blood pressure,,,,138,mmHg,8.0,32.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,108097,control condition,,,,,,,,, 3115,"Rothermund L, etal., J Hypertens. 2006 Sep 24(9).",arterial blood pressure trait,,RS:0000596,MWF/FubRkb,male,100 days,10,,CMO:0000004,systolic blood pressure,,,,159,mmHg,6.0,18.9737,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,108098,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,163.57,mmHg,8.1451,21.55,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108284,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,137.8,mmHg,2.7213,7.2,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108285,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,155.11,mmHg,9.4075,24.89,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,60,min,diclofenac (40 mg/kg) (for 1 hours),108286,diclofenac (40 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,134.58,mmHg,3.7645,9.96,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,60,min,diclofenac (40 mg/kg) (for 1 hours),108287,diclofenac (40 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,143.18,mmHg,9.2526,24.48,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,90,min,diclofenac (40 mg/kg) (for 1.5 hours),108288,diclofenac (40 mg/kg) (for 1.5 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,128.99,mmHg,5.5863,14.78,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,90,min,diclofenac (40 mg/kg) (for 1.5 hours),108289,diclofenac (40 mg/kg) (for 1.5 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,143.46,mmHg,7.1057,18.8,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,120,min,diclofenac (40 mg/kg) (for 2 hours),108290,diclofenac (40 mg/kg) (for 2 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,126.98,mmHg,5.711,15.11,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,120,min,diclofenac (40 mg/kg) (for 2 hours),108291,diclofenac (40 mg/kg) (for 2 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,149.29,mmHg,7.1738,18.98,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,150,min,diclofenac (40 mg/kg) (for 2.5 hours),108292,diclofenac (40 mg/kg) (for 2.5 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,129.07,mmHg,3.7456,9.91,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,150,min,diclofenac (40 mg/kg) (for 2.5 hours),108293,diclofenac (40 mg/kg) (for 2.5 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,155.93,mmHg,7.5668,20.02,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,180,min,diclofenac (40 mg/kg) (for 3 hours),108294,diclofenac (40 mg/kg) (for 3 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,135.22,mmHg,4.9211,13.02,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,180,min,diclofenac (40 mg/kg) (for 3 hours),108295,diclofenac (40 mg/kg) (for 3 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,169.17,mmHg,1.1566,3.06,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus,108296,proestrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,133.83,mmHg,1.9616,5.19,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus,108297,proestrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,166.83,mmHg,0.9978,2.64,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 1 hours),108298,proestrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,127.83,mmHg,0.8769,2.32,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 1 hours),108299,proestrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,160.67,mmHg,1.1112,2.94,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 1.5 hours),108300,proestrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,118.33,mmHg,2.0221,5.35,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 1.5 hours),108301,proestrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,162.67,mmHg,1.6139,4.27,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 2 hours),108302,proestrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,118.83,mmHg,1.6479,4.36,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 2 hours),108303,proestrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,162.33,mmHg,0.6161,1.63,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 2.5 hours),108304,proestrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,121.17,mmHg,1.3607,3.6,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 2.5 hours),108305,proestrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,161.67,mmHg,3.5113,9.29,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 3 hours),108306,proestrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,126.5,mmHg,1.7046,4.51,MMO:0000031,tail cuff plethysmography,,,,,,,proestrus then diclofenac (40 mg/kg) (for 3 hours),108307,proestrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,169.29,mmHg,2.1355,5.65,MMO:0000031,tail cuff plethysmography,,,,,,,estrus,108308,estrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,134,mmHg,4.6187,12.22,MMO:0000031,tail cuff plethysmography,,,,,,,estrus,108309,estrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,164,mmHg,2.967,7.85,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 1 hours),108310,estrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,131.43,mmHg,2.7327,7.23,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 1 hours),108311,estrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,160.29,mmHg,2.0788,5.5,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 1.5 hours),108312,estrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,119,mmHg,3.4773,9.2,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 1.5 hours),108313,estrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,161.57,mmHg,0.9978,2.64,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 2 hours),108314,estrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,123,mmHg,0.9751,2.58,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 2 hours),108315,estrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,161.86,mmHg,1.4854,3.93,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 2.5 hours),108316,estrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,124.14,mmHg,1.6819,4.45,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 2.5 hours),108317,estrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,163.71,mmHg,2.2111,5.85,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 3 hours),108318,estrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,128.43,mmHg,4.494,11.89,MMO:0000031,tail cuff plethysmography,,,,,,,estrus then diclofenac (40 mg/kg) (for 3 hours),108319,estrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,172.71,mmHg,4.7283,12.51,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus,108320,metestrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,132.29,mmHg,2.9746,7.87,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus,108321,metestrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,171.86,mmHg,5.6166,14.86,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 1 hours),108322,metestrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,124,mmHg,1.8898,5.0,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 1 hours),108323,metestrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,163.71,mmHg,5.5183,14.6,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 1.5 hours),108324,metestrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,120,mmHg,3.0842,8.16,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 1.5 hours),108325,metestrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,159.14,mmHg,2.3547,6.23,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 2 hours),108326,metestrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,121.29,mmHg,1.4438,3.82,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 2 hours),108327,metestrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,162.14,mmHg,1.7386,4.6,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 2.5 hours),108328,metestrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,127.57,mmHg,0.7181,1.9,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 2.5 hours),108329,metestrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,165.86,mmHg,3.277,8.67,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 3 hours),108330,metestrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,128.14,mmHg,1.0318,2.73,MMO:0000031,tail cuff plethysmography,,,,,,,metestrus then diclofenac (40 mg/kg) (for 3 hours),108331,metestrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,164.86,mmHg,2.5853,6.84,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus,108332,diestrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,136.71,mmHg,1.7689,4.68,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus,108333,diestrus,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,163.71,mmHg,6.1079,16.16,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 1 hours),108334,diestrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,127.14,mmHg,2.1431,5.67,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 1 hours),108335,diestrus,,,diclofenac (40 mg/kg) (for 1 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,151.71,mmHg,4.2181,11.16,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 1.5 hours),108336,diestrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,114.14,mmHg,1.595,4.22,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 1.5 hours),108337,diestrus,,,diclofenac (40 mg/kg) (for 1.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,152.14,mmHg,2.521,6.67,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 2 hours),108338,diestrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,119,mmHg,2.6458,7.0,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 2 hours),108339,diestrus,,,diclofenac (40 mg/kg) (for 2 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,161.14,mmHg,4.014,10.62,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 2.5 hours),108340,diestrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,122.43,mmHg,2.9519,7.81,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 2.5 hours),108341,diestrus,,,diclofenac (40 mg/kg) (for 2.5 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,162.57,mmHg,4.2389,11.215,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 3 hours),108342,diestrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000967,WAG,female,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,129.57,mmHg,2.5437,6.73,MMO:0000031,tail cuff plethysmography,,,,,,,diestrus then diclofenac (40 mg/kg) (for 3 hours),108343,diestrus,,,diclofenac (40 mg/kg) (for 3 hours),,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,177,mmHg,0.9071,2.4,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108356,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000742,WKY,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,125.3,mmHg,0.6803,1.8,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108357,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,165.9,mmHg,1.5875,4.2,MMO:0000031,tail cuff plethysmography,,,IP,,60,min,diclofenac (10 mg/kg) (for 1 hours),108358,diclofenac (10 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000742,WKY,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,123.7,mmHg,1.0583,2.8,MMO:0000031,tail cuff plethysmography,,,IP,,60,min,diclofenac (10 mg/kg) (for 1 hours),108359,diclofenac (10 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,163.96,mmHg,5.6392,14.92,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108360,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000742,WKY,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,122.8,mmHg,0.6047,1.6,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108361,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,160.57,mmHg,5.2197,13.81,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,60,min,diclofenac (20 mg/kg) (for 1 hours),108362,diclofenac (20 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000742,WKY,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,122.6,mmHg,0.7446,1.97,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,60,min,diclofenac (20 mg/kg) (for 1 hours),108363,diclofenac (20 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,163.57,mmHg,8.1451,21.55,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108364,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000742,WKY,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,123.4,mmHg,0.7559,2.0,MMO:0000031,tail cuff plethysmography,,,,,,,control condition,108365,control condition,,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000015,SHR,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,155.11,mmHg,9.4075,24.89,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,60,min,diclofenac (40 mg/kg) (for 1 hours),108366,diclofenac (40 mg/kg) (for 1 hours),,,,,,,,, 3101,"Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9.",arterial blood pressure trait,,RS:0000742,WKY,male,120 days to 90 days,7,,CMO:0000004,systolic blood pressure,,,,122.9,mmHg,0.7937,2.1,MMO:0000031,tail cuff plethysmography,,,0.1% methylcellulose per os,,60,min,diclofenac (40 mg/kg) (for 1 hours),108367,diclofenac (40 mg/kg) (for 1 hours),,,,,,,,, 3126,"Zoja C, etal., Am J Med. 1992 Apr 27;92(4B):60S-63S. doi: 10.1016/0002-9343(92)90149-6.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,660 days to 540 days,9,,CMO:0000004,systolic blood pressure,,,,168,mmHg,6.0,18.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled protein content diet (20 %) then water (for 120 days),108593,controlled protein content diet (20 %) ,,,water (for 120 days),,,,,, 3126,"Zoja C, etal., Am J Med. 1992 Apr 27;92(4B):60S-63S. doi: 10.1016/0002-9343(92)90149-6.",arterial blood pressure trait,,RS:0000695,Crl:SD,male,660 days to 540 days,8,,CMO:0000004,systolic blood pressure,,,,130,mmHg,7.0,19.799,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled protein content diet (20 %) then perindopril (1 mg/kg/d) (for 120 days),108594,controlled protein content diet (20 %) ,,,perindopril (1 mg/kg/d) (for 120 days),,,,,, 3127,"Markel AL, et al., J Endocrinol. 2007 Dec;195(3):439-50. doi: 10.1677/JOE-07-0254.",arterial blood pressure trait,,RS:0003766,WAG/Nov,male,150 days to 120 days,27,,CMO:0000004,systolic blood pressure,,,,128,mmHg,3.0,15.5885,MMO:0000031,tail cuff plethysmography,,0.0,,,,,ether (for 0.1 hours),108636,ether (for 0.1 hours),,,,,,,,, 3127,"Markel AL, et al., J Endocrinol. 2007 Dec;195(3):439-50. doi: 10.1677/JOE-07-0254.",arterial blood pressure trait,,RS:0001334,ISIAH,male,150 days to 120 days,27,,CMO:0000004,systolic blood pressure,,,,167,mmHg,3.0,15.5885,MMO:0000031,tail cuff plethysmography,,0.0,,,,,ether (for 0.1 hours),108637,ether (for 0.1 hours),,,,,,,,, 3127,"Markel AL, et al., J Endocrinol. 2007 Dec;195(3):439-50. doi: 10.1677/JOE-07-0254.",arterial blood pressure trait,,RS:0003766,WAG/Nov,male,150 days to 120 days,27,,CMO:0000004,systolic blood pressure,,,,137,mmHg,3.0,15.5885,MMO:0000031,tail cuff plethysmography,,0.0,,restraint,30,min,physical restraint in tube type rodent restrainer (for 0.5 hours),108638,physical restraint in tube type rodent restrainer (for 0.5 hours),,,,,,,,, 3127,"Markel AL, et al., J Endocrinol. 2007 Dec;195(3):439-50. doi: 10.1677/JOE-07-0254.",arterial blood pressure trait,,RS:0001334,ISIAH,male,150 days to 120 days,27,,CMO:0000004,systolic blood pressure,,,,198,mmHg,4.0,20.7846,MMO:0000031,tail cuff plethysmography,,0.0,,restraint,30,min,physical restraint in tube type rodent restrainer (for 0.5 hours),108639,physical restraint in tube type rodent restrainer (for 0.5 hours),,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",arterial blood pressure trait,,RS:0000595,MWF/Fub,female,103 days to 100 days,8,,CMO:0000004,systolic blood pressure,,,,156,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,standard diet,109020,standard diet,,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",arterial blood pressure trait,,RS:0000595,MWF/Fub,male,103 days to 100 days,8,,CMO:0000004,systolic blood pressure,,,,165,mmHg,2.0,5.6569,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,standard diet,109021,standard diet,,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",arterial blood pressure trait,,RS:0000595,MWF/Fub,female,103 days to 100 days,8,,CMO:0000004,systolic blood pressure,,,,134,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled sodium chloride content diet (8 %) (for 56 days),109022,controlled sodium chloride content diet (8 %) (for 56 days),,,,,,,,, 3134,"Kreutz R, etal., J Hypertens. 2000 Jun;18(6):777-82. doi: 10.1097/00004872-200018060-00017.",arterial blood pressure trait,,RS:0000595,MWF/Fub,male,103 days to 100 days,8,,CMO:0000004,systolic blood pressure,,,,133,mmHg,3.0,8.4853,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,controlled sodium chloride content diet (8 %) (for 56 days),109023,controlled sodium chloride content diet (8 %) (for 56 days),,,,,,,,, 3136,"Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,253 days to 252 days,5,,CMO:0000004,systolic blood pressure,,,,130,mmHg,2.2361,5.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,cilazapril (15 mg/kg/d) ,109142,cilazapril (15 mg/kg/d) ,,,,,,,,, 3136,"Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,131 days,6,,CMO:0000004,systolic blood pressure,,,,151,mmHg,2.8577,7.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,standard diet,109143,standard diet,,,,,,,,, 3136,"Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,253 days to 252 days,5,,CMO:0000004,systolic blood pressure,,,,170,mmHg,3.5777,8.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,standard diet,109144,standard diet,,,,,,,,, 3136,"Iordache BE, etal., J Am Soc Nephrol. 1994 Dec;5(6):1378-84.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,131 days,6,,CMO:0000004,systolic blood pressure,,,,136,mmHg,2.4495,6.0,MMO:0000031,tail cuff plethysmography,tail,0.0,,,,,cilazapril (15 mg/kg/d) ,109145,cilazapril (15 mg/kg/d) ,,,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",arterial blood pressure trait,,RS:0000731,WKY/NCrl,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,139,mmHg,5.0,15.8114,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),109281,control condition (for 0 hours),,,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",arterial blood pressure trait,,RS:0000744,SHR/FubRkb,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,178,mmHg,2.0,6.3246,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),109282,control condition (for 0 hours),,,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",arterial blood pressure trait,,RS:0000596,MWF/FubRkb,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,146,mmHg,1.0,3.1623,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),109283,control condition (for 0 hours),,,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",arterial blood pressure trait,,RS:0001373,MWF-Chr 6SHR/Rkb,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.6,5.0596,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),109287,control condition (for 0 hours),,,,,,,,, 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",arterial blood pressure trait,,RS:0002073,MWF-Chr 8SHR/Rkb,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,155.9,mmHg,1.9,6.0083,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),109288,control condition (for 0 hours),,,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,112 days,10,,CMO:0000004,systolic blood pressure,,,,126.9,mmHg,4.0,12.6491,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition (10 mg/kg/d) (for 28 days),109407,vehicle control condition (10 mg/kg/d) (for 28 days),,,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",arterial blood pressure trait,,RS:0001011,Crl:WI,male,112 days,10,,CMO:0000004,systolic blood pressure,,,,127.5,mmHg,5.0,15.8114,MMO:0000031,tail cuff plethysmography,,0.0,,,,,finerenone (10 mg/kg/d) (for 28 days),109408,finerenone (10 mg/kg/d) (for 28 days),,,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",arterial blood pressure trait,,RS:0000596,MWF/FubRkb,male,112 days,10,,CMO:0000004,systolic blood pressure,,,,151.5,mmHg,9.0,28.4605,MMO:0000031,tail cuff plethysmography,,0.0,,,,,vehicle control condition (10 mg/kg/d) (for 28 days),109409,vehicle control condition (10 mg/kg/d) (for 28 days),,,,,,,,, 3140,"Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.",arterial blood pressure trait,,RS:0000596,MWF/FubRkb,male,112 days,10,,CMO:0000004,systolic blood pressure,,,,133.9,mmHg,9.0,28.4605,MMO:0000031,tail cuff plethysmography,,0.0,,,,,finerenone (10 mg/kg/d) (for 28 days),109410,finerenone (10 mg/kg/d) (for 28 days),,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,280 days,7,,CMO:0000004,systolic blood pressure,,,,197,mmHg,4.9135,13.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,109522,control condition,,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,350 days,7,,CMO:0000004,systolic blood pressure,,,,206,mmHg,5.6695,15.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,109523,control condition,,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,420 days,7,,CMO:0000004,systolic blood pressure,,,,213,mmHg,4.1576,11.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,109524,control condition,,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,280 days,8,,CMO:0000004,systolic blood pressure,,,,186,mmHg,4.9497,14.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled lisinopril content drinking water (80 mg/l) (for 1 days),109525,controlled lisinopril content drinking water (80 mg/l) (for 1 days),,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,350 days,8,,CMO:0000004,systolic blood pressure,,,,126,mmHg,3.182,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled lisinopril content drinking water (80 mg/l) (for 70 days),109526,controlled lisinopril content drinking water (80 mg/l) (for 70 days),,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,420 days,8,,CMO:0000004,systolic blood pressure,,,,126,mmHg,2.8284,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled lisinopril content drinking water (80 mg/l) (for 140 days),109527,controlled lisinopril content drinking water (80 mg/l) (for 140 days),,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0000742,WKY,male,280 days,4,,CMO:0000004,systolic blood pressure,,,,135,mmHg,3.5,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,109528,control condition,,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0000742,WKY,male,350 days,4,,CMO:0000004,systolic blood pressure,,,,124,mmHg,3.5,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,109529,control condition,,,,,,,,, 3147,"Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.",arterial blood pressure trait,,RS:0000742,WKY,male,420 days,4,,CMO:0000004,systolic blood pressure,,,,136,mmHg,2.5,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,109530,control condition,,,,,,,,, 3162,"Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,140 days,10,,CMO:0000004,systolic blood pressure,,,,150,mmHg,6.6408,21.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,standard diet,109977,standard diet,,,,,,,,, 3162,"Remuzzi A, etal., Am J Kidney Dis. 1999 Oct;34(4):626-32. doi: 10.1016/S0272-6386(99)70385-9.",arterial blood pressure trait,,RS:0004778,MWF/Ztm,male,140 days,7,,CMO:0000004,systolic blood pressure,,,,153,mmHg,5.6695,15.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,standard diet,109978,standard diet,,,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",arterial blood pressure trait,,RS:0000594,MWF,male,140 days to 126 days,7,,CMO:0000004,systolic blood pressure,,,,151,mmHg,3.7796,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,110006,control condition,,,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",arterial blood pressure trait,,RS:0000594,MWF,male,140 days to 126 days,6,,CMO:0000004,systolic blood pressure,,,,146,mmHg,1.633,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,110007,control condition,,,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",arterial blood pressure trait,,RS:0000594,MWF,male,140 days to 126 days,7,,CMO:0000004,systolic blood pressure,,,,150,mmHg,3.5529,9.4,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,110008,control condition,,,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",arterial blood pressure trait,,RS:0000594,MWF,male,146 days to 132 days,7,,CMO:0000004,systolic blood pressure,,,,157,mmHg,5.6317,14.9,MMO:0000031,tail cuff plethysmography,,0.0,,,,,castor oil (for 6 days),110009,castor oil (for 6 days),,,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",arterial blood pressure trait,,RS:0000594,MWF,male,146 days to 132 days,6,,CMO:0000004,systolic blood pressure,,,,145,mmHg,6.1645,15.1,MMO:0000031,tail cuff plethysmography,,0.0,,,,,cyclosporine A (50 mg/kg/d) (for 6 days),110010,cyclosporine A (50 mg/kg/d) (for 6 days),,,,,,,,, 3163,"Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4.",arterial blood pressure trait,,RS:0000594,MWF,male,146 days to 132 days,7,,CMO:0000004,systolic blood pressure,,,,143,mmHg,6.1986,16.4,MMO:0000031,tail cuff plethysmography,,0.0,,,,,cyclosporine A (50 mg/kg/d) (for 6 days) and lacidipine (1 mg/kg/d) (for 6 days),110011,cyclosporine A (50 mg/kg/d) (for 6 days),lacidipine (1 mg/kg/d) (for 6 days),,,,,,,, 3172,"Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y.",arterial blood pressure trait,,RS:0000578,MHS/Gib,male,56 days to 49 days,N/A,,CMO:0000004,systolic blood pressure,,,,168.4,mmHg,1.1,,MMO:0000053,tail cuff piezoplethysmography,,0.0,,,,,control condition,110331,control condition,,,,,,,,, 3172,"Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y.",arterial blood pressure trait,,RS:0000581,MNS/Gib,male,56 days to 49 days,N/A,,CMO:0000004,systolic blood pressure,,,,132.1,mmHg,1.2,,MMO:0000053,tail cuff piezoplethysmography,,0.0,,,,,control condition,110332,control condition,,,,,,,,, 3135,"Ferrandi M, etal., Am J Physiol. 1999 Oct;277(4):H1338-49. doi: 10.1152/ajpheart.1999.277.4.H1338.",arterial blood pressure trait,,RS:0000578,MHS/Gib,male,91 days,N/A,,CMO:0000004,systolic blood pressure,,,,167,mmHg,2.0,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (2.5 g/kg) ,110652,controlled sodium chloride content diet (2.5 g/kg) ,,,,,,,,, 3135,"Ferrandi M, etal., Am J Physiol. 1999 Oct;277(4):H1338-49. doi: 10.1152/ajpheart.1999.277.4.H1338.",arterial blood pressure trait,,RS:0000581,MNS/Gib,male,91 days,N/A,,CMO:0000004,systolic blood pressure,,,,132,mmHg,1.8,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium chloride content diet (2.5 g/kg) ,110653,controlled sodium chloride content diet (2.5 g/kg) ,,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",arterial blood pressure trait,,RS:0001334,ISIAH,male,98 days to 84 days,13,,CMO:0000004,systolic blood pressure,,,,180.72,mmHg,5.03,18.1359,MMO:0000054,tail cuff volume pressure recording,,0.0,,,,,control condition,110681,control condition,,,,,,,,, 3182,"Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21.",arterial blood pressure trait,,RS:0003766,WAG/Nov,male,98 days to 84 days,6,,CMO:0000004,systolic blood pressure,,,,134.58,mmHg,6.28,15.3828,MMO:0000054,tail cuff volume pressure recording,,0.0,,,,,control condition,110682,control condition,,,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",arterial blood pressure trait,,RS:0004946,SD-Myh7bem1Blar+/-,not specified,84 days,N/A,,CMO:0000004,systolic blood pressure,,,,126.6,mmHg,6.7,,MMO:0000076,plethysmography,,0.0,,,,,control condition,110834,control condition,,,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",arterial blood pressure trait,,RS:0004947,SD-Myh7bem1Blar-/-,not specified,84 days,N/A,,CMO:0000004,systolic blood pressure,,,,128,mmHg,7.6,,MMO:0000076,plethysmography,,0.0,,,,,control condition,110835,control condition,,,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",arterial blood pressure trait,,RS:0005005,SD-Myh7bem1Blar+/+,not specified,84 days,N/A,,CMO:0000004,systolic blood pressure,,,,123.8,mmHg,8.2,,MMO:0000076,plethysmography,,0.0,,,,,control condition,110836,control condition,,,,,,,,, 3192,"Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17.",arterial blood pressure trait,,RS:0004947,SD-Myh7bem1Blar-/-,not specified,84 days,N/A,,CMO:0000004,systolic blood pressure,,,,85.2,mmHg,4.7,,MMO:0000076,plethysmography,,0.0,,,,,control condition,110838,control condition,,,,,,,,, 3173,"Parenti P, etal., Hypertension. 1986 Oct;8(10):932-9. doi: 10.1161/01.hyp.8.10.932.",arterial blood pressure trait,,RS:0000577,MHS,male,28 days,11,,CMO:0000004,systolic blood pressure,,,,122,mmHg,7.6,25.2063,MMO:0000053,tail cuff piezoplethysmography,,0.0,,,,,control condition,110941,control condition,,,,,,,,, 3173,"Parenti P, etal., Hypertension. 1986 Oct;8(10):932-9. doi: 10.1161/01.hyp.8.10.932.",arterial blood pressure trait,,RS:0000580,MNS,male,28 days,11,,CMO:0000004,systolic blood pressure,,,,114,mmHg,5.5,18.2414,MMO:0000053,tail cuff piezoplethysmography,,0.0,,,,,control condition,110942,control condition,,,,,,,,,